var title_f36_46_37600="Varus stress test";
var content_f36_46_37600=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Varus stress test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 286px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEeAWIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0f4aXH2r4c+H5/wC/A/8A6MaujrifglP5/wAJPDhIOUidST/10eu1J965rWG9wY/Sm/Whjx/T1pCcUCDNIfSgk/jTT14oAUmm55oJ/Kmk896QCmkpppD1oADxSZ4pCaQn1oACeKaT69qQn3pmcd6ABzmoXPPSnueuajf600BBJx0qJ/apm9RULjNCAgf3qFxU79TUWK0TFYZijFPxSYouALUi+tMXj6ntThUPUY/Oaa2aM+lNJxUDBjUbHFDEGo2NACMfrULtTmNQseppoBHP1qFmz6Urt61Ezc89KpCEc/lXL/ESO+l8Gai+lztDcW6GZyvVohjcP1ro2Oep5piFGfZMoeF/ldD0ZcjI/SrSA5vwDrn9v+ErO6lIN1GDBNjuVCgN9T1q3quprZgKoEkjdAK848FXUnhrxZrHh0P+7nYvCewIG788AD8K7CGKSZjJcNubpyORXNicSqOi3OrD4Z1nd7FP7Kb26NxdY3EgZ9BW/axyZCDaEHygmo7OwSUMrru3H14rWhsEiUR7mAA9M15qk5O8j1uWMVaJHFtVQpU49TVO9XHykZ68/wCFaBt3hJSQ7weQ/qKr3KlRh1zkVqkYyl0RzM8ZJYkkHGM+lS21uhj39l6savG3DS/MM+ntVa7JYi1t+EHMjCqS6kuXQ53WZQ5L42pjp3xXAaxfCTVbaIHCxyB2PoK6vxfqCQFoYXGVU7m7CvMpbp3aUjgyH5j3I9K7MPC8rs5MTP3bLqTSXwMjYUkZOKKoUV23OI/RMBEQLFHHFGOiRoFUfQDgUHrTcgUZPoMfSua4AaaelBPHNITz/SgAP1/GmH/PNLnPemk+lAAeaTPGKQmkJpALSZ9OKTIppNAATSN79aQk+9NIJ57UAITxSE0E4phPUUAI2PyqNqc3emN29aAGN3Hao26U80xj70ICBxUZFTPz2pmOfSqTAjxRjnpTm457UEHv170XAb70pobnmmk0gFPTrTCcUE1Gx6ipGDHFROccZpWNRMff86AGuajduaVjUTt1qhDHaoXbj2p7nmqs0yRAl2x7U1ZbhuK5xWTqN+sYaNCS/Q026vDNkRnanc+tU7a0E0zM5ITPfqa5K2MS92nr5ndRwjfvVPuPPviNZ3Fvcab4lgjO2GVY52HHO4lR+IBr1Kxtor6GG/jJaCeMTDHqcnFP1vRU1rwrqemMF/exbowc4EoHyH8zXP8AwR1Jr7wre6XPkXelSkOD2jYqq/iDuFYcvtKab3X5M6o+5Ustn+h20NsoAZQBx060+bEYyxznjjmrkNsUhODkAd6pXI4Rh6/d9azSsaSm3oV3JmfaxxxwarxSgsyDDEHGe1Mu5SLeWNeGJwD/AHRTNNwCok+RRzj+tarcwkQ6nD9ltneE/Meua4/UtSWGyaO3yZZCe3U11+vpLPC7MwS2HQDqeted6xcJYW81zKBtVPl9c44py0aSGldanA+LJjHcm33bpT80p9D6VztTXc73VzLPKcvIxY1FXq04ckUjzKk+eTYlFLiitLMg/Q6kJ45JqFZ4yMhwDR5qE8OprlugJSf/AKxpueuKiE0eP9YnHvTXnQAHev1NK6AmJ/lTAcg5wMVGs0ZyQ/T1qq9xGshQY5Gd2f0+tJtBYtsxA560buMgZqm067QS64xyM8CmyXUUUTM8qKAOMmjmQ7F3fzmmk8jB69KyZNasIow0t1EoxwAearSeKNKG1VuoznsT1/Sp9pFbsajJ7I3yR19aYW7Gufj8SWUmQHx369TUra9aMB+/TOemaXtYvqHJLsbBIzjoaax4rGbXrEsoeZV3fdyetSrrFqQMzx7umM0/aR7hyvsaJP5imMfpWe2qQEH5hxyeetPi1CF1B3dfejnT6i5WWiaYfbmoRcIcBWH505nBcAHOOaaYWFamn8aUnvTQRg0xCHH0pDikJpCRmmAh60wnPTmhj2GcUx2pDAnk1GxpSfXFMZuDTEIxI/8Ar1Ax7/zpS3PFRM4yfWhAI59ahldUGXYKPemXcxRAI8GVjwPQetVVtsvk5eTuxrOpW5NFudFGg6mrdkEl0HJEA3n17CoGsXl+eQls9d1Xo4gjgEAnPSp5sheOg7VyVJzqbnbTpRp7GO9nGF2sMH2pEjXz9i9BVy4IjQsfwzTLGHLeY/f9axatodS1NGw2LcDaUMkZDNGzBcgHPcjPSvM9h8D/AButWAP9la0EDDgIzNjIyeDtfH513PiLwnbeJ7JYZZGtL+E5tL6MkPA2enUfKc89+OK8J+I2o+LLWWz0TxbJJJcac7TWtw5Jcq5B3K/cHAP4V1YaPO2k990c2JnypabbM9zOvrefFx9Bs5g1pp9sDcFTw0wIVlPrjP6Gr96Slozk5AGFb0NeRfs+3D3fi3WLm6Yy3MsPmNK5yxYvkn6mvS9dv1hsXQHHOaK0FB2MqU3PUq3sgeXajcOfyrRs4vMs2klwrNwD3AHFc1Y3Cyztn5mAMYHsec1vSSEQHDYbHPoKyT1uarUzryOSaN1EpCrwAT1rxHx7qck1+bIZWOPDN7kgV7FqN6lpYzzyNhIwWJJr571S7N9qE9y2f3jZGfSunCw5p8z6EYqfJDlXUqgZIAoYYNXdItWursKBlVBZvyqm3U16SXU8u+omaKSilcZ90rbtjhiPbNM8oklSzfnWq0EitkkMO+RijYMH9383p1r5m8u57nJHsYbxykYXseTuNQywXAwys646AHit82okUnAyO2cVXktFUgAmP1BbNHPLuHsodjBKag27DuF9upqHE8ZOZpd5746V0SWKb9yq5XruLEfpSPbKM7W24HcZH4ntS559w9jDscpNa37/AHbhSnXJfGaqSaRcnO2WZs9cngfTmuvkjmJUR7GB9gBVZlCq+VdZR0AJOfwqXOV9WNU49EcVNpkqLlpTuHqah/sl5QHLuxHG3AxXerbhlTcqs579cfX0qIQSBmK+VheoXBqbsr2cThm0ox5KsTvPQH+VRT2Ho77+gXP6GuymtQr75Vyx6HGAPeqF1pYKO53EjlSP8anVlKmjmG06SQGRQDIoxt3nB/wqKO2j85VlQwnjILnn6c1tx6eUffg7T975+tX5bSJlMYjDBhjnkj8aE31H7JLYy/7MTfm3mnQfxK3/AOup47e5jVv9JJA5Ck9PanSRXWlICv76InAIO5l+o/rW3YWb3EIM5Tc53ZGOnpVpyIdOD3RQhN0VVluSR6txU0VxeAuVIkYdBu/lWj9hCsDGMEc+oNLFAgUvGSJM8gjFaxqzXUzlhqb6GLLrrxfLOCjH16VdtdbRwFY9uetTX9rFcxeXJGpyeSR1+hrlrzRPs0oQvsD/AOqYNw3qD6YrRYmpF73OeeEj0OzjvY5AMEcdaVrmPOQwNcTbW0wLRtKyFTjjnNXGstSjXzI5lcY6cVvDGp7oweEkjqA67S2QVx2pvmB/ucj2rjpp9Ux5cnyfSmE3LY8y6PHAVeCPwFX9cgSsJUZ11xdRw4U5LegFQmfcu52Cr2UVzdvA6AkXBDHr5g5/WrsdkZV3MxkJ/wBrB/Kp+vR7FrBz7mj9oBPXFQyXMakZcAVX/s5FG5omYe0h4/CmOlnG4VoJsAdQCcUvr6/lGsE+rL1vHHK5mkkXd2wc4qeK4geR0G3cvWs6MxEZRGdO5U4P5VeghtGXMaOpPU4rn9vzanUqfKrE32dgdyq2PcdaWUDawIAJ9KEgkBDQXBDjpnkVC04mm+z3H7u8PKH+Fvp7+1aQqczsDg97lWO3N5dhN2ETk1uWunoAoVdwrK0/cskhx82cVsWVxIXXAIFNwcmXGVi15aQvtGD7VgePPCNh430YWF4Vt7tMtbXQUbo25+U+qk4B54xW/chnYY4rC8QaotksfmSCNwc5JxwOtPWnLQir7yPHvhHpdx4X8WeILLV4vLu7eAKpByrfP1U9we1bd7PJrWpfZ4XMdvEf3jjufSjW9el8Q30sNjJGIQ5D3IAJYegPcVNaPbafbiK3Rjt74ySfWtalTnd2ZUqTirGhbafHYxKITz3J6mq13qTM/wBniGCTgmsy91KXBBfy19D1Nc9rJ1mWyf8Ase1JDjmRnw+PYGpS53yo3k1SjeZl/EXxMrQtpFk24NgzSAntn5R/WvOkQu4VRknoKlu4Li3naO7jkjm6kSAg/rXR+Era1kdWILznoowT19K9WlTVONkeRXqub5maXh7SxZadLNLjzHQk+3BrhG617O2j3dxaMqIsYdcLvOP0rg77wJrVsSQkMq5xlJBn8q1dSmly8xjTjLVtHJ0V16/D/WioObMZGcGcUVl7an3NeV9j7fMZBBI3A/5zUkttuy2drY4wa0BAcDBAPoRmoXjlyQVCspyRjsK8NwPZTTKhtwYwSBnuR1qKSBNpzhgO5rUSE4DFxk84ApPJVlLZTOem3qKXKPmsZXlZVc/d6Yz1/GoTComYEYyOYzzn8a1zGqRtjkdlPP5VFFahpGLBhu6eoH1qeUrmM4Kkh8tVCMONuOBVWSxilkYliCpxwcH862jagMwTkj86hFqVJb5Tn+EjpQ4he5gT6e0IbY2QeQM4J+pqs9jJ5JJjMZwMsp/wrpPs6sxE4G0dCRyaR4MHMeQp7VHIO5zRsWfeyRvKPRpMfz7VBLG6ArLEy7h8oDZGfSuoubUv8uCH9R0NRS24VfLPLDpnoaTgUpHI3EKiRVkHX7p7D8KqTwSo4Kg4GeR/hXT3VpkbthyvBBP+eKzpgUTbISI/7w+8Khx1LTKNlJCYypO5+/GCRWzFEpjj8uMcdgawLm38t1mt5NpHduQw9xU9lqAt9kkm7Gdr/wB3H0pLTcT7o6CW2aeNTkIqDIAqu1rh96c4HQ1eV2IDRKGjIypznNTBVKswPy45xxitbXM+axkPECfLdcHHAJrOv9MFxAbdgzBiG4bBBHPB7e9bt1D5YBzu2kYzz1pksZbDDgnjp0qrdCr3Ryl7b4Ull2yD+JeKz4L57acxyNwT1K/p/wDXrqb22w8g5ZNvOev1rlr+MscOn7zdgj1rKatqhJJmhcYkiLjnIyBu5BqnNDC0e90CuBztPNRRsyqAAHYHAxwx9s09ABIXkyjdeTxx2NJu4uWxAsckahmgDxdtzjcPxoWdUc+U5Rz0GMk+2avPLCybmVWJ746VSco8gCQ73z1j+X8eah26BZlmG+V3BZWU9MZxg1chluWzthSVT0UEAtWSInMmTE7EcNuOfyq7DG5/exeZGQeNjAEU4t3BrQ0Pss0km5LYWvHJD5/QUO0tqpDRBlPUqc7vekD3suNrxsCOWAwR9aUMmDmX5gf4TgGtUZ2Ft7tXKxqoRhnGR/Ws/XrOS8tpFaQK6nKMvDKfY1ddmB/eRrj1FRXLlrZ1KjOPqR9DTjLlepVm1oU/Ddw89tIs5BuY22uQMA10VsM4xnPf2rjvDTSW/iC5tpgdrxl0JPU5rsLCQEnPXNdl+qMmrM0yMnJAHFeM/EaObWPGcOnl9tvbQiRtv8e5TxXs166LF8vfj2ryi+iZ/GdzLJtyIYwCB7Uqj5dSoR5k35HPR+HYlhAgdof7oQkD8qbLpGqpGwgmXpxuGa7FbMlAUJz15pjiSAgkA46g1nKq766lxj2OEtbe8gn26lF50bH/AFn9z8O9dPCJI/KJcgH7jK3GK0vLhlBJXK/xAnpVaCBYGaAEGFjmLP8ACfT8auGIu+U5cRh/tFe70y2vphcXltFNcoMK0g3ZHvmmW9nZwvvttPhilB5ZQAR+NaSNuLKxCsvUDr+dQ3hRGWVFbb0YD+dbSd1c47dBm6QOcxkt/tNkCmyxbEJ3MTjPDUvmoVAy2D6806NiSxKAkdzyKlNbDsUPKj/2qKu9ecP+dFPkC59OhR/CuD3z2NNIyc7c9selOwrLtRjx3bvSRHJIBwq9M9RU2Oy5FGm1XDc4OcnrzUoVWAGWJx0NIzmNhvHBPBFDNtmI+deAQMdTRyjvchMYjDZCPnvTMN5QEcinuGqSVWcncytu4Iz2pflGFVipHUgUuUq5WaNlB+Rckcsep96YwYDaFALD5s9TVhyAVTbhAeGFPYsOpyexFS0NMz1hCKS8jHphewp0kRRfMwGXoT3+tWMh+SWVh7U2WURxsz5K4wTjilyjuyuRHj90wbPc9veqdwrqTuAMfoO3vU6Q+VwnzKTkA02VMniY57ocY+lTyml0tinPEkwYxscgc46n61kXtovkkuoAH8S9R6VqTWchUtE6KfY1nyRq5AnifzO7jp7VDgUpGH9lCwsw3SEnkj+tZ1xaOiPjeqsN20dPrXSyKVHlzxE9wyjjFVJocgMoOM4xWbiXcpeHtRMK/ZriTHl9M9x7V0dtOJC/OQPSuR1C2LKZVAZk+YMOp+taehXYWMMrbkb5c/3T6GlF8rt0JlG+qOhMecA5Oef8KUgBMYAJ446Zpsb5Oc429aieRn4GBzkn/PetyNSrcR5YqRk+tc/q1qvmsM4VvmbHSuqQpiTAw3XJrGvYGYSFASQ/HsKicXYd+5gRQ/aWxtO4DO9erGo3QhjHKyEk5O3tj1qeyVY71pGyEbKsPQ1evbBbpS67cqPlOeawSKbM9LJpMMZNyg4wPvVLJbLESqR7j39j70qTPbvDBIAhfOGHQ461JdOd2wyNs65A5JosD7EKs8agxxgL0Kt1qN08v995KxA8lx0FQkiVyJjIrjhcD9aDC5ZA7ZPcE0WugLMkQYAq+GxkEn9RVWWJiQNshPTdJ/8AWoktZIELREtHnlVOcUommGColKf7vA+tFn1FoJGb+3ba0McsJ7N3qxZyq7bE3qQMGKTHA/wqLaspChwjnnDHrUotLZxsmZosjBK+tFuw7orTWa22u2N3bkiNm2Ov61txMI2EifMwbnHcVi38MluYWed5YUkBRwBkcdG9BWuYGgkKur+RIAcqM44rqovSxLSvqWbu6Z1w6qAeVY964fUdsXiETFtnmRgBvoK6i6jVIyqyiROxJ+YVymtlvt9q4ADDIyfTFGKT5b+hpS5baFlLtWjyRkjrTmlV4yJDn37UxYEjfh0LnnOeT7CkDoJMSsE9m4Irm16i06EdxEI2V4mI919Kr3irInBBbGR7H1FXsCZMK6gjgj1+lVp4SoDRgccDJ609egaNajIpLeWJZMrz8rAddw7mp3ERjxnJxxmspEX7RNGxCvgNsJwp7kitSBFdEZWGCM8V3U5cyPKqx5JWKkM0ZBUqS6nBUdjQ8qhgEjH0PWpXghW4cuPvjcQvrViG0LIVWIgd93H5VSi3ojNtIrebJ/dNFXf7Kz3T/vqiqtPsK6Pftn7sj+tKjMD5hDMpGCMYrOvrw2kTy/eDHAWsaY3Ulu0huGD4yADwKyc7HpQpuZ2NyuU45Ixhe9RO6sFTJDZyD6GuZs9f2KqXiuGA4kTkn8BWjHfRTZaNlIPBBOD9a0jJS1RnZx3NNpGIf5mXAHy7anwWJ2ffxg8dfes23uCVYYKhT8pPJYVZaTKlu+cFQ3IFW0F+xOAGDcYYfrUDSSRglV3qOueKVmD4UMcfXvSBxIxGduOMHjNZuIDBIJACq8d8mklUkBXYbT9046VWc7pCBIqjPAHr3qRXzkYPHrSsUN2PEAxfLLwP9qoLvaw3kfKRg1O5kdCCo5HXPQ+1Z97cshSONNzt/DUtFxu2IH3OdrqE6HccZqF0WT5XO1hyuD1p0UQVSpX5WPU84NPbAOEw2BwfSpsX10KM8TMPmcMPT3rPeLcpCnLqfuk4zWpcbhHuxkD0HSqzoZWDLgEDrjrUSiWmYs8WJsxgq6/MwPQ+1VLRWguiwQGFh8wz0PrWzdQMjB2b3PGapPG8cx5Cv6YyGrJxKTuaVs4lO8ODxgHtVh2yAQoBHHB61mWTohLKAI+m30PerSvtKsD3OTjtTiyWiwCHi3vwndfT8apykrKccqTn8Ks7zvGza0f5ZqGTgkDAI4B9veqexDMWeLdOSuA+cn3FSmYbVRiu7PKqealvVYmJ9oXDjPuvcVVkBVt0apnPcYIrJrXQZHqNvG0IONjAhgD/AI1VimEpMcpKgscPjoa0LoLNblnbBA649KyVBWRW8tmB5J3cfXFNx6iTJo4zCNs7LIvXJwM/j2q00UN0iFCqkfxK2cVH9oZk2+SGI4yRwaktIlYB4V8t/wCJW4z9KlIGJ9neLhF3j61SnXc3EYQdCd/Aray8RzHtZT1UnpUbyKWO+IR+uE8zP4VVhXMCSbCBXhkcKeGRe1C3pMWSd8fTDDDL+HetRw8cn7qVFyOjDH6VnXpkZs+SjYHzFcdKnlsVcZ9sC2lwkZDKR/qm65/vD1rtbMpd6PC45YJ/hXm09uyo7WRyrcsDyyH1B9Pauq8E3/n+FoGkOLhCySL0xzx+lXQk4zJqR5lcddQylcm2kOTwCMZrl9WJF9bl4iu3PGOnFemRXE0qxB8HqBx0FcZ4ltx/akEGRuYs2c+1dWI5XBomnJp6ox5ItibyjzEn5iBjbSvDaTb0ZSG/EnPtUv2SWM/LMRk+vT8O9TyW9tuhS4uVScnCKV27z/vdj7VhHDzl0FLFQjpe5kz2cWcrcvCQPu7c5pkEVx8p3SNHnA+TIP41uPbFEKrErP0wTu/Wql7DKs5inm3ScELF8oUfhW6wV+pzvGvoig2mTvexTxhY3QMNpOeCMVbt9OljARm2n09RVTWrbW7mz8jQVjG8gSzSSglR3wD3rY0+2MNtbWyM0rxKAzM2ST9a6oUIwRy1Krm7sdFbJFu2Y3J3IzVmUbFc9B054qwsZ3BuFLDkY3CmypGxlhLcYzz1zV9TNGX5w/vN/wB80VbzjjA4/wBiilaQ7He+JZzHNboeRuwcetWluIjYMoHzcfjVTxHFJcWZCoWkUfu2x1PHWsjSNQ+0Wy8cg7XU9VP+RXLGz0PbpaIsy7476GZAdnQj1q7q1unl7kXy3blSODSQJiYGQZUcgVanX7XcZlLYA4qeWyaHa0kzOt3vIMNHKWPUA8itDTtZjkzHcJ5T/wB7jk+1OEQSIlc5A4FUrm0WSSERIUkY9e/40k5x2YpRjLdHQRSRum0TAjr15FWYnHDSLkZxurlo4GRTwQynG5eoNXoru6TgvvTGMHrVe0XVGMqb6GrdxIPmQDJPJFM+ZCAw9+e1Zq3T7D5qu/fjtUL6qiHaxz7+1HNF7MVpLQ2A2MsWJB4xmqDyJ5+5gd394HrVI6khVgP3hzkBaptqLO+3ynBU5GOhouhpM1pH3lirZyehpkLOGIOFYHnA4IrLbUtzbZBtTHpU8WoxylURwSfSna5S0L0zEsAjZyegqo0wglb903J5XNTpMuecZ9qhn2u4dG6DnPSpsUmR3ZO1ZkIKjquO3pTCkcluXQfe+7u9atoIfLABIPf3+tRxKhYpJzjlfpUuA+YyntvIZduOOen51O+7ywQQVOcrirF+m51CsPTmolRghjJxjqBUclmO9yHgKpXOfQ9qjvMq0ckTYJ++p7ih2khuPLZS0ZGf92o1bzLeLoRj86i3Qb7iyyFmjI5UHcCfWqmoAOxcH5epx1pJH3TGNc88/Ss+8ulRQWBVkyCfUUepkPhuFcbbgspIwOfyoEgUCPJYdiDx+VVlPnRAw4JPOD3pFWWQtEkeJF+bj7w+lFn0GbcBQsjQsJI2GcHtS3MhSMExiTuTxkD2qhZz7JVEiHy5D8g9G9B+FaHm2iKOje7dVoQmrFNJLeZiEkMTdcMDk/jTTFMrEQXW0HkEnn6Zq+IEmUssSAeueP51UuNPj/iby265BGKLBczpW2uftcYkJ5EvH603duTfbzRggcIy53U6UQRuQ7oeMZwcCs+5it8f6LOgYdgD+dTyt7A5pbsguTLkyQIYJv4h1DflVPTtY/si6eS7jP2SVgWdeivjAOPSrDRXG5QtxKyd1Tv9akNoCDBKsbxTfIVIOef6URoTlLRB9YpxWrudjD4giu7eNtMiNwx5BVePrWU8dzJdGW9iUO3IYjH5VLZTNptslrp7/ZoE4EcfAz3Pf0qO9upLg+bczu2ABnI7V6cKXKtbHnVKzm7LYpTyJJMqKrYUnew4xUU1pFqtm1tdoQwOVkHDK395T2PFXkla4DExosf8IPb6VMI41IiRTs/vHqa1MB1ntikG/Aj2bOeTnpnPrXNzysZpbngM5KqPQdM10MmVj5PKsDs9frXPTL59+Y0GFU7nx/KrgklcTL2lq2AApBbJYnvV63yJ1EeEjyQX64HpVOU/Z4cKzLnqqnkipNPl83cR8kWOCOp+tPkdriuXwgQNgyEZ42vjFMUKQSyfMeQWOTUgCHOSMdyaXdGGIUdBnPap5R3Gbn9aKdvb/nkv5UUcjHoemyMlxaSQs4DgbWU9c1wutaTeWepPqWnKX2jFxCP4vQgeuK76RUk+RByDktTJbdDEHjAPZsHOa4LdUepCfKcfpOpw3kfmxSDA6gnlT6GujtZI2iJyM/zrmNX8NRrMZ7GdraUn76gEA/TpzVaO91DTz5WoQ4fPEsZLKw9c1UZ82+5s7SWh1Uu9HJiO7sBTYY2R3lmIMz8EnsPSszTNYjllCPn1FdBAUlXeCGJ6VaBtpEQCAFcYH9al8hWRSVHtUmwdMdelWIw5UcZx1yKHBMjmscx4p8R6Z4Os4b3WjItjcSCEyIudjE8E8Hjg/lV57eG4gSeCWOa3lXMcsZBVx6g+nFcf+0vArfBvUZCBuW6tiOP9th/Wvnv4T/FfU/BEq2VyGvtBkcGS2djmLkZaPng4zx0qvqinC63MfrShUs9j6fuFaIk/eXtSpNlckKPQGpdH1bSvEmjR6notwt1ZSLyw+9Gf7rDHBGOlMaED7uDwcVxSpcrO6M1JXLcUqsgLKM9+KSeCGaMnaCew6VAiSFAQoA9CalEyx/u1GTgHNRYTRRuIHgXdbsSP7hqJLpVIEm6JhztP9KvXBZF4IOACPfNJGkbRgPGrcYyetUpyj5hyJlaO4RyZmYO3161K9zBhd7x4HIyapLaLDKTtxn5sE4De1TTW8ZcQtHvT+tX7V22F7PzG3mp2u9VFynHbNV/7Rh34hmyx5zU09hDEx+QkAcZTj6ZrLNshBK7Bz0B5rOVSa6DVNdyRtatvMVpJkVkydpPXIxkVSOr2yriKZCh5Xnp7U2S1jWYRiFQX9eo+lVRZjzWVYCcHrt7Vk6suxfs0LPqcZdHtmbeDkgdWpkuovMyj7O27P3cdaumzZEHyBQe5ABogslWYK/3mySe6+lL2s1sifYxZlvNdxIyLAGQnKDnKk9abvvQVdo0O3pgnitq5tkUBYwdxPJHJqC4gMUDHeDtPQnk/hU8027DcIpXM6Jpg3mFvnY5x7+tXJJruVxvmO5v7tWRbZ4HJVvSphB8hfHLISOOlepCgkjx515Se5Qt9PZ2UebJ5jnHXpT73TRFMsRzLt5YqSf61rWUebqHdwDIu72FRzR/6ROV+Zd5AIPvWip+Rk5t9TPj+0quA7Dn5VIGBTp/tEkbNK6vKo6gVcERDA4A696Ioh5U+TzjOfxq1TJ5ipDDJ5oB24xnFUoUCSxSHIkCsqk/WtkbQyFlLDp+NZV4rRzZVcJGpZQe/NWkhXJnISNYsksc/d6k1AbdppkQRlBHyxPerVvEkUBkZS8rKTzwBViIIlvHJsIV+DnrmqURNlbACNGFwjH8GHrTjnyUdVPAyR7etLtYFv4ecK3oKkkZFG88ow+YelD7AY3iEXzxQR6VcCCVmAmdjgeX3/GsufVbSwWO0s3Se6HUg559TWV4s1O5l1GWC3fbawqQ6qTl3zwM/Sn+HdNMFpGZsvcsSzNtBbnoK3UFFJy1JvfQ0rbzrq4LXDMzMMYP07Vv2MaxQ7I9xfuvc0yxt1hGfKAY5+91qx5jltiIOnU8UXb1YEzsior9CpztPrUaPtGSD8p3/AE9qURSksWfO4YwR0+nrUMYypYDp1BPFQ0gLe8nncaKq+VcHkebj2SilYD1u62WhlZRhWXIOc4NI85iiVEwccbwODmob1hO+RyqrnHY0kUu+OInaIQcEdhXBbU9McIo5lliIOMZ+tZptk27JxuQfKM1rLtA35wrHHB6elJJEjCZD2XIPrUSj1KjM5y50OOZXVRtkXlSDjNVbeW706Qo43IO2O1dDCWVoC2SCNufSoriMTBg/OR8jDjn0qoz6SKfkLp14s8fnK249x6VqW12JVwMY74ri7lvsEonU7Yi2HA6fWr63UsRBiGVI3DArZK+wtXuZ/wAe4Tc/CTXkYgKio/I/u7z/AEr5k/4RJfCGjeEPFur2q6npOpkm5tT2jPQA44JG7B9QK+o/EMI8QaBd6XPIoS4xuJHGBnj9aoa74btNZ8Ft4ZmUJaraeTCw/gdAxUj/AIFitY1OVWMJ0m3c5vTPAGlaFe2uufDrVbmyt54xIYJm+1RXkZ7DIG3v82TXdwNuwSozxkfhXln7P2sXQj1LwTrgMOpaS7GNHGG2AkMg78M2enQivV2jwQw69DzWFZO+p00JR5dEBZY0YgnJPzd+Paqx2ZLv8ueAvf2p33XySCemOgqPcWnYqoYAfeb29K5rJHQpBcRnyo2BLFDwMY5qKAJO8iTFwCeccfrUssjKkbctk8gelPL7IcsBkHjPp6moauUiO7HlxEK2WxgAjJz7VWjiZ3yCQR056Ut0xLeaTjy+g7g/WhJDHERGOfvj3+tTuUMnR5mEMjts6kD1pBaQQAurFT0IIzmp0Kkc5SQ4yCc4zSN+7bbnd1we5pqIrXK/kby/lqCw6ZPWqxa4RhGyB5OmFPP4+lWHudjR7uN5xkevpSxv+9dvuk8uR976ZpummK7RE1pPPJgyKCeGY8gD0AqvKptl3WpDk5Uswz+PvUlzexR23LgGMF2/A9Kz4J5pAoVRvc5HoBS9ihczJJIWREWPPnZ3FifvZ/lU13Astm7SY4C4HQrz696WORbVgmfNZycnqB9KXUJY5IHjc7WAGfXj3pxp2ZMpNrUJJOCVUDdSRkG3jOf4COvvUBcyRxvGu7cmeOM1k3+uT6bEqS6PPJEx+WVZl2g+mK9ZQvseFc3kyWODzxjHagMyq2Fxz61zug67eapO3lWYitU/1jnBPsBXReflcKuQfXtVcjWgrjzyACyqfzpgSMB2c545wcDrTkuU8llNpl1/i3DB/CpBqT5UJBbjd1V492KLBcZHtM8YC4TdjHWsWZt0IZwWkcMjHPHXt6VtfaXmuC8ixhmfoi7QPwqnqcluNOghhgdJ1fDMXBVuc9KaQiOYOUiQEKuB+I9KfK4wYgCRgE88KBSrAVAMzhnUZ8sN0qF7lYmKCN3cjJUAgfn0oS7AW54Uj8osWkEsSyrjoAe31rF1u5ZUkhhwWkU8D+EVM0txdoI3P2dFJ2gdcY6ZqpcW8YjRIpD83Lk8kj60Rsutwucpougka5eXUrtJbmQSbGbq+OGz6D0rsbS38veXZFz1YnFEUIiCYwEPBPauY+IMUzWME9u02A4R1Tpgk9sc1pGLnK7Fc61XhcHy7hJQDglGDgfiKmVkCAOWIyR9K4n4drPapew3Fu0Vq21kbbg56+ldjuymwDJxnHr70PsBZV08tWUMGHBOcgVWRthKMR024ptrJalmS8keFCO3Ofyq6JrGAkx28kzD+NpBjP0qWguVfPlHAdv++qKu/wBrOOlrZ490H+NFFl2Hc7pZiI2ycHqQe1JbzLgQE/I55PYDvVbUt1tKkwH7sn5v/r06BVkeTcMxFcKD15Febrseq9rl+OXbIIfvFemOmKlklVe+G5xn3rHgeSOUBSwAPB/oalu5nkBPKhTwPQ//AF6OhNtS4WbEceRuHOexpszjywU5GMkHqKiW4DxK653gYI9/SollWaQEjBzg0rDTKGpKs9pOmP8AWqdo9KtWjxpaRE8kqFP4DFRXL+VqSBxkKpOO1NtAwhjAwd7nH506bszVJSROIBLvdEUAY7cmrdrbZXdI2SD071dgt1jQJnpy/pmpRGrLu281ruzO6Wh4R8cbG78H+MNE+IuhrnZKsV7GoO1mGCd3bDZx9cV6ha30Op6ZaahYSrJZ3MSyRlTnqBnOPfNXfFWnW2teHdU0fUButb2Ao/GSpHzKR7hgp/CvGfgfrFzpV/rPgTXJWW7sGd7TzD1VdxZB7klSOe/tTn70fNfkTB8k/J/merxHzmbGMdDTp8MypnYq4yV649KIHXzAyqOtIF2yiQozSMxC+vPpXJudexNGu0lx06LGOo/+tVF2lbcJcbR+7Cr0/wD11eadYyQy4JyhB9R1qtAEikM20FVHyp6UcvQpMieMAxrI/wAmf3gWow2yJ2HBIJ/LpVWaZowd5zubJPpVdpC+Sr4AG4HNFki1qaQuYRGGfbuZcEen/wBeqE98DjYxwoI3A8jIrOvZvLTcj46ZyfWueW/aObbK5ClznnqO1N2Gjoo9RVLshiHKRgAnsfWlfVJIYJJYwDJjIHbPv7VzPnbNRkc5O45Qf57VI95/q2Uk7Tz6EYoTE7E+ozkxGHzSyKC8r55L9vwq6t8kcUaJjcUC7V69O9ce9y11qcyR7xEnAPYP2NaOmXJRnIXAfgSP3I71KeugNaHXK4t7dCqgycnnsB1NRwT/AGm1YjB3k4Y9dvrWMl00kpLS5ypTJP4HH1qA3bvblEkaKOImIBepAp3sQ4m9a3KzQRtGcBD5ZHoaezJIrxTfNC/3kHGPce9c9o0xhglgRduf32T19MVqNPJLl23H69q9Wi+aCZ4laPJNxLOiW0On2f2YS5JYnce/PAq+ZNox1/nWRuw2WUEYzkVcmEaFVCBsqCd1aWMiaJiZXPKp0IzT94V1bHRsY9apw5LMAgGR27+1TSEFC+SAoyAe9KwEy8zHjO0beT3rP14zTJPFYgGYEFHbkA4/i9attbxTBmYguDwx9Kr3WyMTkHhVzn396a3AzVsZ7HZfLczXV0y4lBOU+gFattqLXlqAkgKgncnofQ03TZPNtxHxjrk1Rvke1nkmtAUOAGA/jpNcz0DY0JIvk3BSV5+map28TyTzIDlUhyfQDNX59Qt5rS0t41CoEErg/wATHjJ96qC4wAuz/eJqVGW420TpDGVEZJ/DoKSS1NxCSgO1CCW9COlOiuTyo5A9P61dsrxZZJ7fhWeMy4HfYOaeqFoUWhYfeZmBAy1OSMYTB553Y9O1SNcrKIiMjrke1WPtNhEA0VqZsDlpe5/Cj3gMqRFKkqrFk+/tHOKPKbOSuQf71ab6lcSRslrthif70UPcehzVZkSQYeHDEZxJ/TFPmsBS+xn+8PzoqfYv/PJKKLsDvLmVprKa3ZT935SRTdNb7RbCRj85+XI9RwKaCCrS7iV9/SorcjD+XlWPavMPVexO5ZSAf9cmTx6UNOpbz8ZjYYPuaguZCjwyPypyGYHtVcTLEk0BOSD5qN6hugp9RFi2k2TSo/QuTx/KnTSYRH7rzgd/aqW8AqW+8D1p802YTuOCB1xSsMk1SdYytxkBVT5varvhg77GGdlw2W2A98nrXMvIt/dQaezEo6lnOOSgPIrsEPkIojXhRtUYxgDihLUtLQutcHeYxzjliO5qQShkxg5rNSTD8Dryc1almKx7sDJ4xW8WZyjYrXzI25ew614h8ddLuNM1XSfHukqou7OZY7sLwXIORIcdudp+or1++nw/I5xisvUrSDVNOudOvuLa7QxSZ5wCQc/pWanyyuW4c0bDdD1e01rQ7XV7IhobqMOD0AYAbx+BJBp8d6xAZl2sxI2g5GK84+Emm6/4eh1fQ9TjU6THLvtZTICQTknA9G4z6HNehhDGAW+dcZziolFRlZGlO8o3e5baVVZmB5XAGfSq11cAupH3WYsfy/lVVwsjCRyV8sknnhs9Kju5AsSkkBzwq+gqLGqewyY5HlnO3q319KznupYrhIXKkA5Yg9vSpJruKPenmZk3bs4rHuZttzHtyxKkkkY70rFXJNUnAlVhIBvyOeh9qwYLkRvNNKP3inYq9cU+5kTE6SNlUOR/s56msue5USJFGCwcDkjkn1qXpqCZpxytK8buMKh3HPcdMUl0VluVhgzsk5kHcD2rLuLiURpGATIzFQxGO3pVRUntrMs0h8/qTR5CubM/lRzMIyBvXaCP4vf61Hb6pEDJgEt91jjoRXP3M0u0TSMFA4U56e9R2cqRcROpzyzbgcntUu99Aujo5dRMU0jxI37xVVQ3GOxxUwDJbi2z/rOS2efxrn5rkIuWZWZsYw2cUHWY7ZtrOZpRwTnAHtTSfYHNHR2+oWsU9vDD80h4l3H7q+hraiuAE2gEN3PY150t1uTfIqK8zYO1uf8APFdJpOqte2ouoAS6na6kdT6iu7B1PsM83G09edHSJqKOvlyZyP0q215G0Crvb5M9B1rn1u1kjO9FJPTHY0sF2YxtkUlc8NjFd9jzzooZoWt0nWSTdvKspXGB6/jUjXCjK5yWGBmuchvVTz4mXbHIBhs55HNTJfRyCPeCGY/MPSiwG+NsiNnI2/h+NROqCQgMAr988/lWTHfRoXVySVTkE4P5VDYa3ZXNwgsrgPIp27CM4ppA9DQ0/etmzrIW2uwIPHGa0N0U8Q3MSehOO1ZMN01sZVULIrHOB29aWPUkQ4NqMnnHmUOLFck1axlEyyQsCVUKO2QOcVHaXomcBgFlx86k96snV2fB8hQFOcF+tZuo3CTXO82XlsnO8P8A0pqLe4N2NNXZGII5I4I6A1PaXzRTQzFSQHAcqMnZn5qwL3UJbWNZo7PzlI3SKspyAO4/wqXTNVa4USRwK9tL0cPyremKHHTUFubU0iefKYgGRnZgfQHoDSQzRoo3KSw5P0rnhqkF005sbsuYWCuoj+XOcHnvigSzNuzLkY4+Wjl7gXPEp1Ca2aTR7zynA5iIA3fSq3hFp30JHuHk+0O+9g/XjIqu5mkj3NKd/YgbajV3VRhyFHAwelD2SGdL570Vy/mN/f8A/HqKj2aHc9fsJB5NxGTkY3cj9KZAfKwrn515Df0qhE5hvArZ2zMG/pirkozLjsf515SPXZM8ySxndjOCGXt9ax5JFRlQknJxu9u1W3ZGiPHz9CDWUpBv0yTsQZ59+34UmCWpeuJA92URsKEC1Sv7qTzYbe0XzbmQ4CZ6D1NUbm9W1+0Sj53LFY1X+M+3510XgrRXR2uLwDz2XDnB9+KL62LUbK7LHh3RTpyPNO++5nOWY9uOg9BW6wcADcPqRVi4gzGRu+70NQiDK/vXKqB3q1HXUbehA0yRHDtnPf0qhdXLM5ZT8oHFN1SVW+SAcevrWU8N1K3BwnpjpWl0iVFvUbd3zgHpntnnmqebq6TdIQATxgdavf2cwIZ1yex9PepnjWFc54Xt61my0iG23RKvn5OOgJzxUtxKEQqchH+bPpiluruG2VZ5SAh61zN/qj6lK62wO3+eKh6FIt/2gkgkAP8AEcKe9ZxcXFx99lbPOelH2FyiSXLlFU8kHpVG/vPMn8rTypVRgynofaps1uPmQTqloZHc5L9qypbqW5kcD5YlIy3fFEt7slyTvI6lvWsOfUJJHa2sYmnlZuFX19TSSb0RE6qirsluJ4xDudtpLEHPcZ9Kk0jStQ1N8QQn5Sdjngbe3aul8O+DN0SXGtSh52BxCM4X612sCRW8aRxr5YUBcA1208vlLWWh5dXMukDgrTwfqkvzSEAFsBjzk/St1PAAlj3T3ZLkbcYIrpRdLGSUc8ccUw3LMT8xHfmt1gILc53jasupzQ8E2KKIpw7heCCx5FWR4V0kRBY7cKB2zzW4ziTGSS3rTHVsYLL7HHNS8HDsJYiT3ZyM3hnTHnw0TAAngHFM/wCEI0yYEBXKk54YgmtrUQ8Mgc52njIptpe7HwTj+tc7w6i7NGyqtq9zFl8BW+0+Srbh6t2/Ks248G3Nq4bT5Xjcf8s2JIr0aOXeBtYcDPNRXJLA5OTR9XS1Qe1lseeXdrcWeDIo99q96h+2Eg7gGB9CO1ddenerA9DWBPpEN2HNq621zjA3AlD9QK6YVre7Iya7GBrGrxWFusk8UjoeCFGcGq2m6rFfjfbCXAOMMhGPrW1H4e1ONdrnz890yFP4Vl6zY65axK2nWx88MTJGw+WRMdB75rdSTWhNzUnuoGNvcjJkC7ZQR94+tZdhDZ2dxJ9liCF8ncOCT9azZdTv7EQG40u4kDD95yPlPqOOlagubaZcSQyK2MqwIAU0kxm5byW8pTzZGh9WHOD+FbD6DLIA9tewzZ7ZCk1ydtfQRyxiYkRSHGB/e7GrxSGOfCkxSNyGJBDGrWojck0S/hjdyIvLHUlxxVBluEB2sHUfLgjrUSTTdGdHU9VYZ/GrNv8AaLmaOFTCC7feK8CnqtxXIkuQ+wvG0eAVJQ4z+XaqF5pcsxkbS7lIY7ggTRgYG3oSn90+/rVyctbzzIyM+DjzEOFP4VCssf2bYiMkqNgKevNO7WgJFi00yGzi8i2iCQqOo6sfU+poaGQLgMPywaqpdzRv97Cr/e55qpq+tatbSRmx0yO8icZJwMhsc9e3tSQ7di6/nRSfeDLnBGKrsyqM9AOR60uia5NfRP8A2npzWcwOVUYww/CrxezcLwmSeCR1oEZ+5T/corR8m19EoqP63RVzvZZ/MmVunlnAPo1XC+UJHccf1rmoNWhaYyFs4GcetTpqKAlmJVDwjeua8hNHsNMs3NxuHA/eAjB+nrWV9oMj7uPlYkjsPWmx3m6V2zx2BrPtSdQ1HyrfJhcgMV7nPI/DvUSlZXNYRuzc8O2x1HVRdNGSiN+544znr+Veo21tHBaqkXAQDLDvWZoWmx2NuobZvA6jGB7VrfalCY3AE/ka1pwe7HOS2iV5wSCwPSq0uo7gttGMMeuOppl5MYJGAI2t0Oe9Y95evER5RCY+8x61bdiUuZ6luaIIxyAh70ySZVVdoAUcH61hy6ssbNy0jkcfWoHuJZh5jkjtj1qbdjR6bmrfakI1wmCcYHrWBd31xIDtXaF796jmdkkyOZD0U0QwNIv70MSOee1S9WQpaaFKWO7vyDK2F6D0NSu9vpduBt3S9gOpNJeamkGIYeWXjcvasJpRcMXkcrGThnbr9Kzk7PQq9tyS4u7vUX2qAoH3vQfWqV9cJFZmK3K7VHzy/wAQqPWdSgtovKt22xDqe5qzoHhSbWraPUNUjni0sYKxKOWIPVueBxWlKlKrLlic1fERoxvIxdO03VfEMscdjCYbVuPPYHpzyv5V3uieErbRocRMzSHG6RhyTXTQy2zRKkHlKoAUEADHHsKsAAqP3sJ9t3Jr26GFhRXmeDWxNSs9TIWymBBLEfSl+yYzulcitUhOdwl+gHFLviAwqEn3FdGhhqZSQZAxuamyKy/wtmtQFWbYYlwRTzGjDa6qV9Kl2HqYrysBt8tvTNMZpHGBuHpWyYYsY4yfWq81mrBSjfj6VLRaZjyxF0IbOD1zWFcI0DEgnaDwR1rqXhYNgLn6dDWZf25IYEdeB7VjOKe5rCViDT744CPjP6GtYSbkByB9K5IlreXD7th5BH8JrYsrw/KjHk/rWSj0NWx2oR/KGGeawpJGRyVJ3CullAdCuQfY9RXLajuguguevSoqU7ocZGzpt6CQynnPNdJGLa8t3huY0ZHGCQOR7ivPIZisnmQsAR1GetdPpV8JUHXPQjuKzgmnqDOQ8UW+p6BfCI3Ms1k5/cSuAQwz0OO/NYs+pLMVM9jbKw6tEDlvc57167cwWmoWT215GssDjoRkg+orzHxj4ebQbhJbdnl0+X7jkD5DnG010q7POre0ovmg9PyKCy2juRvcKegbtV+2lDqykpIUXI3HhhXMMRjP4io2ftuIH1NWo2M446X2lc7m3aNoopIpRCx6huo9vpUyTvsKrKpbsB2rmLPxHNa26RGFJNnRiTT5/GGok4jhj245FGvU6Viqb6nUh7iaMRwHc38RNJcRXckS5jyfXvxXKW3jC7jk3T2EUwzkruYZ/Kr3/Ccx4ONHWHIOCjMcH15p210LWIpvqazLLtJaBCVGS3bHvWXFqK3MeLdUNvHKxyP4X74rN1jxWdTsTZzJMsBIZgq43EVjaRqNvpeoGdLeRo3G2SI5w47UWVivbQ7o6uW9dEXY7Ebcgeh9Kge5fyyWaQY6e1Zs/i61UfJpJkPq2RWVe+K7uVwbLT4oVHXcTQ7dx+2j3R04vo8chs/WiuJ/4SDWPWKipuu7F7ePdHtMvh+5jBMDqExjBIqve6fqXkqvkjy4+mHzXo5hDkvs+VuBxUN1bArh9289EU4r5iz2ufSc55UY70AqIZA79/Sun8M3EGlxAk4mJJZiP5Ct1rSd8EFUQeo/rWcbI3MjRxW5ZAeXI6nvz6UoycWXzJmuni9Y8J5bhT04JyPXrUa+J03Eusm32UnFUE0QqQxBxjbyaryeGwXbbM+AOcMSBW6xEuxK5TSvfEcSZeR3OeNm3J/KucudfmvJljXCZyOvarkPhme6QyPLhM8MVOT+lNk8GktmOXBPTqf6VTxLfTQashdPZAGMhyc8Me1aZkOweXg++azz4SvUXEV0PoR3pZNG1K3jKNcxl/QLVLEx7C5b9TQs4UZzJIwJXnr0rN1TUfNdorNtqZwznr9BTP7Jv1Ta74J7DvUUWiXJjKbN7scghsYFQ8QnoU12M94kWIySMRGO/d6z7mYrAZJOEHCpjp/9euiuPDtzLGC0i7l6Ju6VFF4cnmZMkM2enYe9R7SN12Ia003KPh7RrQ3UN/qrJJjmK34wp9Tx39O1d9a3WWGyZVXH+rHTH0rB/wCEeeNG3yK564AxTotEmkOfMKMOB9PevSp5hTpR5YRseZUwM6suaTudC9vp90GKO0Mvqq8E/wBKruk9qf3i717Njis+LTrlQAlyuenAzVhrO8KMJLlin93B5+lN5nF9xLL5InTWIQVVt2884UZ6VbXULcgEBVJ7McVlR6IWHmFyCOmBipk8PwSYd2lZh6seKlZn5DeXeZoC6iI3CRBk9+MUNJGc7JN5J61SGi2wGxvMbHP3+9L/AGTEDhPMRD1+Y5/Oq/tNdUxf2e+5aBLjOQR3C84pw2hMscoOPSq8emBctHJIo9mPP1pJNLUqWLyY/wB40f2nHsw/s59x7PGM4JGehPFVLwxLESSD2OOaSfTQ6KJHZVHffVabTowP3Zkbb0+ak80h/Kx/2bL+Yw9WjTBIY8e3FZtncmKQo4WSMHAGcFa6C4sUK7PnLk84yazn0K3R2ZRIzYzw5IBqHmUL7Mv+z5dWi4JmRQSoKEdQc4rK8QW5mtA8fDx5YN3xWhHpKq+12lVME/fI5qvdWKr/AByBewyTmq/tOnbZi+oTXVHM2bl1EmOO49KtQagYLhXGdhOGA9KkfRdsgWOcqScngmlHht5CR9rC9zlTUf2hSe9weBqHUWl8jRAhs5HHFWXeO4t3gu4xLC3VW6VxiWF3ZMVju0dF6Eili1HUWjJ2K6qcEDFdMMdRe7sYTwVVdDP8SeELi1aS50oCez6+WD86deg7iuQnR4iBKjIxGcMMGvSIvEVxbKxaBwuMHaM/niqWp6hYa1ZtHqEIUD7hUbHH411RxEHs0ebUy6V20rHn5OVyKbGSxbntzz1rT1HRzApksblJ4dobHQg+mKwmZ1znp39av2sTkeEqLSxYJPSmufeo1lDjA696b5igFW4YHFVzIz9jJdB7H09KhZjnPpShxgHPHTpUczKqsSenp3pc2hfsXfYR2z14xTWNQTyhFBBH500zAHcDlQOead7iVJk+8+tFQefD/fH50UuZGnspH22ti8qhcbAD0qP7HEoctgyngHBrchidnkXlVVslh9O1Pa1VG3BeeoHfNeF7M+o5mczJpiSMgctsQbmyePpURxCdkMYzJ0A6flWveCSeYQhwqjlyO31qva2Ie6Lo52DgN3z7VDjroaJ33MlrRwQJ/kAPzDqfwpot/NjdECQx4weMFjXRRWQDOfL81/7zDpVK5sz58ZYGVi2c9xU8lhqRlWts8bOWlZkBwuTwKuNDHAMp80r8beuKu/YyjDdHGQeiEHcKLC0JaRpOcHqKahYd7meYWxsz83ckVXWyiWQ7g0smck9h7V0ZthIGlGFC8ZNVki8zgYzn04NJwHzGdJZtjGxASeGA5qD+zZWyY0EZPp3Fb7QGMbgpLdv/AK1RMZCu7YTIegHXFHICZhjTYXUH5S/Rsqf1p6WrxjYBEB1+RcVt21uwyzghm6g0+W2hZSrqoc+gqVAq5hjTxy7BcsOPah7JNhDsVx/d6k1seT8uFiBYcDI4+tLDasuWIUk8knpT5BmLa2REClbZYwOGYjn61LBablUykEj7pHGa2kiyCD0PUnvSvbxpOqgFyRk47U+Qnm6GSYlX5Qm4dzilMAIxETk9q1/IBbKqVA4qM2TkEIyqp/iHWjlC5k/Y1QYZxuPWnCAKcsdy+tXVtUhlwFLn3qXy1GFPyt2FLkGjLnjCjYnAPQVA8XzLuYLwfoa2WtAzcndgcE1SmtAsqrgZB61DiXFoyp4DI65VMD7vHBps8DMVjCpHxklRj8K2LmJGIVFzt5z2FVXRBBLNI2Bjt2Hak4ldDEjsJGMnlfKAcs2f0qVrVYoUhjjRV9cctVuDcbMiNDnrk9DSrafvRtclsct2UVkl1HYz5NPa6byywMfXnqao3liyExjaQvfHr0Arp7VUUDHLE/MKrzRKZ2KoNydm75oaC+pzEVjEjAuCXIwTzVRtNZvNfzBtBIOeciuhvorhZI2Yqm75cJ1qleQrbTeRExJYdvWlyjucp9hEibXQBk6e49aq2dvI000qHYspyowccccV1EmmtIULNyThQOw96ZLYkBI1Ujaw+oqeUdyikUYCx7gHblk6ZqC50aCWV/MgXkAAEZrWTTmnX5gFwep6GtBdLkwoWTBxxjpVpW0JbOIuPDNpuCwAmQ85U4A9qwtX8FPK2+A7HTngn9fWvUDorHJIOT1xUUmlyRk7gAgGAcc1SclsyXCMt0eJy+FL6MqQvGcsVyMVVudJniKiWHcVBw2OTXtsmlROuHX5jwcjrVC68Pw7CyZWTrkDjim61buR9Xp9jw+/gKxFTE4jfaPMUEYNVhbyltoUFl4Ax1r1fUNHaIDzYwVPIIHH41RTSbKSRQ8KiTpvA6VSx00rE/U4bnlE2lXSlhs4z0qWPRi8cixl/Q5OK9Nu/D0ESrgE46gdhWfJovmMxlAOR0x0FW8wl1EsFT7HnX9m44Kjj2or00aLBgfIP++aKX9oj+qw7H1fudXVY4ywHXHb606dZdh3upQjohzn61piKQJ8ny56kDNUr7TWABjZlDnBxzkmu7ldjkUtdTKgtw048uMMcfPg8CrsFuiRlxwQcAHvVnT7JrEeXIPmY54Oc1cltlldeCSO54xSUNCnNX0M6JGO4SodrHOB0/Gq9zbqZ0HKADllGcVrC1kjVig5JyOc042y+XsPJ7mjlDmRjRxiObahEgx1NQXQmG4wquTxnsa2ZdsMRwQfTA5NZ8Mc0dwhkQmJgePTNQ0axd9SokDRoPPAL9eTVqDZGpbYoB7tVydVO0ZO36ZNQRRxM+xEZtvduM0+W2xSaa1IUfzJFxGGU9D2qw8MYAcqFzxk1OISg3Roob68U5IyBl03v7miwm0VLiIKoYFSPX1qJUBy+0A+1an2YN8ygB+47VEFUsMjkeg4pOIlMoxIrluD0zn19qf5QYYwQpqzIu4lY0K+rEYx+FMVCGIJyemfaiw7leRApPllfcjrSQwbhuJY++OatGHEvY7R1zwKHDeaFQ89x2osMjCbAegHvUQZATgfMe5/pVuW3bqqj3O6q7wgEnzOT0OKloSaK824hVXJk+nNQsrKn+rG72+8atBCmQDhT1B7/jTkMYUrGMADGX4pWLTKBnlVTgdO7cEVRjSS4lLvlSvQith4PMlwcAKM88VCWigQ7SWGfuoM/nUOLZSdtjPupY4ASGAP933qhqM0bWnlZRZJWGeeprVuQ7W7yAAEDOMAk1m6fp7O32icKz9VUnge9ZyT2RSsWRFHEhUEknjOO1MkAltmS2IjiTn3Y1MNiyEMoMmODnrUFyjFF81xweI09PelawyrdTsSYrGIKNvLH19qijRoLfbLndnJZulaodYIsyIBnGcDpWTKftFzg7ljX7ofj61DXUa7FS4kNzdRiA5CDJx0GaqXEDpdwu8m8q2Tj+Vb8NmqIxMfy8kle4qOK0S6zMCFTovPOKXKVcoi2Vh5rttVh+ZprWwa53YLHIwcdK3UtVBZUUBepyaIkQTMij5E4U46+tVyCuY1rbiIFZFGC3BqzBEpkcYwBgirM0SyWx2/fDZXj3pkTGBSXAd27etWoha4qRlUYOV45571GLZXh/eJgkcgirsaSNF5gQAsclc5xTZnV5R8u5fY9KbihehjXOnhv9WuMHINVZYHjb5hlSMcdq3Zt+4BRweKpTIdxEoA9RnpUOBSZkS2kci4ZQynsRXKarou1nMXy7jyR7V3BRXDqDjHp3qjdRLImQRuHQe9ROmpKw72ZwFvFcRM6PKXAOGU/wAVWZ4bZ8mILuB3c9j7Vp6raHzVaJMSfpVG9DArJEBuzjHqK5pU+XQq5S2XH/Pq/wCVFW/7RlHaisrQ7juz6dkSbJaNgo9D3qubae4dX3nA98c/StJUUqGbJHYZqU8YCACvp3E8PntsY81pMu12YbweCW7VLJPJDGHkUFAeeeaueQrMWck4pTEjDLqDjoDU8vYfOupWEk00W5AIlI4J5J/CoPKaMbXy5xn72DVsEGQxxjB9Tzil2Z4GNxH3jzQ1cpSsVLVI3OT8zDtjpUzbUfL9ulOdPIGV4PtTSnmIQx69TRaw731M6eTEo8tRhj1606IRxuS5wT6GppbVCyhcqwHBpzwImAQD2NRY15layGGTYcYz+NOQEqGK49e9WI1QL90U2QEZwfl9KLE819CHzEb5BuHrxTNik7lbZj1FPKhgV6e9NfONpwV75FIr0IDvdsRS4I6nGRViMAxlcjcO+KkjVFjwi4BpTGuzv1o5eoOS2KU7mPARdzn06E00BxkFstjOQlXQgRQAKZ80mVQ7ccnNFhqRRkeRsqgx/tZz+lMEc7naHRPUlQc/h2q8sWBtXAb1pGiXHO4npnPNQ0PmKMcahtuTI2eT2qPUrgW0RZYvMPRVFW3kWIMAnyqPxrPRxNJ5nIx0FTsi1ruJYrcyxhrn5A38A5P51cWOKM7cBTnJGMURs/klsruxjOKieONGDSGR3Pq2R+VJKw3qV74iWTyEwFOCXB6+1QzgMixQsG+bG0Ht2OamntigZ3ZeeyDFLZ2Ubr53KnsF4AqGrsadkQeQIZEVCC+ctlei1KIbWGRiriSV/wAcVLawJIziQuWx1z29KbcQxxTlVUADrjjIo5dLjb6Gbcp9pbGdi56Yzx3qNQ4VkWJZucAk4IrWlgDMVTAz3IzVXUQdPVEG1mYZDAdCKmUXe40+hnOjzObaHKMfmcE9B6VdgiVUCCIKFHHOcUtpbo8Jd2kMjncW3d60IokaPnIOOx4pRgU5GdOrDasQ/edh1qF7V5WYyOUzwFVcVqvFzknB6ZHFVJkKRF97Ej1NVygmZgtPn+XfsUgDkjJqaSCRnAWIKV/iLZFSxyTXSIysqoD0xzxVk2jMuWlbaewOKEuw+axQdJBHtdt4PdDjFKytlNq42nJ4xVuK2jWMgbtwOMg1WuJHLqmQCx4NO3Upa6EZbH8OffOKq3EcZLeYDk84zmrE3KZ96pTyOrqMqQWAGRyBSt3HYrsqxjIHyjtiqssYXG4Dd1HtVpJS88keBgHnio5gAC3OT8v4dqTiDZlzQo7KRwEOCawNSgSAsp+8ThOcc11GAI9p6YrN1W3RgjkAkHvWUo3BM5IwSZ6/pRWv5Z7GiuX2bLuf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The varus stress test is used to determine the integrity of the lateral collateral ligament. One hand is placed above the knee medially and one hand is placed along the lateral gastrocnemius muscle. The upper hand is used to stabilize the thigh while the lower hand places inward pressure on the calf. Pain, movement of the lateral joint space, and the elasticity of the ligament are noted.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37600=[""].join("\n");
var outline_f36_46_37600=null;
var title_f36_46_37601="Dermoscopy melanoma 4";
var content_f36_46_37601=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Melanoma with white shiny lines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Melanoma with crystalline structures (white shiny lines) (dashed square).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37601=[""].join("\n");
var outline_f36_46_37601=null;
var title_f36_46_37602="Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia";
var content_f36_46_37602=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37602/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37602/contributors\">",
"     Lloyd Axelrod, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37602/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37602/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37602/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37602/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/46/37602/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 74-year-old woman returns to your care after an interval of 10 months. Fasting laboratory values obtained five days ago in anticipation of this office visit are as follows: glucose 389",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (21.6",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    BUN 48",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    creatinine 1.6",
"    <span class=\"nowrap\">",
"     mg/dL;",
"    </span>",
"    sodium 142",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    potassium 6.0",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    chloride 107",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and bicarbonate 30",
"    <span class=\"nowrap\">",
"     meq/L;",
"    </span>",
"    A1C 8.8 percent; hematocrit 34.4 percent. The sample is not hemolyzed. The urinalysis reveals 2+ protein, as in the past, when a 24-hour urine collection contained 771 mg of protein. A repeat serum potassium level was 5.9",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    yesterday. A blood glucose value in the office by finger stick is 401",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    (22.3",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    patient lives in Italy and travels to the United States (US) every year to see her family. In Italy she sees a local physician. Although you send a copy of your office notes with the patient when she returns to Italy each year, the patient's medications are usually different when she returns.",
"   </p>",
"   <p>",
"    The patient's glucose diary contains only occasional entries. The fasting blood glucose values in Italy were usually 140 to 170",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.77 to 9.44",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Since her arrival in the US three weeks ago, the fasting blood glucose values have been in the 251 to 411",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (13.9 to 22.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    range. Values before supper in Italy were usually in the low 200s; since her return to the US they have been in the mid to high 300s. She complains of a dry mouth and nocturia two to three times a night. An electrocardiogram shows non-specific ST and T wave changes. The T waves are not peaked and the QRS interval is not prolonged.",
"   </p>",
"   <p>",
"    She has a 23-year history of type 2 diabetes with persistently elevated A1C values in the 8.8 to 10.4 percent range complicated by retinopathy, nephropathy with proteinuria, and distal sensory neuropathy. She has enteropathy with episodes of recurrent severe constipation and abdominal pain over the last eight years treated with enemas,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"     lactulose",
"    </a>",
"    , intermittent oral phosphosoda (in the past), and intermittent Miralax (polyethylene glycol) more recently. The patient has a three-year history of anemia, previously treated with transfusions of packed red blood cells, but now treated with Aranesp (darbepoetin alpha). She has hypertension and mixed hyperlipidemia. Her lipid disorder is treated with medical nutrition therapy, efforts to achieve metabolic control of the diabetes, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    . One year ago a renal duplex ultrasound revealed no evidence of renal artery stenosis or hydronephrosis.",
"   </p>",
"   <p>",
"    On examination, the patient is in no acute distress. Blood pressure is",
"    <span class=\"nowrap\">",
"     150/70",
"    </span>",
"    supine,",
"    <span class=\"nowrap\">",
"     160/80",
"    </span>",
"    upright, heart rate 78 regular, weight 161 lbs, height 5' 1\", BMI 30.4. Her fundi are obscured by central cataracts. The chest exam is clear to percussion and auscultation. The cardiovascular exam reveals no increase in jugular venous pressure, a normal S1 and a single S2. There is no murmur, rub, gallop, or heave. The abdominal exam reveals a well-healed right upper quadrant cholecystectomy scar and no palpable liver, spleen, kidney or mass. There is no distension or tenderness. Neurological examination shows reduced sensation to light touch to the knees, absent vibratory sensation at the great toes and medial malleoli, and absent knee jerks and ankle jerks. Peripheral pulses are intact.",
"   </p>",
"   <p>",
"    Her medications are as follows: NPH insulin 32 units before breakfast and 32 units before supper,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    25 mg daily,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    40 mg every evening,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    81 mg daily, Aranesp 25 micrograms subcutaneously every two weeks,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40276?source=see_link\">",
"     senna",
"    </a>",
"    tablets 2 every evening, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    syrup 1 to 2 teaspoons at night periodically. The patient had previously been on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    , which had been stopped because of mild hyperkalemia, in the 5.2 to 5.4 range.",
"   </p>",
"   <p>",
"    What is your assessment and plan?",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      You conclude that the patient has hyperglycemia-induced hyperkalemia in the setting of renal insufficiency. You attribute the renal dysfunction to diabetic nephropathy in a patient with proteinuria and retinopathy, and note that the patient also has erythropoietin deficiency, probably on the same basis. You decide that hypertension may also contribute.",
"      <br/>",
"      <br/>",
"      You review the patient's diet with emphasis on the intake of potassium and provide a printout of a low potassium diet. She notes a high intake of tomatoes but says she cannot live without tomatoes in her diet. You advise her to reduce the quantity of tomatoes by at least half. You refer the patient to a nutritionist for further discussion of a low potassium diet. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a1?source=see_link\">",
"       \"Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A1\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You conclude that the patient has hyperglycemia-induced hyperkalemia in the setting of renal insufficiency. You attribute the renal dysfunction to diabetic nephropathy in a patient with proteinuria and retinopathy, and note that the patient also has erythropoietin deficiency, probably on the same basis. You decide that hypertension may also contribute.",
"      <br/>",
"      <br/>",
"      You review the patient's diet. She acknowledges that she has been eating much larger portions of carbohydrates such as pasta and bread since her return to the US. She notes a high intake of tomatoes but says she cannot live without tomatoes in her diet. You advise her to reduce the quantity of tomatoes by at least half. You also instruct her to reduce portions of the pasta and bread to the quantities she consumed in Italy but not to eliminate these items from her diet. You emphasize the need to reduce the intake of potassium and provide a printout of a low potassium diet. You refer the patient to a nutritionist for medical nutrition therapy of diabetes and for further discussion of a low potassium diet. You ask your nurse to give the patient 8 units of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/45/8922?source=see_link\">",
"       regular insulin",
"      </a>",
"      . You increase the morning dose of NPH insulin to 40 units and the presupper dose of NPH insulin to 35 units. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a2?source=see_link\">",
"       \"Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A2\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You conclude that the patient has hyperkalemia due to renal insufficiency. You attribute the renal dysfunction to diabetic nephropathy in a patient with proteinuria and retinopathy, and note that the patient also has erythropoietin deficiency, probably on the same basis. You decide that hypertension may also contribute.",
"      <br/>",
"      <br/>",
"      You advise the patient to eliminate orange juice, bananas, and dried fruits to reduce dietary potassium intake. You refer her to a nephrologist. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a3?source=see_link\">",
"       \"Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A3\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      You conclude that the patient has hyperkalemia due to hyporeninemic hypoaldosteronism (type 4 renal tubular acidosis [RTA]). You attribute this disorder to diabetic nephropathy in a patient with proteinuria, and note that the patient also has erythropoietin deficiency, probably on the same basis.",
"      <br/>",
"      <br/>",
"      You advise the patient to eliminate orange juice, bananas, and dried fruits to reduce dietary potassium intake. You prescribe",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"       fludrocortisone",
"      </a>",
"      0.1 mg by mouth daily as a mineralocorticoid replacement therapy for the aldosterone deficiency. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a4?source=see_link\">",
"       \"Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A4\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4221 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-89.32.226.102-21F53BA666-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37602=[""].join("\n");
var outline_f36_46_37602=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a1?source=related_link\">",
"      Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a2?source=related_link\">",
"      Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a3?source=related_link\">",
"      Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?36/46/37602-a4?source=related_link\">",
"      Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia &ndash; A4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_46_37603="Vecuronium: Patient drug information";
var content_f36_46_37603=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Vecuronium: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/46/15079?source=see_link\">",
"     see \"Vecuronium: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/49/43797?source=see_link\">",
"     see \"Vecuronium: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F233672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Norcuron&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be watched closely by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles during surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691273",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles while on a breathing machine.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to vecuronium or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to benzyl alcohol, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698250",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10987 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-189.41.172.26-82104FD738-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37603=[""].join("\n");
var outline_f36_46_37603=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233672\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022169\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022171\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022170\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022174\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022175\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022177\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022173\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022178\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022179\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/46/15079?source=related_link\">",
"      Vecuronium: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/49/43797?source=related_link\">",
"      Vecuronium: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_46_37604="Calcium glubionate: Drug information";
var content_f36_46_37604=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Calcium glubionate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/24/13700?source=see_link\">",
"    see \"Calcium glubionate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?24/29/25045?source=see_link\">",
"    see \"Calcium glubionate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3274451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Calcionate [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F144620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Calcium Salt",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F144595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage is in terms of",
"     <b>",
"      elemental",
"     </b>",
"     calcium",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dietary Reference Intake for Calcium:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults, Females/Males: RDA:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     19-50 years: 1000 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &ge;51 years, females: 1200 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     51-70 years, males: 1000 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Females: Pregnancy/Lactating: RDA: Requirements are the same as in nonpregnant or nonlactating females",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral: 15 mL 3 times/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F144608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?24/29/25045?source=see_link\">",
"      see \"Calcium glubionate: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage is in terms of",
"     <b>",
"      elemental",
"     </b>",
"     calcium",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dietary Reference Intake for Calcium:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-6 months: Adequate intake: 200 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7-12 months: Adequate intake: 260 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-3 years: RDA: 700 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-8 years: RDA: 1000 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     9-18 years: RDA: 1300 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Females: Pregnancy/Lactating: RDA: Requirements are the same as in nonpregnant or nonlactating females",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Infants &lt;12 months: 5 mL 5 times/day; may mix with juice or formula",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children &lt;4 years: 10 mL 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children &ge;4 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F144596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dietary Reference Intake for Calcium:",
"     </b>",
"     RDA: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Females: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Males &le;70 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Males &gt;70 years: 1200 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F144577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Calcionate: 1.8 g/5 mL (473 mL) [contains benzoic acid; caramel-orange flavor; equivalent to elemental calcium 115 mg/5 mL]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F144563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3888536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take with a full glass of water or juice, 1-3 hours after meals and other medications, and 1-2 hours before any approved iron supplements.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F144579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dietary supplement",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F144627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Calcium glubionate may be confused with calcium gluconate",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F144618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not defined; symptoms reported with hypercalcemia:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, constipation, nausea, thirst, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Polyuria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F144582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F144566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal effects: Constipation, bloating, and gas are common with calcium supplements (especially carbonate salt).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Achlorhydria: Calcium absorption is impaired in achlorhydria; common in elderly, use an alternate salt (eg, citrate) and administer with food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoparathyroid disease: Hypercalcemia and hypercalciuria are most likely to occur in hypoparathyroid patients receiving high doses of vitamin D.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Kidney stones (calcium-containing): Use caution when administering calcium supplements to patients with a history of kidney stones.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Minerals/other oral drugs: Calcium administration interferes with absorption of some minerals and drugs; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vitamin D: It is recommended to concomitantly administer vitamin D for optimal calcium absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Absorption: Taking calcium (&le;500 mg) with food improves absorption.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F144571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Calcium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral calcium supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Acetate: Calcium Salts may enhance the adverse/toxic effect of Calcium Acetate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Calcium Salts may diminish the therapeutic effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Calcium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOBUTamine: Calcium Salts may diminish the therapeutic effect of DOBUTamine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Calcium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., calcium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Estramustine: Calcium Salts may decrease the absorption of Estramustine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May increase the serum concentration of Calcium Salts.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Calcium Salts may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Calcium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Moxifloxacin (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Strontium Ranelate: Calcium Salts may decrease the serum concentration of Strontium Ranelate.  Management: Separate administration of strontium ranelate and oral calcium salts by at least 2 hours in order to minimize this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Calcium Salts may decrease the serum concentration of Tetracycline Derivatives.  Management: If coadministration of oral calcium with oral tetracyclines can not be avoided, consider separating administration of each agent by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Calcium Salts may diminish the therapeutic effect of Thyroid Products.  Management: Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Calcium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Calcium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Calcium Salts may enhance the adverse/toxic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F144589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may increase risk of osteoporosis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Food may increase calcium absorption. Calcium may decrease iron absorption. Bran, foods high in oxalates, or whole grain cereals may decrease calcium absorption.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13333820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Calcium crosses the placenta. Intestinal absorption of calcium increases during pregnancy. The amount of calcium reaching the fetus is determined by maternal physiological changes. Calcium requirements are the same in pregnant and nonpregnant females (IOM 2011).",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13333821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Calcium is excreted in breast milk. The amount of calcium in breast milk is homeostatically regulated and not altered by maternal calcium intake. Calcium requirements are the same in lactating and nonlactating females (IOM, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F144585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken before meals to enhance absorption. May decrease iron absorption so should be administered 1-2 hours before or after iron supplementation. Limit intake of bran, foods high in oxalates, or whole grain cereals which may decrease calcium absorption.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F144578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Serum calcium: 8.5-10.5 mg/dL. Monitor plasma calcium levels if using calcium salts as electrolyte supplements for deficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Due to a poor correlation between the serum ionized calcium (free) and total serum calcium, particularly in states of low albumin or acid/base imbalances, direct measurement of ionized calcium is recommended",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     In low albumin states, the corrected",
"     <b>",
"      total",
"     </b>",
"     serum calcium may be estimated by:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Corrected total calcium = total serum calcium + 0.8 (4.0 - measured serum albumin)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Calcium (BE, NO);",
"     </li>",
"     <li>",
"      Calcium Pliva (PL);",
"     </li>",
"     <li>",
"      Calcium Polfa (PL);",
"     </li>",
"     <li>",
"      Calcium Sandoz (AT, ES, FI, HR, NL);",
"     </li>",
"     <li>",
"      Calcium-Sandoz (CH, DK, FR, IN, SE, ZA);",
"     </li>",
"     <li>",
"      Sandocal (PT);",
"     </li>",
"     <li>",
"      Satural (PL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F144565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As dietary supplement, used to prevent or treat negative calcium balance. The calcium in calcium salts moderates nerve and muscle performance and allows normal cardiac function.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F144581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Requires vitamin D; calcium is absorbed in soluble, ionized form; solubility of calcium is increased in an acid environment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily feces (as unabsorbed calcium); urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Calcium and Vitamin D",
"      </i>",
"      , Washington, DC: The National Academies Press, 2011.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9188 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-82D89F4E57-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37604=[""].join("\n");
var outline_f36_46_37604=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3274451\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144620\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144595\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144608\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144596\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144577\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144563\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3888536\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144579\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144627\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144618\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144582\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144566\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298940\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144571\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144589\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333820\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333821\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144585\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144578\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038546\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144565\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144581\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9188\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9188|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/24/13700?source=related_link\">",
"      Calcium glubionate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?24/29/25045?source=related_link\">",
"      Calcium glubionate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_46_37605="Mechanism for lateral condyle elbow fracture";
var content_f36_46_37605=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral condyle elbow fracture mechanism of injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 598px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The most common mechanism of injury is believed to occur when the elbow is forced into varus (bottom left), which, along with the extensor muscles and lateral collateral ligaments, applies an avulsion force to the lateral condyle. When the fracture line extends to the trochlear notch (bottom right), the elbow becomes unstable.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Beaty JH, Kasser JR. The elbow: Physeal fractures, apophyseal injuries of the distal humerus, avascular necrosis of the trochlea, and T-condylar fractures. In: Rockwood and Wilkins' Fractures in Children, 5th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins 2001.&nbsp;Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37605=[""].join("\n");
var outline_f36_46_37605=null;
var title_f36_46_37606="MRI of CIS presenting as optic neuritis";
var content_f36_46_37606=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 471px\">",
"   <div class=\"ttl\">",
"    Brain MRI of a clinically isolated syndrome suggestive of multiple sclerosis presenting as optic neuritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 451px; height: 493px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Brain MRI of a 30 year old woman presenting with optic neuritis. Fat saturated T2-weighted coronal (A) image shows hyperintensity in the right optic nerve (arrow). Post-gadolinium fat-saturated T1-weighted coronal (B) image shows abnormal enhancement in the right optic nerve (arrow). Four years later, sagittal FLAIR (C) shows two plaques radiating outward from the corpus callosum (arrowheads), suggestive of multiple sclerosis.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37606=[""].join("\n");
var outline_f36_46_37606=null;
var title_f36_46_37607="Sinus biopsy 1A answer";
var content_f36_46_37607=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53937%7EID%2F58489%7EID%2F71272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53937%7EID%2F58489%7EID%2F71272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucor from sinus biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lactophenol-blue wet mount of sinus biopsy specimen (x400) shows large, irregular, non-septate hyphae which are characteristic of Mucor, Rhizopus, or other zygomycetes. Mucor was identified from this specimen on Sabouraud's agar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucor on Sabouraud's agar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The mold Mucor exhibits an exuberant, cottony appearance when grown on Sabouraud's agar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Swartz-Lamkin's wet mount of mold growing on preceding culture (x400) shows the round sporangium characteristic of either Mucor or Rhizopus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37607=[""].join("\n");
var outline_f36_46_37607=null;
var title_f36_46_37608="Acute cutaneous lupus erythematosus - malar";
var content_f36_46_37608=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75781%7EDERM%2F55875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75781%7EDERM%2F55875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute cutaneous lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Malar erythema and subtle edema are present in this patient with systemic lupus erythematosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute cutaneous lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, edematous eruption is present on the malar area. Note the sparing of the nasolabial folds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37608=[""].join("\n");
var outline_f36_46_37608=null;
var title_f36_46_37609="Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)";
var content_f36_46_37609=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37609/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37609/contributors\">",
"     Elizabeth Gunther Stewart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37609/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37609/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37609/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37609/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/46/37609/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvar pain syndromes are characterized by unexplained burning or any combination of stinging, irritation, pain, or rawness located anywhere between the mons and the anus and causing physical, sexual, and psychological distress. Despite this definition, the diagnosis and treatment of vulvodynia remain controversial, neither clinicians nor researchers have a consistent approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Localized, provoked vulvodynia (formerly referred to as vulvar vestibulitis) was first described in 1986 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/2\">",
"     2",
"    </a>",
"    ]. It is characterized by severe pain provoked by focal touch or pressure of the vulva. The vulvar vestibule is the most common site of pain (",
"    <a class=\"graphic graphic_figure graphicRef79727 \" href=\"mobipreview.htm?9/38/9824\">",
"     figure 1",
"    </a>",
"    ). Provoked pain of the clitoris or of other focal vulvar sites has been reported, but less frequently.",
"   </p>",
"   <p>",
"    Localized, provoked vulvodynia is considered a mysterious condition because advances in vulvovaginal diagnosis and treatment have not kept pace with other advances in medicine and are not well addressed in educational programs. Since localized, provoked vulvodynia represents pain only on touch, the condition continues to be regarded with skepticism. With the advance in understanding of central sensitization in pain syndromes, and with the recognition of myriad possibilities for vulvar pain, it appears that localized, provoked vulvodynia may often be the result of known causes of vulvar pain (",
"    <a class=\"graphic graphic_table graphicRef77461 \" href=\"mobipreview.htm?39/43/40635\">",
"     table 1",
"    </a>",
"    ) or an idiopathic condition yet to be understood.",
"   </p>",
"   <p>",
"    The pathogenesis, clinical manifestations, and diagnosis of localized, provoked vulvodynia will be reviewed here. Generalized unprovoked vulvodynia and the treatment of vulvodynia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23128?source=see_link\">",
"     \"Differential diagnosis of sexual pain in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16249?source=see_link\">",
"     \"Treatment of vulvodynia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23348339\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terminology used to describe vulvar pain syndromes has varied over time. The current classification system, which was agreed upon at the 2003 Congress of the International Society for the Study of Vulvovaginal Disease, consists of two major categories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Vulvar pain related to a specific disorder",
"      </strong>",
"      :",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infectious (eg, candidiasis, trichomoniasis, herpes simplex virus)",
"     </li>",
"     <li>",
"      Inflammatory (eg, lichen simplex chronicus, lichen sclerosus, lichen planus, atrophic vaginitis, immunobullous disorder)",
"     </li>",
"     <li>",
"      Neoplastic (eg, Paget disease, squamous cell carcinoma)",
"     </li>",
"     <li>",
"      Neurologic (",
"      <a class=\"graphic graphic_table graphicRef65491 \" href=\"mobipreview.htm?7/2/7211\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Vulvodynia",
"      </strong>",
"      - Vulvar discomfort, most often described as burning pain, occurring in the absence of relevant visible findings or a specific, clinically identifiable, neurologic disorder. The term vestibulitis has been eliminated from this terminology because the presence of inflammation (implied by the suffix &ldquo;-it is&rdquo;) has not be documented. Vulvodynia is divided into two subcategories:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Generalized",
"      </strong>",
"      &ndash; Generalized vulvar discomfort that is provoked (by physical contact that is sexual, nonsexual, or both); unprovoked; or mixed (a combination of provoked and unprovoked).",
"     </li>",
"     <li>",
"      <strong>",
"       Localized",
"      </strong>",
"      (eg, vestibulodynia, clitorodynia, hemivulvodynia) &ndash; Localized vulvar pain that is provoked (by physical contact that is sexual, nonsexual, or both); unprovoked; or mixed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology and pathogenesis of provoked vulvodynia have not been established. Various factors (genetic factors, inflammation, allergy) may play a role in initiating a neurologic process that results in the patient's symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268647\">",
"    <span class=\"h2\">",
"     Potential etiologic factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268736\">",
"    <span class=\"h3\">",
"     Genetic and immune factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with vulvodynia are more likely to carry immune-related gene polymorphisms that result in enhanced production of more potent proinflammatory substances (interleukin-1&beta;, tumor necrosis factor-&alpha;) and less production of potent anti-inflammatory counterparts (interleukin -1 receptor antagonist) than women without vulvar pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/5\">",
"     5",
"    </a>",
"    ]. This impairs their immune system's ability to stop the inflammatory response triggered by exposure to agents such as infection or chemicals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/6\">",
"     6",
"    </a>",
"    ]. Homozygosity for allele2 of the gene encoding the interleukin-1 receptor antagonist occurs in 25 to 50 percent of women with localized, provoked vulvodynia compared with fewer than 10 percent of unaffected controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/6\">",
"     6",
"    </a>",
"    ]. This suggests polymorphism in this gene may be a factor influencing susceptibility to localized, provoked vulvodynia, severity of symptoms, or both [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/6\">",
"     6",
"    </a>",
"    ]. Interleukin-1 receptor antagonist homozygosity has also been associated with chronic inflammation at other body sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268877\">",
"    <span class=\"h3\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized, provoked vulvodynia was initially termed vestibulitis because the principal pathologic feature was thought to be inflammation of the minor vestibular glands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/7\">",
"     7",
"    </a>",
"    ]. Although inflammation probably triggers pain in women with localized, provoked vulvodynia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/8\">",
"     8",
"    </a>",
"    ], histology to date has not provided clear support for the role of vestibular inflammation, as seen in the following lines of evidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The same nonspecific inflammatory infiltrate has been demonstrated in healthy vestibular tissue [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Immunohistochemical analysis of the neuroendocrine cells of the minor vestibular glands of affected patients is similar to that in unaffected controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The inflammatory mediators cyclooxygenase-2 and inducible nitric oxide synthase show low expression in both patients and unaffected women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Expression of interleukin&ndash;1B and tumor necrosis factor-A is not consistently different for affected and unaffected women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. In one study, expression of tumor necrosis factor was actually decreased in the areas of highest hyperalgesia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4269115\">",
"    <span class=\"h3\">",
"     Allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vaginal fluid of some women with localized, provoked vulvodynia contained levels of IgE consistent with vaginal allergy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Mast cells have also been noted in biopsy specimens from women with localized, provoked vulvodynia. Some women with vestibulodynia are sensitized to seminal fluid; an allergic reaction to seminal fluid may be the source of their symptoms, but this is extremely rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2511280\">",
"    <span class=\"h3\">",
"     Pelvic floor dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women with localized, provoked vulvodynia exhibit abnormal finding on electromyographic evaluation of the pelvic floor, including: instability of pelvic floor muscles at rest, elevated resting baseline tension, reduced muscle activity, poor muscle recovery, and reduced contraction strength [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/16\">",
"     16",
"    </a>",
"    ]. This destabilization perpetuates vulvar tissue inflammation by its effects on local autonomic (sympathetic) mediated activity, leading to vascular changes and histamine release. Muscles of the pelvic floor may become destabilized from cutaneous vulvar disease or from joint abnormalities of the spine or pelvis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4269246\">",
"    <span class=\"h2\">",
"     Neurologic sensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized, provoked vulvodynia may not be the result of a single etiologic factor, but may be triggered by a variety of conditions (",
"    <a class=\"graphic graphic_table graphicRef77461 \" href=\"mobipreview.htm?39/43/40635\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The original insult may cause pain, but the pain persists after the original condition has resolved. There is mounting evidence that an insult to the mucous membrane of the vulvar vestibule triggers a chronic inflammatory condition. This then results in central nervous system sensitization so that the sensation of touch that would not ordinarily be painful is transformed into that of pain (allodynia) (",
"    <a class=\"graphic graphic_figure graphicRef55588 \" href=\"mobipreview.htm?8/56/9091\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/19-24\">",
"     19-24",
"    </a>",
"    ]. The pain can be accentuated by reflex contraction of the pelvic floor musculature.",
"   </p>",
"   <p>",
"    This hypothesis of alterations in the vestibule in response to inflammation is supported by the observation that women with localized, provoked vulvodynia have a significant increase in the number of intraepithelial nerve endings in the vestibule and increased superficial blood flow and erythema, probably caused by neurogenic inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4267978\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data regarding the prevalence of localized, provoked vulvodynia in the general population. In questionnaire studies of 1000 or more women, 16 percent of women report a history of vulvar pain lasting at least three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/29\">",
"     29",
"    </a>",
"    ] and 4 to 7 percent report current symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study found that the incidence of one or more episodes of vulvar pain lasting for at least three months was similar in white (14 percent) and African American women (16 percent), but significantly higher in Hispanic women (23 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pain initiated by touch of the vulvar vestibule is the leading cause of superficial dyspareunia in women under the age of 50 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of conditions have been found to be associated with localized, provoked vulvodynia. The role of each of these factors in the etiology of this condition is uncertain. Some may be triggers of neuroinflammatory pain, while others involve other mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268153\">",
"    <span class=\"h2\">",
"     Vulvovaginal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of vulvovaginal candidiasis is the single most consistent feature reported by women with localized, provoked vulvodynia, thus Candida may be a trigger to the neuroinflammatory process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/7,32-35\">",
"     7,32-35",
"    </a>",
"    ]. Antifungal treatment usually fails to relieve localized, provoked vulvodynia (and may aggravate symptoms) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/14\">",
"     14",
"    </a>",
"    ]. This is not surprising, however, because antifungal regimens eliminate the trigger, but do not address the nociceptive pain that results.",
"   </p>",
"   <p>",
"    Genital herpes is a known cause of vulvar pain, and thus is not classified as localized, provoked vulvodynia (LPV).",
"   </p>",
"   <p>",
"    An association with bacterial vaginosis has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. In our experience, however, bacterial vaginosis is responsible for odor and discharge, but not pain. In women with bacterial vaginosis and vulvodynia, we have always identified another source for the pain.",
"   </p>",
"   <p>",
"    It is unclear whether there is a relationship between localized, provoked vulvodynia and other vulvovaginal infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. Human papillomavirus appears to have no relationship to genital pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268181\">",
"    <span class=\"h2\">",
"     Hormonal factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are contradictory results from studies of the expression of the estrogen receptor-alpha in women with LPV. One study reported decreased expression in the vestibular mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/45\">",
"     45",
"    </a>",
"    ]. Researchers in a recent small study took biopsies in the same phase of the menstrual cycle and found a significant increase in estrogen receptor-alpha compared to controls. These results imply that topical estrogen might have a role in the treatment of LPV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Estrogen is known to affect inflammatory neuropeptides involved in chronic pain, in which the lack of estrogen is associated with increased density of sympathetic, parasympathetic and sensory nerve fibers in the vulva, whereas acute or chronic estrogen administration may result in a decrease in the total and sympathetic fiber numbers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Comparative studies have reported an association between oral contraceptives (OCs) and LPV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/36,47,49-52\">",
"     36,47,49-52",
"    </a>",
"    ]. As an example, a case control study found that the odds of a diagnosis of vulvar vestibulitis were 6.6-fold higher in women who were current or past users of OCs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/51\">",
"     51",
"    </a>",
"    ]. Early age at first use of OCs, longer duration of therapy, and lower doses of estrogen appear to be associated with a higher risk of developing vulvar pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/49-53\">",
"     49-53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Knowledge of the hormonal effect of OCs on lower genital mucosa derives mainly from study of the endometrium and reports of the type of effect vary. As an example, in one study, use of OCs was associated with an increased expression of estrogen receptor-beta, while in another study, OCs were associated with a decrease in vulvovaginal estrogen and androgen receptors, and an increase in atrophy and pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/46,54\">",
"     46,54",
"    </a>",
"    ]. Some data suggest that OC use results in shallower and sparser dermal papillae of the vulvar vestibule, which may lead to a more fragile and sensitive mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/55\">",
"     55",
"    </a>",
"    ]. Successful treatment with topical estrogen and testosterone replacement has been reported in one patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, women without dyspareunia who use OCs have lower vestibular pain thresholds to mechanical stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/48\">",
"     48",
"    </a>",
"    ]. While more data are needed, these findings may reflect a progestogenic effect and suggest an increased risk of developing pain in the vestibule from using pills with high progestogenic potency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our practice, we continue to prescribe OCs as needed, but advise that both users and prescribers are aware of such side effects as dryness, soreness, and pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/54\">",
"     54",
"    </a>",
"    ]. When possible, we perform a trial of OCs for three to six months to judge effect on pain.",
"   </p>",
"   <p>",
"    Regarding other hormonal factors, some data suggest that the postpartum period is associated with LPV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23128?source=see_link&amp;anchor=H14#H14\">",
"     \"Differential diagnosis of sexual pain in women\", section on 'Postpartum'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a subset of women who develop LPV during menopause. Vulvovaginal pain during menopause is generally assumed to occur because of diminished estrogen-mediated trophic support of vaginal target cells. However, in addition, increased sympathetic innervation may change vasoconstriction and promote vaginal dryness, while sensory axon proliferation may contribute to pain, burning and itching associated with menopause and vulvodynia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Estrogen can therefore alter the pain threshold and be a potent mediator of peripheral nerve remodeling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268195\">",
"    <span class=\"h2\">",
"     Interstitial cystitis/painful bladder syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;LPV coexists with interstitial",
"    <span class=\"nowrap\">",
"     cystitis/painful",
"    </span>",
"    bladder syndrome in many women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/60-63\">",
"     60-63",
"    </a>",
"    ]. As an example, one study of 122 women found that 80 percent of those with vulvodynia also had symptomatic interstitial",
"    <span class=\"nowrap\">",
"     cystitis/painful",
"    </span>",
"    bladder syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of this association is not well understood. Vulvodynia may represent referred bladder pain in some women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/64\">",
"     64",
"    </a>",
"    ]. Alternatively, this association may be related to the common embryological origin of the epidermis of the vestibule, bladder mucosa, and urethra, which are derived from the urogenital sinus. Neural hyperplasia has been observed in biopsies of both women with localized, provoked vulvodynia and those with interstitial",
"    <span class=\"nowrap\">",
"     cystitis/painful",
"    </span>",
"    bladder syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/65\">",
"     65",
"    </a>",
"    ]. However, defects in the urogenital epithelium noted in the bladder of patients with interstitial",
"    <span class=\"nowrap\">",
"     cystitis/painful",
"    </span>",
"    bladder syndrome have not been identified in patients with vulvodynia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4268304\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many potential risk factors have been proposed for localized, provoked vulvodynia. Some of these have not been fully investigated and others appear unlikely to be etiologic factors. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Somatization",
"      </strong>",
"      - The relationship between psychosexual dysfunction and localized, provoked vulvodynia is debated, and has not been evaluated with high quality studies. While psychological factors are clearly operant in some women with vulvar pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/68\">",
"       68",
"      </a>",
"      ], they cannot explain the striking sensory abnormalities found in localized, provoked vulvodynia cases compared with controls: lowered pain thresholds, increased sensitivity to heat, cold, vibration, and distention [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/28\">",
"       28",
"      </a>",
"      ]. Overall, the background rate of psychological disorders is probably not increased in women with localized, provoked vulvodynia, but the chronic, often severe, pain can lead to secondary psychological effects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Chronic pain conditions",
"      </strong>",
"      - Chronic pain conditions that may be associated with localized, provoked vulvodynia, in addition to interstitial",
"      <span class=\"nowrap\">",
"       cystitis/painful",
"      </span>",
"      bladder syndrome, include: trigonitis, urethral syndrome, fibromyalgia, migraines, depression, chronic fatigue syndrome, temporomandibular joint syndrome, and endometriosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Hyperoxaluria",
"      </strong>",
"      - Excessive urinary oxalate excretion has been proposed as an etiology of vulvar pain, based upon a case report of one patient in whom complete remission of symptoms occurred with a low oxalate diet and use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38628?source=see_link\">",
"       calcium citrate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/71\">",
"       71",
"      </a>",
"      ]. However, a comparative study showed no difference in urinary oxalate excretion between women with and without pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/72\">",
"       72",
"      </a>",
"      ]. It is possible that urinary oxalate acts as an irritant to exacerbate the pain of already established localized, provoked vulvodynia, but is not a primary cause of the disorder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of pain upon vaginal penetration or with other focal vulvar pressure is the cardinal sign and symptom of localized, provoked vulvodynia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. The vulvar vestibule is the most common site of pain (",
"    <a class=\"graphic graphic_figure graphicRef79727 \" href=\"mobipreview.htm?9/38/9824\">",
"     figure 1",
"    </a>",
"    ). Provoked pain of the clitoris or of other focal vulvar sites have been reported, but less frequently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vulvar pain in women with localized, provoked vulvodynia is initiated, most commonly, by attempted vaginal intercourse. Other complaints include discomfort with insertion of a tampon or speculum, tight clothing (eg, pants with a prominent inseam), washing or wiping the vestibule, prolonged sitting, biking, or horseback riding. The character of the pain has been described as burning",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an incisive pressure sensation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vulvar discomfort can last hours after the initial provocation. When the vestibule has not been touched or had other contact or pressure, women with localized, provoked vulvodynia are asymptomatic. In addition, it is not unusual for patients to report periods lasting days or weeks that are free of symptoms or transient symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/77\">",
"     77",
"    </a>",
"    ]. The reason for this reprieve is unknown.",
"   </p>",
"   <p>",
"    Vulvar pain may be incorrectly described by the patient as vaginal pain. Also, constant burning or irritative symptoms may be reported by the patient as a yeast infection.",
"   </p>",
"   <p>",
"    Deep dyspareunia and pelvic pain are not features of localized, provoked vulvodynia, but may occur if interstitial cystitis or endometriosis is also present.",
"   </p>",
"   <p>",
"    Some women with localized, provoked vulvodynia have unprovoked symptoms, and therefore mixed vulvodynia. As an example, in a study of 220 women with vulvar vestibulitis, 38 percent of patients had constant burning or irritation in the vestibule (ie, local, unprovoked vulvodynia), 75 percent had excessive vaginal discharge, and 10 percent had chronic urinary tract symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Localized, provoked vulvodynia has a marked impact on sexual function with loss of libido and avoidance of sexual activity. Fear of pain is associated with decreased genital sexual arousal in women with and without provoked vulvodynia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/78\">",
"     78",
"    </a>",
"    ]. Women with provoked vulvodynia become hypervigilant for pain-related stimuli and are distracted from sexual stimuli, thereby negatively impacting arousal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/79\">",
"     79",
"    </a>",
"    ]. Distraction may result in an experience of spectating (watching their body perform).",
"   </p>",
"   <p>",
"    Many women progressively tense the muscles of the pelvic floor. Some develop secondary vaginismus, which becomes an additional source of pain. The bulbocavernosus muscle is often in a state of spasm, contracting even during deeper levels of general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/80\">",
"     80",
"    </a>",
"    ]. In our experience, the pain turns a woman's sexual partner, through no intention of",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    own, into an instrument of torture instead of a lover. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23128?source=see_link&amp;anchor=H7#H7\">",
"     \"Differential diagnosis of sexual pain in women\", section on 'Vaginismus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pain that interferes with sexual functioning can lead to emotional disequilibrium and distress, low self-esteem, and reduced social functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/81\">",
"     81",
"    </a>",
"    ]. In some women, it may result in depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of local, provoked vulvodynia is clinical, based upon history and physical examination. The presence of pain on vaginal penetration and tenderness provoked by focal vulvar pressure and lasting at least three to six months are the cardinal signs and symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/73,74,83\">",
"     73,74,83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other categories of vulvar pain should be excluded, including: pain caused by a specific disorder (eg, inflammatory, neurologic, infectious) (",
"    <a class=\"graphic graphic_table graphicRef77461 \" href=\"mobipreview.htm?39/43/40635\">",
"     table 1",
"    </a>",
"    ) and generalized or unprovoked vulvodynia. (See",
"    <a class=\"local\" href=\"#H23348339\">",
"     'Terminology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H11\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Establishing a diagnosis of localized, provoked vulvodynia in appropriate patients is important. The huge sense of relief these patients feel upon receiving a concrete diagnosis cannot be underestimated. Confirmation that the pain is real and the condition is not malignant or communicable is also reassuring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical history includes questions regarding characteristic symptoms and potential triggers for the vulvar pain. The clinician should ask the patient when the first painful experience occurred and about the events preceding it (eg, vulvovaginal infection, contraceptive use, sexual factors). A timeline of pain-related events should be developed. The diagnosis of localized, provoked vulvodynia should not be made in women complaining of vulvar pain of only a few weeks' duration. The clinician should determine the types of contact that elicit the pain (eg, vaginal intercourse, tampons) and the duration of each painful episode. Comments made by patients that are suggestive of localized, provoked vulvodynia are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef61872 \" href=\"mobipreview.htm?0/43/699\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Localized, provoked vulvodynia may be either primary or secondary:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary localized, provoked vulvodynia refers to introital dyspareunia dating from initiation of sexual activity or (among women who have never been sexually active) intolerable pain consistently present upon insertion of a tampon or vaginal speculum since first use. It accounts for 20 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37609/abstract/32\">",
"       32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Primary localized, provoked vulvodynia can often be diagnosed by history alone. The evaluation should be completed, however, since it often results in identification of triggers that can be treated.",
"     </li>",
"     <li>",
"      Secondary localized, provoked vulvodynia describes women who have introital dyspareunia that develops after a period of comfortable sexual relations, tampon use, or speculum examinations. This is often associated with other etiologies of vulvar pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Symptoms that suggest other etiologies of vulvar pain should be reviewed (",
"    <a class=\"graphic graphic_table graphicRef77461 \" href=\"mobipreview.htm?39/43/40635\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Clinical manifestations'",
"    </a>",
"    above.) The history should also include a gynecologic (with a detailed history of vulvovaginal conditions), sexual, urinary, bowel, dermatologic, and musculoskeletal history. The approach to the medical history in a woman with sexual pain can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43032?source=see_link&amp;anchor=H7#H7\">",
"     \"Approach to the woman with sexual pain\", section on 'History'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11773204\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pelvic examination is performed. An initial inspection and palpation should be performed prior to a bimanual or speculum examination, since doing these first may make it difficult to determine the exact trigger points of the vulvar pain.",
"   </p>",
"   <p>",
"    The components of the pelvic examination are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Initial inspection",
"      </strong>",
"      &ndash; An initial inspection is performed to exclude dermatologic causes of vulvar pain (eg, eczema, psoriasis, lichen sclerosus, lichen planus, lichen simplex chronicus). The vulva is scrutinized to confirm normal architecture of the labia minora, the prepuce, and the clitoris with lack of scarring around the introitus (",
"      <a class=\"graphic graphic_figure graphicRef79727 \" href=\"mobipreview.htm?9/38/9824\">",
"       figure 1",
"      </a>",
"      ). Careful search for tiny fissures or lesions is conducted.",
"      <br/>",
"      <br/>",
"      Erythema is often present and may be diffuse, in patches, or appear as focal red spots near the minor vestibular gland openings. The diagnosis of localized, provoked vulvodynia may be made even in the absence of vestibular erythema. Vestibular erythema, however, may be seen in women without pain and should not be a diagnostic criterion.",
"      <br/>",
"      <br/>",
"      We find use of a large hand-held magnifying glass helpful in evaluating the vulva for dermatologic abnormalities. Colposcopy is not required;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"       acetic acid",
"      </a>",
"      significantly worsens vulvar pain.",
"     </li>",
"     <li>",
"      <strong>",
"       Palpation",
"      </strong>",
"      &ndash; Gentle palpation with careful mapping of findings is performed to determine the location of pain. The labia majora, interlabial folds, and perineum are palpated to determine if tender areas exist outside of the vulvar vestibule. Understanding the anatomy of the vestibule is essential. With the labia minora gently parted, the examiner uses a moist cotton-tipped applicator to determine whether pain is provoked by pressure at one or more points around the vestibule (",
"      <a class=\"graphic graphic_figure graphicRef72614 \" href=\"mobipreview.htm?24/50/25379\">",
"       figure 3",
"      </a>",
"      ). Such tenderness is easily overlooked in general gynecology evaluations without careful exposure and Q-tip evaluation of the vestibule.",
"     </li>",
"     <li>",
"      <strong>",
"       Single digital examination",
"      </strong>",
"      &ndash; A single digit examination just beyond the vaginal introitus is performed to palpate the bulbocavernosus, levator, and obturator muscles for tenderness and spasm. Such findings suggest vaginismus or other pelvic floor dysfunction.",
"     </li>",
"     <li>",
"      <strong>",
"       Speculum examination",
"      </strong>",
"      &ndash; The vagina is evaluated for atrophy; pallor or loss of vaginal rugae is noted. Vaginal infection is assessed for using a small cotton swab to collect vaginal fluid. The pH is measured and samples are collected for microscopy or other indicated samples for laboratory evaluation.",
"     </li>",
"     <li>",
"      <strong>",
"       Bimanual examination",
"      </strong>",
"      &ndash; This examination should confirm that the examining hand does not elicit causes of pain beyond the vestibule and introitus (eg, vaginal, cervical, or pelvic tenderness). If there is tenderness over the bladder from the vaginal or abdominal surface, the patient should be asked about symptoms of interstitial",
"      <span class=\"nowrap\">",
"       cystitis/painful",
"      </span>",
"      bladder syndrome (eg, pain upon bladder filling",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      emptying). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examination of the mouth and skin should be performed to assess for lesions suggestive of lichen planus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link\">",
"     \"Lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;A vaginal pH and wet mount for microscopy should be performed to exclude vaginitis. Candidal vulvovaginitis is most closely associated with localized, provoked vulvodynia, and so this must be carefully excluded. A yeast culture should be collected, and sent if microscopy is nondiagnostic for candidal infection. Yeast is best excluded by examining and culturing the woman when her symptoms are maximal and she has not been treated with oral or topical antifungals in the preceding two weeks. We repeat yeast cultures several times, since a false negative result may occur. We frequently ask women to come in for testing if new symptoms develop or give instructions and materials to do a home yeast culture at a time when she is most symptomatic. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link&amp;anchor=H6#H6\">",
"     \"Candida vulvovaginitis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing for herpes, gonorrhea, and chlamydia should also be obtained, if appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2509002\">",
"    <span class=\"h2\">",
"     Vulvar biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no unique histological findings associated with localized, provoked vulvodynia, so biopsy is not required for diagnosis. When the etiology of the patient&rsquo;s symptoms is uncertain, however, a biopsy may lead to diagnosis of another cause of pain (eg, dermatitis, neoplasia). Early lichen sclerosus, for example, is not always white. Early lichen planus is erythematous, not eroded. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of vulvar pain includes infectious, dermatologic, neurologic, musculoskeletal, psychosexual conditions (",
"    <a class=\"graphic graphic_table graphicRef77461 \" href=\"mobipreview.htm?39/43/40635\">",
"     table 1",
"    </a>",
"    ). Candidal vulvovaginitis may mimic localized, provoked vulvodynia, and may also be an initial trigger for this condition. Patients with vulvovaginal itching or burning should be evaluated for a candidal infection with microscopy and serial yeast cultures. Recurrent yeast infections require prolonged antifungal therapy. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Laboratory'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link&amp;anchor=H18#H18\">",
"     \"Candida vulvovaginitis\", section on 'Recurrent infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vulvar lichen sclerosus and lichen planus must be excluded in women with vulvar pain. These conditions result in characteristic lesions, synechiae, and introital narrowing, which can cause dyspareunia. Biopsy may be necessary to confirm the clinical diagnosis. In women with these dermatoses who are well controlled on steroid therapy, coexistent localized, provoked vulvodynia should be considered if the patient has ongoing focal vulvar tenderness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=see_link\">",
"     \"Vulvar lichen sclerosus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/5/36952?source=see_link\">",
"     \"Vulvar lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of vulvodynia is discussed in detail separately. (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16249?source=see_link\">",
"     \"Treatment of vulvodynia\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    Basics topics (see",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/33/36370?source=see_link\">",
"     \"Patient information: Vulvar pain (The Basics)\"",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Localized, provoked vulvodynia (formerly referred to as vulvar vestibulitis) was first described in 1986. It is characterized by severe pain provoked by focal touch or pressure of the vulva. The vulvar vestibule is the most common site of pain. Provoked pain of the clitoris or of other focal vulvar sites has been reported, but less frequently. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cause of localized, provoked vulvodynia is unknown. An insult to the mucous membrane of the vulva appears to trigger chronic inflammation that ultimately results in neural sensitization so that the sensation of touch is transformed into that of pain (allodynia). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that are associated with the development of localized, provoked vulvodynia include: candidal vulvovaginitis, use of oral contraceptives, and interstitial",
"      <span class=\"nowrap\">",
"       cystitis/painful",
"      </span>",
"      bladder syndrome. All known causes of vulvar pain must be ruled out before the diagnosis of vulvodynia may be made. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of local, provoked vulvodynia is clinical, based upon history and physical examination. The presence of pain on vaginal penetration and tenderness provoked by focal vulvar pressure are the cardinal signs and symptoms. Physical findings are limited to vestibular erythema. There are no pathognomonic histological features, and biopsy is not required to make a diagnosis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis and evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Establishing a diagnosis of localized, provoked vulvodynia requires that other etiologies of vulvar pain are excluded. The differential diagnosis of vulvar pain includes infectious, dermatologic, neurologic, musculoskeletal, psychosexual conditions (",
"      <a class=\"graphic graphic_table graphicRef77461 \" href=\"mobipreview.htm?39/43/40635\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/1\">",
"      Reed BD, Haefner HK, Edwards L. A survey on diagnosis and treatment of vulvodynia among vulvodynia researchers and members of the International Society for the Study of Vulvovaginal Disease. J Reprod Med 2008; 53:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/2\">",
"      Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987; 32:110.",
"     </a>",
"    </li>",
"    <li>",
"     International Society for the Study of Vulvovaginal Disease, XVII World Congress, jointly sponsored by the American College of Obstetricians and Gynecologists, October 12-16, 2003, Salvador, Brazil.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/4\">",
"      Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004; 49:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/5\">",
"      Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Interleukin-1beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003; 107:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/6\">",
"      Jeremias J, Ledger WJ, Witkin SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000; 182:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/7\">",
"      Pyka RE, Wilkinson EJ, Friedrich EG Jr, Croker BP. The histopathology of vulvar vestibulitis syndrome. Int J Gynecol Pathol 1988; 7:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/8\">",
"      Foster DC, Piekarz KH, Murant TI, et al. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am J Obstet Gynecol 2007; 196:346.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/9\">",
"      Lundqvist EN, Hofer PA, Olofsson JI, Sj&ouml;berg I. Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol 1997; 77:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/10\">",
"      Slone S, Reynolds L, Gall S, et al. Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study. Int J Gynecol Pathol 1999; 18:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/11\">",
"      Bohm-Starke N, Falconer C, Rylander E, Hilliges M. The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis. Acta Obstet Gynecol Scand 2001; 80:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/12\">",
"      Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997; 89:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/13\">",
"      Eva LJ, Rolfe KJ, MacLean AB, et al. Is localized, provoked vulvodynia an inflammatory condition? J Reprod Med 2007; 52:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/14\">",
"      Ledger WJ, Kessler A, Leonard GH, Witkin SS. Vulvar vestibulitis-a complex clinical entity. Infect Dis Obstet Gynecol 1996; 4:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/15\">",
"      Babula O, Bongiovanni AM, Ledger WJ, Witkin SS. Immunoglobulin E antibodies to seminal fluid in women with vulvar vestibulitis syndrome: relation to onset and timing of symptoms. Am J Obstet Gynecol 2004; 190:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/16\">",
"      White G, Jantos M, Glazer H. Establishing the diagnosis of vulvar vestibulitis. J Reprod Med 1997; 42:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/17\">",
"      Glazer HI, Rodke G, Swencionis C, et al. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 1995; 40:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/18\">",
"      Baggish MS, Miklos JR. Vulvar pain syndrome: a review. Obstet Gynecol Surv 1995; 50:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/19\">",
"      Meyer RA, Davis KD, Cohen RH, et al. Mechanically insensitive afferents (MIAs) in cutaneous nerves of monkey. Brain Res 1991; 561:252.",
"     </a>",
"    </li>",
"    <li>",
"     Levine, J, Taiwo, Y. Inflammatory pain. In:Wall, PD, Meltzack, R (eds): Textbook of Pain, 3rd ed, Churchill Livingstone, Edinburgh 1994. p. 45.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/21\">",
"      Warner TF, Tomic S, Chang CK. Neuroendocrine cell-axonal complexes in the minor vestibular gland. J Reprod Med 1996; 41:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/22\">",
"      Bornstein J, Shapiro S, Goldshmid N, et al. Severe vulvar vestibulitis. Relation to HPV infection. J Reprod Med 1997; 42:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/23\">",
"      Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1999; 48:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/24\">",
"      Bohm-Starke N, Hilliges M, Brodda-Jansen G, et al. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain 2001; 94:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/25\">",
"      Westr&ouml;m LV, Will&eacute;n R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998; 91:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/26\">",
"      Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998; 46:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/27\">",
"      Halperin R, Zehavi S, Vaknin Z, et al. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest 2005; 59:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/28\">",
"      Bohm-Starke N, Hilliges M, Blomgren B, et al. Increased blood flow and erythema in the posterior vestibular mucosa in vulvar vestibulitis(1). Obstet Gynecol 2001; 98:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/29\">",
"      Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003; 58:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/30\">",
"      Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol 2008; 112:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/31\">",
"      Meana M, Binik YM, Khalife S, Cohen DR. Biopsychosocial profile of women with dyspareunia. Obstet Gynecol 1997; 90:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/32\">",
"      Witkin SS, Gerber S, Ledger WJ. Differential characterization of women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002; 187:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/33\">",
"      Nunns D. Vulval pain syndromes. BJOG 2000; 107:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/34\">",
"      Marinoff SC, Turner ML. Hypersensitivity to vaginal candidiasis or treatment vehicles in the pathogenesis of minor vestibular gland syndrome. J Reprod Med 1986; 31:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/35\">",
"      Rylander E, Berglund AL, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect 2004; 80:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/36\">",
"      Edgardh K, Abdelnoor M. Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo. Acta Derm Venereol 2007; 87:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/37\">",
"      Smith EM, Ritchie JM, Galask R, et al. Case-control study of vulvar vestibulitis risk associated with genital infections. Infect Dis Obstet Gynecol 2002; 10:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/38\">",
"      Sarma AV, Foxman B, Bayirli B, et al. Epidemiology of vulvar vestibulitis syndrome: an exploratory case-control study. Sex Transm Infect 1999; 75:320.",
"     </a>",
"    </li>",
"    <li>",
"     Neill, SM, Ridley, Cm. Vulvodynia. In: The vulva. Neill, Sm , Ridley, CM, (Eds) Oxford, Blackwell Scientific,1999, p. 192.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/40\">",
"      Wilkinson EJ, Guerrero E, Daniel R, et al. Vulvar vestibulitis is rarely associated with human papillomavirus infection types 6, 11, 16, or 18. Int J Gynecol Pathol 1993; 12:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/41\">",
"      Bergeron C, Moyal-Barracco M, Pelisse M, Lewin P. Vulvar vestibulitis. Lack of evidence for a human papillomavirus etiology. J Reprod Med 1994; 39:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/42\">",
"      Prayson RA, Stoler MH, Hart WR. Vulvar vestibulitis. A histopathologic study of 36 cases, including human papillomavirus in situ hybridization analysis. Am J Surg Pathol 1995; 19:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/43\">",
"      Morin C, Bouchard C, Brisson J, et al. Human papillomaviruses and vulvar vestibulitis. Obstet Gynecol 2000; 95:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/44\">",
"      Gaunt G, Good AE, McGovern RM, et al. Human papillomavirus in vulvar vestibulitis syndrome. J Reprod Med 2007; 52:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/45\">",
"      Eva LJ, MacLean AB, Reid WM, et al. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol 2003; 189:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/46\">",
"      Johannesson U, Sahlin L, Masironi B, et al. Steroid receptor expression in the vulvar vestibular mucosa--effects of oral contraceptives and menstrual cycle. Contraception 2007; 76:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/47\">",
"      Harlow BL, Vitonis AF, Stewart EG. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J Reprod Med 2008; 53:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/48\">",
"      Bohm-Starke N, Johannesson U, Hilliges M, et al. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? J Reprod Med 2004; 49:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/49\">",
"      Bazin S, Bouchard C, Brisson J, et al. Vulvar vestibulitis syndrome: an exploratory case-control study. Obstet Gynecol 1994; 83:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/50\">",
"      Sj&ouml;berg I, Nylander Lundqvist EN. Vulvar vestibulitis in the north of Sweden. An epidemiologic case-control study. J Reprod Med 1997; 42:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/51\">",
"      Bouchard C, Brisson J, Fortier M, et al. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol 2002; 156:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/52\">",
"      Berglund AL, Nigaard L, Rylander E. Vulvar pain, sexual behavior and genital infections in a young population: a pilot study. Acta Obstet Gynecol Scand 2002; 81:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/53\">",
"      Greenstein A, Ben-Aroya Z, Fass O, et al. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J Sex Med 2007; 4:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/54\">",
"      Bohm-Starke N. Medical and physical predictors of localized provoked vulvodynia. Acta Obstet Gynecol Scand 2010; 89:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/55\">",
"      Johannesson U, Blomgren B, Hilliges M, et al. The vulval vestibular mucosa-morphological effects of oral contraceptives and menstrual cycle. Br J Dermatol 2007; 157:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/56\">",
"      Goldstein A, Burrows L, Goldstein I. Can oral contraceptives cause vestibulodynia? J Sex Med 2010; 7:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/57\">",
"      Goetsch MF. Postpartum dyspareunia. An unexplored problem. J Reprod Med 1999; 44:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/58\">",
"      Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/59\">",
"      Ting AY, Blacklock AD, Smith PG. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod 2004; 71:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/60\">",
"      McCormack WM. Two urogenital sinus syndromes. Interstitial cystitis and focal vulvitis. J Reprod Med 1990; 35:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/61\">",
"      Fitzpatrick CC, DeLancey JO, Elkins TE, McGuire EJ. Vulvar vestibulitis and interstitial cystitis: a disorder of urogenital sinus-derived epithelium? Obstet Gynecol 1993; 81:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/62\">",
"      Tarr G, Selo-Ojeme DO, Onwude JL. Coexistence of vulvar vestibulitis and interstitial cystitis. Acta Obstet Gynecol Scand 2003; 82:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/63\">",
"      Gardella B, Porru D, Nappi RE, et al. Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study. J Sex Med 2011; 8:1726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/64\">",
"      Kahn BS, Tatro C, Parsons CL, Willems JJ. Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity. J Sex Med 2010; 7:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/65\">",
"      Boardman LA, Peipert JF. Vulvar vestibulitis: is it a defined and treatable entity? Clin Obstet Gynecol 1999; 42:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/66\">",
"      Gillespie L, Said J, Sostrin S, Kleiwer K. Immunofluorescent and histochemical staining confirm the identification of the many diseases called interstitial cystitis. Br J Urol 1990; 66:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/67\">",
"      Stewart EG, Berger BM. Parallel pathologies? Vulvar vestibulitis and interstitial cystitis. J Reprod Med 1997; 42:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/68\">",
"      Harlow BL, Stewart EG. Childhood victimization and the risk of Vulvar Dysesthesia. Ann Epidemiol 2003; 13:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/69\">",
"      Munday P, Buchan A. Vulval vestibulitis. BMJ 2004; 328:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/70\">",
"      Masheb RM, Nash JM, Brondolo E, Kerns RD. Vulvodynia: an introduction and critical review of a chronic pain condition. Pain 2000; 86:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/71\">",
"      Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med 1991; 36:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/72\">",
"      Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol 1997; 177:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/73\">",
"      Masheb RM, Lozano C, Richman S, et al. On the reliability and validity of physician ratings for vulvodynia and the discriminant validity of its subtypes. Pain Med 2004; 5:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/74\">",
"      Reed BD, Haefner HK, Harlow SD, et al. Reliability and validity of self-reported symptoms for predicting vulvodynia. Obstet Gynecol 2006; 108:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/75\">",
"      Gordon AS. Clitoral pain: the great unexplored pain in women. J Sex Marital Ther 2002; 28 Suppl 1:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/76\">",
"      Bergeron S, Binik YM, Khalif&eacute; S, et al. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001; 98:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/77\">",
"      Reed BD, Crawford S, Couper M, et al. Pain at the vulvar vestibule: a web-based survey. J Low Genit Tract Dis 2004; 8:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/78\">",
"      Brauer M, ter Kuile MM, Janssen SA, Laan E. The effect of pain-related fear on sexual arousal in women with superficial dyspareunia. Eur J Pain 2007; 11:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/79\">",
"      Payne KA, Binik YM, Amsel R, Khalif&eacute; S. When sex hurts, anxiety and fear orient attention towards pain. Eur J Pain 2005; 9:427.",
"     </a>",
"    </li>",
"    <li>",
"     Pacik PT. When sex seems impossible. Odyne, Manchester, New Hampshire 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/81\">",
"      Van Lankveld JJ, Weijenborg PT, ter Kuile MM. Psychologic profiles of and sexual function in women with vulvar vestibulitis and their partners. Obstet Gynecol 1996; 88:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/82\">",
"      Stewart DE, Reicher AE, Gerulath AH, Boydell KM. Vulvodynia and psychological distress. Obstet Gynecol 1994; 84:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37609/abstract/83\">",
"      Bachmann GA, Rosen R, Arnold LD, et al. Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey. J Reprod Med 2006; 51:3.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5413 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-125.39.66.146-3A500C5829-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37609=[""].join("\n");
var outline_f36_46_37609=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23348339\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4268647\">",
"      Potential etiologic factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4268736\">",
"      - Genetic and immune factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4268877\">",
"      - Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4269115\">",
"      - Allergy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2511280\">",
"      - Pelvic floor dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4269246\">",
"      Neurologic sensitization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4267978\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4268153\">",
"      Vulvovaginal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4268181\">",
"      Hormonal factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4268195\">",
"      Interstitial cystitis/painful bladder syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4268304\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS AND EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11773204\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2509002\">",
"      Vulvar biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5413\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5413|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/38/9824\" title=\"figure 1\">",
"      Vulvar anatomy 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/56/9091\" title=\"figure 2\">",
"      Physiological model vulvar pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/50/25379\" title=\"figure 3\">",
"      Vulvar anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5413|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/43/40635\" title=\"table 1\">",
"      Differential diagnosis of vulvar pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/2/7211\" title=\"table 2\">",
"      Neurologic causes vulvar pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/43/699\" title=\"table 3\">",
"      Suspicion for vestbulodynia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=related_link\">",
"      Candida vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23128?source=related_link\">",
"      Differential diagnosis of sexual pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/33/36370?source=related_link\">",
"      Patient information: Vulvar pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16249?source=related_link\">",
"      Treatment of vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/5/36952?source=related_link\">",
"      Vulvar lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=related_link\">",
"      Vulvar lichen sclerosus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_46_37610="Clinical care of incarcerated adults";
var content_f36_46_37610=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical care of incarcerated adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Ingrid Binswanger, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Joann G Elmore, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Suzanne W Fletcher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/46/37610/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/46/37610/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthcare in the correctional system, which consists of local, state, and federal jails and prisons, should be available and provided at the same standard as healthcare in the general population. The provision of medical care in correctional facilities has been strongly informed in the United States by the legal case of Estelle v. Gamble, 1976 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In this case, the Supreme Court deemed that deliberate indifference to serious illness or injury in a prisoner can be considered cruel and unusual punishment, in violation of the Eighth Amendment of the Constitution. Cases following this ruling have upheld three basic rights: the right to access to care, the right to care that has been ordered by a health professional, and the right to a professional medical judgment.",
"   </p>",
"   <p>",
"    Correctional medicine provides an opportunity to promote public health in a targeted, high-risk population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/3\">",
"     3",
"    </a>",
"    ]. Unfortunately, healthcare data sets intended to be nationally representative in the United States frequently exclude individuals who are incarcerated, so that health information for the incarcerated population is not complete [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific medical conditions are of particular concern due to their high prevalence among incarcerated individuals and the increased risks for transmission of infection due to congregate living conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/5\">",
"     5",
"    </a>",
"    ]. Since the burden of disease is high, correctional medicine may be more demanding and costly than care for non-incarcerated populations of similar age.",
"   </p>",
"   <p>",
"    In addition to the high-risk population served, the design of prisons and prison services themselves may unintentionally facilitate the transmission of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/6\">",
"     6",
"    </a>",
"    ]. Prisons often lack space for isolating potentially contagious sick inmates, and overcrowding is a risk factor for communicable diseases. Infection control in correctional facilities may be adversely impacted by limited access to showers, a controlled supply of clean clothes, and prohibitions against bleach and condoms. Inmates may be expected to wash their own laundry by hand, rather than use institutional laundry services, and this may be insufficient to disinfect clothing. Additionally, inmates employed as kitchen workers and barbers may not have adequate training in infection control.",
"   </p>",
"   <p>",
"    This topic addresses health issues of particular relevance to the adult incarcerated population. Issues related to care of children of incarcerated parents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15607?source=see_link\">",
"     \"Developmental and behavioral implications for children of incarcerated parents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, correctional facilities include both prisons and jails. Jails are generally local or county institutions, detaining individuals awaiting trial and sentencing, as well as some who have been sentenced to short prison terms or who are being transferred between facilities. Jails often have the added responsibility of dealing with acute health problems, such as alcohol or narcotic withdrawal, less likely to confront healthcare staff in prisons. Persons detained in jails generally have short stays, although jails may also house individuals when prisons are overcrowded.",
"   </p>",
"   <p>",
"    Prisons in the US generally house persons who have been sentenced to longer terms, including life sentences. State and federal prisons house individuals who have been convicted of a crime and sentenced either by a state or the federal government, respectively. Parole and probation violators generally go directly to prisons, although this varies by state. A few states, and some other countries, including England and Wales, have combined jail and prison facilities that include inmates awaiting trial or sentencing, and those serving sentences.",
"   </p>",
"   <p>",
"    Individuals on parole (also called community supervision) have been released from prison but are still under the supervision of the criminal justice system and may return to prison for violation of their parole terms. Probation refers to supervision of individuals as an alternative to incarceration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HEALTH SERVICES IN CORRECTIONAL FACILITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health service availability and delivery in jails and prisons vary by county, state, and country. There is wide variation in the size of jails and prisons, and facilities are often in rural locations and geographically isolated.",
"   </p>",
"   <p>",
"    Financial and human resource constraints pose challenges for correctional systems in meeting the significant medical needs of the inmates they serve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/7\">",
"     7",
"    </a>",
"    ]. Medical costs accounted for approximately $3.7 billion in the United States in 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/8\">",
"     8",
"    </a>",
"    ], and costs have risen substantially since then. In Massachusetts, prison healthcare costs in 2011 ($100 million a year) were nearly double the cost in 2001 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/9\">",
"     9",
"    </a>",
"    ]. Many inmates have not had adequate access to healthcare prior to their incarceration and have medical needs at the time of booking and intake. Furthermore, community resources to care for their needs after release may be lacking or difficult to procure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/10\">",
"     10",
"    </a>",
"    ]. Thus, correctional providers face the complex task of addressing many barriers in meeting the health needs of their patients while striving for quality goals. Groups have sought to identify appropriate quality and patient safety indicators for care in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Health services in correctional facilities are provided in a variety of ways. Counties, states, or the federal government may hire their own health providers and administer their own healthcare, as is the case in Washington State. Providers or the healthcare system may be managed using for-profit contractors. A university medical center may be involved in providing care for a correctional system, such as the University of Texas Medical Branch [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/13\">",
"     13",
"    </a>",
"    ]. Local public health departments may provide care to those detained in jails. The San Francisco Department of Public Health, for example, provides the care for the San Francisco County jails. Telemedicine is making inroads into correctional healthcare as a way to address the lack of availability of specialty services in some rural areas or in a geographically large state such as Michigan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In prisons, patients generally lose any insurance coverage they had prior to incarceration. The burden of paying for prison medical services, mandated by federal law, is the responsibility of the county or state. &nbsp;Sometimes, inmates may be charged copayments to access healthcare services [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DEMOGRAPHICS (US DATA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States at year end in 2010, 7.1 million people were under correctional supervision (eg, in jail, prison, on probation, or on parole) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Approximately 3 percent of US adults were under correctional supervision at year-end 2010 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/17\">",
"     17",
"    </a>",
"    ]. The number of prisoners in the US has tripled since 1987 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/18\">",
"     18",
"    </a>",
"    ], but growth has slowed since 2000 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/19\">",
"     19",
"    </a>",
"    ]. There are approximately 10 million releases from jail and over 700,000 releases from prison into the community per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Given high rates of recidivism, there is also substantial return back to jail or prison [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Minorities are disproportionately represented among incarcerated persons (",
"    <a class=\"graphic graphic_figure graphicRef52434 \" href=\"mobipreview.htm?1/9/1182\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The burden of infectious disease, such as HIV and hepatitis C, among incarcerated persons is high. An estimated one in seven people with HIV passed through a US correctional facility in 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/22\">",
"     22",
"    </a>",
"    ]. Attention to infectious disease prevention and treatment in correctional settings is important to minimize the risks of transmission among inmates and correctional staff, as well as in the community when inmates are released and staff members return home. Psychiatric illness is also more prevalent among the incarcerated population than in the community and inmates with severe psychiatric disorders have mandated mental healthcare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific challenges are posed in a setting designed to deliver healthcare while maintaining security for inmates and safety for healthcare personnel. Several organizations have created guidelines for the delivery of healthcare in correctional facilities. The National Commission on Correctional Health Care has published a number of guidelines for healthcare in correctional settings (",
"    <a class=\"external\" href=\"file://www.ncchc.org/\">",
"     www.ncchc.org",
"    </a>",
"    ). The Commission has also published Standards for Health Services in Prisons and Standards for Health Services in Jails, which provide guidance for compliance with constitutionally acceptable healthcare for inmates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Centers of Disease Control and Prevention (CDC) published guidelines for the Prevention and Control of Tuberculosis in Correctional Facilities in 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/27\">",
"     27",
"    </a>",
"    ]. These guidelines include correctional-specific issues, such as avoiding housing new inmates with other inmates until TB screening is completed.",
"   </p>",
"   <p>",
"    Accreditation of medical services in jails and prisons is voluntary. Both the",
"    <a class=\"external\" href=\"file://www.ncchc.org/\">",
"     National Commission on Correctional Health Care",
"    </a>",
"    and the",
"    <a class=\"external\" href=\"file://www.aca.org/standards/healthcare/\">",
"     American Correctional Association",
"    </a>",
"    offer voluntary accreditation of correctional healthcare services.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INITIAL SCREENING AND ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals entering correctional facilities from the community should be screened for acute and chronic medical and psychiatric problems, as well as optical and dental needs, upon admission. Screening should include assessment for potential drug and alcohol withdrawal, injuries, conditions that may have an immediate flare or require uninterrupted medical treatment (eg, treatment for cancer or tuberculosis), continuing medication therapy, suicide risk, transmissible diseases, and pregnancy. The following conditions should be considered:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Drug and alcohol withdrawal",
"    </span>",
"    &nbsp;&mdash;&nbsp;A quarter of jail inmates were incarcerated for drug offenses in 2002 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/28\">",
"     28",
"    </a>",
"    ]. Based on the 2004 Survey of Inmates in State and Federal Correctional Facilities conducted by the Bureau of Justice, just over half of state and federal prison inmates reported the use of drugs or alcohol at the time they committed their offense. Fifty-six percent of state inmates reported using drugs during the month before the offense [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/29\">",
"     29",
"    </a>",
"    ]. This is in comparison to the 8.7 percent of persons over 12 years of age in the United States who reported any illicit drug use in the past month [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/30\">",
"     30",
"    </a>",
"    ]. In addition, 24 percent of state inmates reported three or more positive answers to the CAGE instrument, consistent with a history of alcohol abuse or dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/24/25993?source=see_link&amp;anchor=H1272522#H1272522\">",
"     \"Screening for unhealthy use of alcohol and other drugs\", section on 'CAGE questions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The high rates of drug and alcohol use, and potentially life-threatening complications from unrecognized withdrawal, make initial screening for alcohol, benzodiazepine, and barbiturate withdrawal crucial. Ongoing monitoring of inmates for use and withdrawal syndromes may be necessary, since alcohol and drug use may occur in jail or prison [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/32\">",
"     32",
"    </a>",
"    ]. Appropriate and effective treatment of withdrawal may decrease drug use and syringe-sharing during incarceration, and improve the ability of prisoners and detainees to make informed legal decisions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of withdrawal syndromes is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=see_link\">",
"     \"Benzodiazepine poisoning and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries from both accidents and violence are common during incarceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/34\">",
"     34",
"    </a>",
"    ]. They are often related to altercations that led detainees to jail, skirmishes with police officers, sports in jail or prison, deliberate self-harm, attempted suicide, and conflicts with other inmates. A study of prison inmates in Texas demonstrated that 2.9 percent were treated for fractures during a one-year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/35\">",
"     35",
"    </a>",
"    ]. Injuries were the most common cause of evaluation at a local Scottish emergency department near to a prison: 22 percent of injuries were due to deliberate self-harm, 18 percent due to injury resulting from violence, and 15 percent due to sports injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute intoxication may mask serious and potentially life-threatening injuries such as occult head or spine trauma. Cervical spine immobilization and evaluation with radiography is indicated if any doubt exists about the presence of occult injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Continuity of care for chronic conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many chronic medical problems require uninterrupted medication, even during short periods of incarceration. Inquiry into the possibility of these conditions, as well as inquiry into medications used, is essential at reception into jail. A complete health assessment is often recommended within a 7- to 14-day time window from admission to the jail; this delay should not result in interruption of maintenance medications. Medication changes in regimens at entry into prison can have untoward effects on the mental health of individuals with mental health disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uninterrupted medication is crucial for many medical conditions, including: human immunodeficiency virus (HIV) therapy, TB, psychotic conditions, asthma, seizure disorders, coronary artery disease, diabetes mellitus, deep venous thrombosis, arrhythmias, and rheumatologic conditions. Brief lapses in therapy can have significant untoward effects, such as diabetic ketoacidosis or the evolution of resistance for HIV therapy.",
"   </p>",
"   <p>",
"    Obtaining an accurate list of medications and dosing from the patient's community provider should be a priority, especially if any doubt is present about dosing. This is particularly important for pain medications, which can be the source of friction between patients and correctional facility providers; providers may fear that narcotics will be misused, while patients fear inadequate pain relief.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Suicide prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suicide is an important issue for new inmates, especially in jails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/38\">",
"     38",
"    </a>",
"    ]. In the US nationally, 29 percent of deaths in jails were due to suicide from 2000 to 2007, and suicide rates were higher in small facilities than large facilities. Men and whites were at higher risk of suicide than females, blacks, and Hispanics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Heightened periods of suicide risk include the time of arrest, actual conviction, admission to prison from jail, and any significant life event such as the birth of a child on the outside to a male inmate or news that the spouse is divorcing the inmate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/40\">",
"     40",
"    </a>",
"    ]. The first week of admission is the highest risk period for suicide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. One study found that 48 percent of all jail suicides occurred within the first week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/31\">",
"     31",
"    </a>",
"    ]. An Italian study found that completed suicides occurred 10 times more frequently in overcrowded prisons than non-overcrowded prisons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hanging, generally using bedclothes and window bars, was the most common method of suicide in a British study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/42\">",
"     42",
"    </a>",
"    ]. Among prisoners who had been admitted into inpatient healthcare, more than one-third of suicide deaths occurred within seven days of discharge from inpatient care; many had been discharged without a scheduled follow-up appointment. Over 50 percent of inmates who died from suicide had symptoms of mental disorder at the time of admission into prison, including intoxication or withdrawal from drugs or alcohol, thoughts of self-harm or suicide, or anxiety. Just over half of those who died of suicide had a history of self-harm, as confirmed in other studies of prison and jail suicides [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/44\">",
"     44",
"    </a>",
"    ], and a quarter were thought to be at particular risk of suicide at the time of death.",
"   </p>",
"   <p>",
"    An Austrian study found that a history of suicidality, psychiatric diagnosis, psychotropic medication, violent offense, and single-cell accommodation were risk factors for suicide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/45\">",
"     45",
"    </a>",
"    ]. In a review of suicides in New York State prisons, 95 percent of inmates had a history of substance abuse, 65 percent had received bad news from home or adverse information about their criminal cases, and 70 percent presented psychological distress such as anxiety or agitation just before suicide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several suicide screening instruments exist for correctional facilities, including the Suicide Risk Assessment Scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/47\">",
"     47",
"    </a>",
"    ]; these instruments are generally implemented by correctional officers. Proactive efforts to prevent suicide include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Supervise inmates in dedicated facilities when screening reveals a suicide risk.",
"     </li>",
"     <li>",
"      Provide cells without window bars and safer bed linens for high-risk inmates.",
"     </li>",
"     <li>",
"      Provide drug and alcohol detoxification facilities.",
"     </li>",
"     <li>",
"      Follow-up within 24 hours for inmates with a history of mental disorders.",
"     </li>",
"     <li>",
"      Follow-up within seven days for inmates discharged from inpatient prison healthcare facilities.",
"     </li>",
"     <li>",
"      Train correctional staff in recognizing, assessing, and managing suicide risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To date, no large scale trials have been performed to demonstrate the effectiveness of these measures at preventing suicides. The one factor that seems to predict success in suicide prevention is not leaving the at-risk inmate alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/40\">",
"     40",
"    </a>",
"    ]. However, segregation with observation is common practice for those screened and found to be at suicidal risk, due to constraints related to staffing availability and costs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chlamydia, gonorrhea, syphilis, and Trichomonas vaginalis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for sexually transmitted infections are common among jail inmates. In one survey of female county jail detainees in Oregon, 43 percent of respondents had a history of trading sex for money [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/48\">",
"     48",
"    </a>",
"    ]. Rates of infections with chlamydia, gonococcus, syphilis, and Trichomonas vaginalis are high in jail populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study in Alabama in 1998, 11 percent of women who agreed to be tested were positive for chlamydia, 8 percent were positive for gonococcal infection, and 2 percent were positive for both [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/49\">",
"       49",
"      </a>",
"      ]. In comparison, overall rates among women in the United States in 2001 were 0.4 percent for chlamydia and 0.1 percent for gonorrhea [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/52,53\">",
"       52,53",
"      </a>",
"      ]. Among male detainees, 6.2 percent at an Illinois jail had chlamydial or gonorrheal infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In Maryland, 0.6 percent of jail and prison entrants tested positive for syphilis in 2002 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"       50",
"      </a>",
"      ]. The prevalence of syphilis was 655 per 100,000 inmates in Texas prisons [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/55\">",
"       55",
"      </a>",
"      ], while national rates of syphilis in 1999 were 2.5 per 100,000 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/56\">",
"       56",
"      </a>",
"      ]. An outbreak of syphilis occurred in Alabama state prisons from 1995 to 1997, with an annual incidence of early syphilis of 1337 per 100,000 prisoners. Syphilis seroprevalence rates are higher among adult detainees than adolescents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Trichomonas vaginalis infections were identified in 8.5 percent of a sample of women in US federal prisons [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to facilitating treatment of asymptomatic infection in a high-risk population, screening of jail inmates for sexually transmitted infections may reduce community rates of these infections following detainee release. Nonetheless, most correctional institutions do not routinely screen for these infections. The Centers for Disease Control (CDC) recommends universal screening of female adolescents for gonorrhea and chlamydia at intake and screening up to age 35 years depending on local institutional prevalence data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/57\">",
"     57",
"    </a>",
"    ]. They also suggest screening of sexually active young men when resources permit. The CDC also states that universal screening for syphilis should be based on local area and institutional prevalence. The US Preventive Health Services Task Force (USPSTF) recommends screening for chlamydial infection in sexually active women &lt;25 years old as well as in older women at increased risk of infection. These guidelines are not specific to jail or prison inmates, but are applicable to those settings.",
"   </p>",
"   <p>",
"    Testing and treatment of sexually transmitted infections are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/46/42728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incarcerated persons are at higher risk for active tuberculosis (TB) than the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Between 1993 and 2003, rates of cases of active tuberculosis in federal and state prisons were more than four times higher than the non-inmate population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/60\">",
"     60",
"    </a>",
"    ]. Contributing factors are a higher than average risk of HIV, history of drug use, and socioeconomic characteristics. The incarcerated population also has a high risk of latent tuberculosis infection (",
"    <a class=\"graphic graphic_table graphicRef64357 \" href=\"mobipreview.htm?36/13/37083\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef65668 \" href=\"mobipreview.htm?2/59/3004\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/61\">",
"     61",
"    </a>",
"    ]. In a study from the CDC, 25 percent of persons in six different correctional facilities had positive tuberculin skin tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Correctional facilities provide environments that may promote person-to-person TB transmission due to conjugal living, poor ventilation, and overcrowding. Outbreaks of TB have occurred in state prisons in which HIV-infected inmates lived with hundreds of other HIV-infected inmates in special housing units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/63\">",
"     63",
"    </a>",
"    ]. Possible secondary transmission of TB to visitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/64\">",
"     64",
"    </a>",
"    ] and to correctional employees [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/65\">",
"     65",
"    </a>",
"    ] has been reported. Additionally, the frequent movement of individuals between correctional environments and the community, and between different correctional facilities, provides additional avenues for spread of infection.",
"   </p>",
"   <p>",
"    CDC Guidelines for the Prevention and Control of Tuberculosis in Correctional Facilities advise inquiry about a history of TB and screening for symptoms of TB during the initial medical screening and prior to integration with the general correction population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/27\">",
"     27",
"    </a>",
"    ]. Inmates should be specifically questioned about prior history of TB and symptoms of active TB, including prolonged cough, hemoptysis, or chest pain, using a systematic screening tool administered by trained staff. Individuals with symptoms should be placed in an airborne infection isolation room and evaluated for TB (chest radiograph, Mantoux",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    or the QuantiFERON&reg;-TB Gold test, and sputum examination if indicated).",
"   </p>",
"   <p>",
"    The CDC recommends a yearly assessment of each correctional environment for the risk of TB transmission and classifies the facility into minimal risk or non-minimal risk TB categories based on specific criteria. Facility risk assessment can help determine the implementation of further TB screening within a given facility. Screening with chest radiographs, the Mantoux",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    , or the QuantiFERON&reg;-TB Gold test, is generally recommended for inmates in non-minimal risk facilities, and among inmates at high risk for TB in minimal-risk facilities. Latent tuberculosis should be treated in correctional facilities, with attention to the likelihood of completion of TB treatment prior to release.",
"   </p>",
"   <p>",
"    Inmates and employees with symptoms of active TB should be identified quickly and reported to local health departments. Persons with possible TB should be isolated in airborne infection isolation rooms, if available at the correctional facility, or transferred to a facility with appropriate isolation rooms. Persons with suspected or confirmed active TB should be treated with directly observed therapy (DOT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and management of TB and latent tuberculosis infection are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/12/4298?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Testing for HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV prevalence estimates in jails and prisons vary. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'HIV prevalence, prevention, and treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    HIV screening policies differ by state and correctional system, ranging from mandatory screening on intake or release to voluntary testing in response to inmate request or clinical indication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/66\">",
"     66",
"    </a>",
"    ]. The CDC recommends an \"opt-out\" policy for HIV screening in correctional healthcare settings (ie, the inmate should be informed that HIV screening will be performed unless specifically declined) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/67\">",
"     67",
"    </a>",
"    ]. In one state prison system, the rate of HIV screening among inmates increased with sequential changes over time in testing policy as follows: 5 percent for testing on request; 72 percent for opt-in; 90 percent for opt-out [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/68\">",
"     68",
"    </a>",
"    ]. The CDC also recommends that patients at high risk for HIV infection be screened for HIV infection at least annually. A more general discussion of HIV screening is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/34/10793?source=see_link\">",
"     \"Serologic screening for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon the CDC definition of high risk (injection drug users, persons who exchange sex for money or drugs, men who have sex with men, sex partners of individuals with HIV infection, and individuals who have had more than one sex partner or whose partners have had more than one sex partner since their last HIV test), many individuals in correctional facilities are high risk and therefore should be considered for annual HIV testing. Furthermore, since inmates may be hesitant to report high-risk behavior in prison (ie, needle sharing, sexual contact, or rape) testing on demand is also offered in many settings.",
"   </p>",
"   <p>",
"    It is paramount that plans to provide results to inmates who may be released before results are available be explicitly made at the time of testing. Results from Rhode Island suggest that HIV testing within 24 hours of admission to a correctional facility resulted in greater identification of previously unknown cases of HIV than delayed testing at seven days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/69\">",
"     69",
"    </a>",
"    ]. The role of rapid HIV testing in corrections is growing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. The necessity for confirmatory testing of positive rapid tests should be emphasized to patients and confidentiality of results is all-important in the correctional setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pregnancy testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women at risk for pregnancy should be tested if new medications are initiated at intake, if radiographs are required, or if they may be likely to undergo opiate withdrawal. Women who might be pregnant or who are concerned that they are pregnant should also be tested.",
"   </p>",
"   <p>",
"    All pregnant patients should be referred to appropriate prenatal services. (See",
"    <a class=\"local\" href=\"#H1302394819\">",
"     'Pregnancy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Hepatitis C",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of chronic hepatitis C among jail inmates in the US has been estimated as ranging from 12 to 35 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/72\">",
"     72",
"    </a>",
"    ] and most inmates are unaware of their infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Correctional settings are an ideal place for targeted prevention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/74\">",
"     74",
"    </a>",
"    ]. Efforts should be made to identify individuals with HCV infection and educate inmates about HCV. CDC guidelines recommend an assessment of risk factors for hepatitis C at entry medical evaluations and testing of individuals with risk factors for hepatitis C [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/72\">",
"     72",
"    </a>",
"    ]. However, screening only those reporting risk may miss a significant number of inmates with HCV: in one report from the Rhode Island Department of Corrections, 66 percent of male inmates who tested positive for HCV did not report injection drug use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/75\">",
"     75",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    A rapid fingerstick test is available to screen for HCV. Some have argued for opt-out routine testing for HCV for jail entrants, recognizing that treatment for confirmed positive tests would require counseling and coordination with outside medical services on release from jail [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/73\">",
"     73",
"    </a>",
"    ]. This strategy might identify half a million new cases of hepatitis C in the first year of implementation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MANAGEMENT FOR SPECIFIC CONDITIONS AND POPULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The traditional model of healthcare delivery in correctional facilities has been \"sick call,\" in which patients with symptoms are brought to providers for evaluation and treatment. The high prevalence of chronic conditions and opportunities for prevention among the incarcerated requires an approach that also incorporates routine scheduled follow-up visits and chronic disease management clinics. One review from Switzerland suggests targeting four high-risk conditions for preventive measures among the incarcerated population: tuberculosis, HIV, hepatitis, and sexually transmitted diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/76\">",
"     76",
"    </a>",
"    ]. Management of chronic disease has the potential to not only improve health for the individual, but also to decrease costs of care for complications and off-site transport and treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of asthma in jails and prisons is estimated at 8.5 percent (",
"    <a class=\"graphic graphic_table graphicRef65668 \" href=\"mobipreview.htm?2/59/3004\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/77\">",
"     77",
"    </a>",
"    ], slightly higher than the 2001 US national prevalence of 7.3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/78\">",
"     78",
"    </a>",
"    ]. The National Commission on Correctional Health Care has published guidelines for the management of asthma within the correctional setting, similar to the guidelines of the National Asthma Education and Prevention Program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potential barriers to quality asthma care in the correctional setting include lack of timely access to urgent care, lack of a smoke-free environment, and restrictions on patients carrying their own medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/77\">",
"     77",
"    </a>",
"    ]. Efforts should be made to minimize these barriers.",
"   </p>",
"   <p>",
"    The clinical management of asthma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=see_link\">",
"     \"An overview of asthma management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of diabetes mellitus among prisoners has been estimated at 2.6 to 5.0 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/24,35\">",
"     24,35",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef65668 \" href=\"mobipreview.htm?2/59/3004\">",
"     table 2",
"    </a>",
"    ); the incidence of diabetes in the US population is estimated at 6 percent, but the younger age distribution of inmates makes comparisons difficult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Managing diabetes mellitus poses special challenges for incarcerated persons. Restrictions on use of injecting equipment and blood glucose monitoring limit patient autonomy, an important component of diabetes self-care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/81\">",
"     81",
"    </a>",
"    ]. Self-management of diabetes (self-testing and administration of insulin) should be encouraged within the limits of individual facility policies. Other problems include the timing and type of food, limited exercise, and delays in accessing medical care. Efforts should be made to assess facility resources for diabetes management and transfer inmates with diabetes to facilities with 24-hour nursing care and better dietary resources, when appropriate.",
"   </p>",
"   <p>",
"    The American Diabetes Association has issued guidelines for diabetes care in correctional settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/82\">",
"     82",
"    </a>",
"    ]. Patients with risk factors for diabetes should be screened for diabetes, and pregnant women should be assessed for gestational diabetes. A team approach to diabetes management is emphasized, as is self-management education. Correctional staff should be trained to recognize and treat hypo- and hyperglycemia.",
"   </p>",
"   <p>",
"    The Federal Bureau of Prisons also has guidelines for the treatment of diabetes in federal prisons. As an example, the guidelines address the need for contingency plans if a lockdown or emergency count occurs after administration of insulin and prior to eating [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fundamentally, the standard of care should be the same as that for the general population, accommodating additional precautions that may be necessary due to security constraints in the correctional setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/38/36458?source=see_link\">",
"     \"Overview of medical care in adults with diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/55/15225?source=see_link\">",
"     \"General principles of insulin therapy in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Seizure disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizure disorders are more common in the incarcerated population than in the general US population. Prevalence among Texas prison inmates was 1.9 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/35\">",
"     35",
"    </a>",
"    ], compared to 0.5 percent in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/84\">",
"     84",
"    </a>",
"    ]. Substance abuse and history of head trauma may contribute to the higher rate of seizures among inmates.",
"   </p>",
"   <p>",
"    The US National Commission on Correctional Health Care has published clinical guidelines on the management of epilepsy in the correctional setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/85\">",
"     85",
"    </a>",
"    ]. An audit of provision of healthcare to inmates with epilepsy in the United Kingdom suggested that care fell short of guidelines for clinical excellence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Details of the management of first seizures, epilepsy, and alcohol withdrawal seizures are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     HIV prevalence, prevention, and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incarcerated population is at excess risk for HIV infection due to injection drug use, a history of work in the sex industry, or trading sex for drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/20\">",
"     20",
"    </a>",
"    ]. One out of seven individuals infected with HIV in the United States passed through the correctional system in 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/70\">",
"     70",
"    </a>",
"    ]. Data from 2008, based on reporting by correctional authorities to the Bureau of Justice Statistics, were that 1.5 percent of men and 1.9 percent of women in state prisons were reported to be HIV infected (approximately 2.4 times the rate in the general population) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transmission of HIV may occur in jails and prisons. An analysis of inmates who seroconverted to HIV-positive while incarcerated identified the following risk factors: male-male sex, tattooing, age &gt;26 years, serving for five or more years, black race, BMI &lt;25.4",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    on prison entry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/88\">",
"     88",
"    </a>",
"    ]. Incarcerated persons may not have access to condoms or clean injecting equipment to prevent transmission. Non-consensual sex may also limit the ability of incarcerated persons to protect themselves from infection. Estimates of sexual assault in prison range from 0 to 40 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/89\">",
"     89",
"    </a>",
"    ]. Needle and syringe exchange programs in correctional settings have been piloted internationally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/66\">",
"     66",
"    </a>",
"    ], and condoms could be made available to inmates. HIV education is also imperative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/90,91\">",
"     90,91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines are available to assist in the use of antiretroviral therapy in HIV infected adults and in pregnant women and for the prevention and management of opportunistic infections. These guidelines can be accessed at",
"    <a class=\"external\" href=\"file://aidsinfo.nih.gov/Guidelines/Default.aspx?MenuItem=Guidelines\">",
"     file://aidsinfo.nih.gov/Guidelines/Default.aspx?MenuItem=Guidelines",
"    </a>",
"    . Correctional facilities should consider the use of HIV experts to manage the care of their HIV-infected inmates. Telemedicine may facilitate access to expert guidance.",
"   </p>",
"   <p>",
"    A few points regarding the management of HIV in the correctional setting warrant emphasis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coinfection with hepatitis B",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hepatitis C is common among incarcerated HIV infected individuals; screening for hepatitis B and C in HIV infected inmates is particularly important [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/72,92\">",
"       72,92",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For inmates already on highly-active antiretroviral therapy (HAART), uninterrupted treatment is essential to prevent the evolution of resistance to medications. Patients should continue the medications they are taking in the community immediately upon intake into jail, and all doses should be available to inmates on time.",
"     </li>",
"     <li>",
"      For inmates not on HAART at the time of incarceration, appropriate prophylaxis against opportunistic infections should be provided for patients with low CD4 counts, and HAART should be offered to inmates who will be incarcerated for longer periods of time and for whom HAART is indicated according to current guidelines.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Establishing or maintaining continuity of care is essential upon release from prison or jail. In one study, prisoners who had been treated with HAART and who were subsequently reincarcerated after a period of release had a higher viral load at reincarceration than study participants who remained incarcerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/93\">",
"     93",
"    </a>",
"    ]. A Texas study reported that only 5 percent of inmates filled an initial prescription for antiretroviral therapy within 10 days of prison release and 30 percent within 60 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/94\">",
"     94",
"    </a>",
"    ]. Only one-fifth of inmates with HIV initiated care at an HIV clinic within 30 days of their release from Texas prisons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/95\">",
"     95",
"    </a>",
"    ]. Providers and discharge planners should ensure that inmates have an adequate supply of medications to last until they can follow-up with a community provider. Transfer of the prison medical record to the community provider should be made to ensure that information about the patient's history of HIV treatment is available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hepatitis A virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis A virus is transmitted by fecal-oral route via household contact, sexual contact, drug use, or contaminated food. The age-adjusted prevalence of hepatitis A in correctional populations is reported to be similar to the prevalence in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"     50",
"    </a>",
"    ], but outbreaks have been reported, corresponding to hepatitis A virus epidemics among injection drug users in the community [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hepatitis A vaccination should be provided to inmate populations at risk for hepatitis A, including men who have sex with men, injection and non-injection drug users, and those who could suffer from severe adverse outcomes if infected (ie, those with chronic liver disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"     50",
"    </a>",
"    ]. Given the high prevalence of drug abuse and dependence among the incarcerated, these recommendations are likely to apply to many inmates. Vaccine should be administered as soon as possible after incarceration, and a system to track completion of the series should be established. Individuals should be encouraged to complete the series at release from prison, and immunization records should be transferred to the inmate's medical provider in the community upon release [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inmates with signs of acute hepatitis should be tested for viral hepatitis. If hepatitis A is identified, close contacts (ie, cell mates, sexual contacts) should be treated with immunoglobulin for post-exposure prophylaxis, and health authorities should be notified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7591?source=see_link\">",
"     \"Overview of hepatitis A virus infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Hepatitis B virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis B virus (HBV) infection is common among inmates, as are lifetime risk factors for HBV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/97\">",
"     97",
"    </a>",
"    ]. A 2002 seroprevalence study of inmates entering Maryland correctional facilities demonstrated that 25 percent of inmates had evidence of HBV exposure (surface antigen, core antibody, or surface antibody), and nearly 9 percent were HBV surface antigen-positive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Incarcerated individuals are also at risk for acquiring HBV infection during incarceration. In one outbreak of acute HBV infection in a state prison, the only identified risk factor was men having sex with men in the affected dormitory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/97\">",
"     97",
"    </a>",
"    ]. During the resultant investigation, 52 percent of 907 susceptible male inmates at the facility reported at least one risk factor for acquiring HBV, including having sex with men, sharing a razor, and receiving a tattoo during incarceration.",
"   </p>",
"   <p>",
"    The CDC recommends that all incarcerated adults who do not have proof of prior vaccination or serologic evidence of immunity be vaccinated against HBV, including pregnant women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/99\">",
"     99",
"    </a>",
"    ]. Immunization records should be transferred to the inmate's medical provider in the community upon release.",
"   </p>",
"   <p>",
"    The CDC also has issued guidelines for prevention of perinatal transmission of HBV infection. All pregnant women should be tested for HBV surface antigen, regardless of the results of prior testing and vaccination. Infants born to mothers who are HBV surface antigen-positive should receive immunoglobulin and the first dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/36/27207?source=see_link\">",
"     hepatitis B vaccine",
"    </a>",
"    within 12 hours of birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/31/4602?source=see_link\">",
"     \"Epidemiology, transmission, and prevention of hepatitis B virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Post-exposure prophylaxis should be available for inmates who have had a potential exposure to HBV. Chronic HBV infection should be treated according to standard practice and the latest treatment guidelines. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/60/31690?source=see_link\">",
"     \"Hepatitis B virus vaccination\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/51/24378?source=see_link\">",
"     \"Overview of the management of hepatitis B and case examples\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Hepatitis C virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis C virus (HCV) infection is common among individuals in correctional facilities (",
"    <a class=\"graphic graphic_table graphicRef64357 \" href=\"mobipreview.htm?36/13/37083\">",
"     table 1",
"    </a>",
"    ). It was estimated that 29 to 43 percent of all US residents infected with HCV passed through the correctional system in 1997 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/100\">",
"     100",
"    </a>",
"    ]. HCV antibody seroprevalence rates among the incarcerated have been reported between 25 and 42 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/74,98,101\">",
"     74,98,101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inmates with signs or symptoms of liver disease should be tested, and inmates with HCV should have further work-up to evaluate the extent of liver disease and eligibility for treatment. Hepatitis A and B vaccination should be provided to those inmates with HCV who have not already been vaccinated or are not immune or infected. Substance abuse treatment is recommended for those people with HCV who are not eligible for treatment due to active drug or alcohol use. Education regarding factors that may contribute to worsening liver disease, such as alcohol intake, is recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment for HCV infection is feasible in the correctional setting, as demonstrated in Rhode Island [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/102\">",
"     102",
"    </a>",
"    ]. Costs of treatment for HCV can be a concern, given prison budget constraints, although one analysis found treatment in the prison population could be cost-saving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/103\">",
"     103",
"    </a>",
"    ]. Since treatment for HCV infection can exacerbate depression, obtaining psychiatric clearance prior to initiating therapy for HCV infection is judicious, given the high rate of depression and suicide among people incarcerated. Further information regarding therapy for HCV is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=see_link\">",
"     \"Overview of the management of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CDC recommendations for the prevention and control of hepatitis viruses, including hepatitis C, in correctional settings can be found at the CDC's website (",
"    <a class=\"external\" href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5201a1.htm\">",
"     www.cdc.gov/mmwr/preview/mmwrhtml/rr5201a1.htm",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Methicillin-resistant Staphylococcus aureus (MRSA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRSA is a common cause of skin and soft tissue infections in many correction systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/74,104\">",
"     74,104",
"    </a>",
"    ]. Infections related to MRSA were the fifth most common infectious disease in a study in the Texas correctional system in the year 2000 (",
"    <a class=\"graphic graphic_table graphicRef65668 \" href=\"mobipreview.htm?2/59/3004\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/35\">",
"     35",
"    </a>",
"    ]. From 1999 to 2001, the estimated incidence was 12 MRSA infections per 1000 person years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/101\">",
"     101",
"    </a>",
"    ]. The following risk factors for MRSA in correctional settings have been identified: proportion of inmates with drug offenses, history of antimicrobial use, comorbidities, crowding, and inadequate hygiene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/96,105,106\">",
"     96,105,106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRSA transmission has been documented in several correctional systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/74,102,107\">",
"     74,102,107",
"    </a>",
"    ]. Strict attention to inmate hygiene, including wide access to soap, high-temperature laundering and drying of clothing, and timely access to medical care may prevent the spread of MRSA infections. The CDC also recommends skin screening at intake and skin monitoring, culturing lesions, and using appropriate antibiotic therapy for MRSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/74\">",
"     74",
"    </a>",
"    ]. The Federal Bureau of Prisons has issued guidelines on the management of MRSA in federal prisons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/104\">",
"     104",
"    </a>",
"    ]. In a Georgia detention center, implementation of measures to improve screening for skin disease, and improve inmate personal hygiene, wound care, and proper use of antimicrobial therapy decreased the incidence of MRSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Tobacco use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking is highly prevalent among both inmates and correctional staff. A survey of older inmates in Iowa demonstrated that 70 percent were current smokers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/109\">",
"     109",
"    </a>",
"    ]. Another survey conducted at a Mississippi women's prison demonstrated that 74 percent of women were current tobacco users and another 7.6 percent were former users; 69 percent of the cigarette users had their first cigarette within 30 minutes of waking in the morning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/110\">",
"     110",
"    </a>",
"    ]. Despite the young age of these women (95 percent were less than 50 years old), 12.5 percent described a smoking health problem. Sixty-four percent were interested in a smoking cessation program, if the prison offered a program.",
"   </p>",
"   <p>",
"    Some correctional facilities have banned smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/111,112\">",
"     111,112",
"    </a>",
"    ], with evidence that smoking bans improve prison indoor air quality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/113\">",
"     113",
"    </a>",
"    ]. However, resumption of tobacco use after release from prison is common, with self-reported abstinence of only 3.1 percent at six months among individuals with chronic health conditions released from a tobacco-free jail in the community [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/114\">",
"     114",
"    </a>",
"    ]. Smoking cessation programs could have a lasting impact on the health of the incarcerated population. Correctional medical providers should discuss smoking and smoking cessation with their patients. A prison-based multimodal smoking cessation intervention has been found to be feasible in New South Wales [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Substance abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority (80 to 85 percent) of prisoners with substance abuse do not receive treatment while incarcerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/116\">",
"     116",
"    </a>",
"    ]. Treatment of incarcerated drug abusers has the potential to decrease recidivism, decrease transmission of HIV and hepatitis C infection, and improve public safety. Injection drug use during incarceration has been reported in 3 to 34 percent of inmates in countries in the European Union [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/117\">",
"     117",
"    </a>",
"    ]. In the United States, 2 percent of inmates reported injection drug use in prison during a CDC epidemiologic investigation into an outbreak of hepatitis B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Federal Bureau of Prisons has issued guidelines for detoxification of chemically dependent inmates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/118\">",
"     118",
"    </a>",
"    ]. Heroin withdrawal should be managed in a compassionate way [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/119\">",
"     119",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     Methadone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    are not widely available in correctional settings, although the National Commission on Correctional Health Care has the authority to accredit opioid treatment programs in correctional institutions. Methadone is more available in US state and federal prisons for use in opioid-dependent pregnant inmates and for short-term detoxification rather than for maintenance therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/89\">",
"     89",
"    </a>",
"    ]. The National Institute on Drug Abuse (NIDA) in the United States has published principles for treatment of drug abuse in the criminal justice population (",
"    <a class=\"graphic graphic_table graphicRef54669 \" href=\"mobipreview.htm?11/25/11676\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Analyses of the cost-effectiveness of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    treatment in prisons in New South Wales suggest that it is comparable to outcomes with methadone in the community [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/121\">",
"     121",
"    </a>",
"    ]. A randomized trial in prisons in Australia found that methadone treatment for inmates, compared with wait-list controls, significantly reduced self-reported syringe sharing at initial and four-month follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/122\">",
"     122",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/52/29514?source=see_link\">",
"     \"Treatment of opioid abuse and dependence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3897?source=see_link\">",
"     \"Opioid intoxication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to effectively treating substance abuse during incarceration, it is important to establish transitional care, as drug cues in the environment after release can trigger renewed craving and resumption of abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Mental illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mental illness, particularly schizophrenia and bipolar disorder, is far more prevalent among incarcerated individuals than the general population. The prevalence of severe mental illness has been estimated at 15 to 24 percent of US inmates, and half of all inmates have at least one mental health condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/123\">",
"     123",
"    </a>",
"    ]. Inmates with bipolar disorder are 3.3 times more likely to have had four or more previous incarcerations, compared with inmates with no major psychiatric disorder.",
"   </p>",
"   <p>",
"    Co-occurring severe mental disorders, substance abuse, and antisocial personal disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/124\">",
"     124",
"    </a>",
"    ] add complexity to the management of mental illness in corrections. A history of trauma is common among inmates, particularly women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/125\">",
"     125",
"    </a>",
"    ]. Mood disorders and personality disorders are also prevalent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/125\">",
"     125",
"    </a>",
"    ]. Suicide was the fifth leading cause of death in prison inmates in the US from 2001 to 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/126\">",
"     126",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of psychiatric disorders in prisons and jails often requires specialty input from forensic psychiatrists. Management of psychiatric conditions in prison should continue into solitary confinement settings such as Supermax facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/127\">",
"     127",
"    </a>",
"    ]. Of major importance, assuring mental healthcare continuity in the community for inmates on release from prison may prevent subsequent incarceration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Sexual violence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual violence during incarceration is common. One survey of male inmates in seven midwestern prisons in 2000, which was limited by a low return rate (25 percent), found that 21 percent of inmates had experienced forced or pressured sexual contact during incarceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/128\">",
"     128",
"    </a>",
"    ]. Reported rates of sexual violence for women range from 8 to 27 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/129\">",
"     129",
"    </a>",
"    ]. To comply with the Prison Rape Elimination Act (PREA), the Bureau of Justice Statistics measures the incidence of prison rape. Reported rates were lower in a survey of 23,000 state and federal prison inmates conducted by the US Bureau of Justice Statistics in 2007, in which 4.5 percent reported one or more incidents of sexual victimization involving other inmates or staff [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/130\">",
"     130",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Providers should report abuse, counsel victims, treat injuries, arrange for follow-up, and gather forensic evidence either on or off site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/131\">",
"     131",
"    </a>",
"    ]. Facilities should develop protocols for appropriate management of abuse. Methods to prevent sexual violence among the incarcerated deserve further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1302394819\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, women and adolescent girls are the fastest growing population among prison and jail inmates, and management of the pregnant incarcerated woman presents special challenges [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/132\">",
"     132",
"    </a>",
"    ]. Standards for prenatal and obstetrical care have been published by the National Commission on Correctional Health Care (NCCHC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/133\">",
"     133",
"    </a>",
"    ]. Prenatal care for incarcerated women is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/39/632?source=see_link\">",
"     \"Prenatal care for incarcerated women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Special needs to be considered for pregnant women in jail or prison include levels of work activity, housing issues (lower bunk bed), nutritional needs, vitamin supplementation, drug and alcohol treatment, smoking cessation, screening for infections, and mental health issues. The use of shackles for pregnant women has been barred in several states and in federal facilities except in extreme situations, due to concerns of safety related to balance issues, as well as postural needs during labor and delivery. Maternal and fetal outcomes for incarcerated mothers, compared to nonincarcerated women in similar populations, are generally improved, with higher birth weights and lower rates of stillbirth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/134\">",
"     134",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postpartum issues relate to difficulties with breastfeeding and the lack of nursery facilities in most prisons leading to need for newborn foster care. Providing family planning services prior to release is an important issue, since unplanned conception within 90 days of leaving jail is common and women who choose not be become pregnant are more likely to initiate contraception when provided in the prison than when offered free in the community [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/135\">",
"     135",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer diagnoses are increased among the incarcerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/136\">",
"     136",
"    </a>",
"    ]. In one population, the most prevalent cancers were lung, non-Hodgkin lymphoma (NHL), and cancers of the oral cavity and pharynx [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/136\">",
"     136",
"    </a>",
"    ]. Cervical cancer was the most common cancer in women. In addition to increased prevalence, median survival for lung, hepatic, and NHL was lower in the inmate population, compared to an age-matched population (21 versus 54 months).",
"   </p>",
"   <p>",
"    Cancer was the second leading cause of death among deaths occurring in prison from 2001 to 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/126\">",
"     126",
"    </a>",
"    ], with lung cancer as the leading cause among cancer deaths in prison and after release from prison [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/137\">",
"     137",
"    </a>",
"    ]. Smoking cessation and close attention to early signs and symptoms of lung cancer should be considered by correctional medical professionals.",
"   </p>",
"   <p>",
"    Cancer screening for inmates in long-term facilities should be performed according to guidelines for screening in the general population. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=see_link\">",
"     \"Overview of preventive medicine in adults\"",
"    </a>",
"    .) Cancer screening in short-term facilities may be an opportunity to provide preventive services to a population with high risk for cervical cancer and lower colon cancer screening than the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/138\">",
"     138",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12232669\">",
"    <span class=\"h2\">",
"     Geriatric populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increasing concern is management of the health needs of older prisoners, a growing population in the criminal justice system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/139,140\">",
"     139,140",
"    </a>",
"    ]. Prisons are generally not prepared to address the aging prisoner with medical comorbidities, functional impairment, or cognitive impairments, or to provide palliative care services when needed. Designated facilities that meet the special needs of older incarcerated individuals identified with functional impairments or geriatric syndromes may be one way to manage this problem, in conjunction with evaluation of the older adult prisoner for functional and cognitive limitations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/18/38186?source=see_link&amp;anchor=H22#H22\">",
"     \"Geriatric health maintenance\", section on 'Functional assessment and geriatric evaluation'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Healthcare maintenance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incarceration presents an opportunity to provide preventive services to a high-risk population who may otherwise have poor access to care. Routine healthcare maintenance, as would be offered to patients in the community, is indicated for the incarcerated, including age-appropriate cancer screening, and vaccinations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/138\">",
"     138",
"    </a>",
"    ]. Additionally, incarceration offers an opportunity to address lifestyle issues for a vulnerable population. In a systematic review of noncommunicable diseases among prisoners in 15 countries, female prisoners in the US and Australia had a greater likelihood of obesity compared to the general population, salt intake was more than twice recommended levels for prisoners in nine studies, and levels of physical activity for prisoners varied by country [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/141\">",
"     141",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Incarceration itself has been associated with an increased risk for hypertension and left ventricular hypertrophy, after adjustment for other risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/142\">",
"     142",
"    </a>",
"    ]. This underscores the need to provide healthcare screening to incarcerated persons, a population more likely to be medically-underserved upon release. Additionally, incarcerated women are at high risk for STDs and unplanned pregnancy, and attention to reproductive health needs in this population could benefit the women and their community outside the prison [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/143\">",
"     143",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=see_link\">",
"     \"Overview of preventive medicine in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SPECIFIC ETHICAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ethical concerns arise frequently in any medical practice, but have particular pertinence in providing care to the incarcerated patient. Specific issues to be addressed here are pain management, hunger strikes, and end of life care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain management can be complex in the correctional setting. Providers fear prescription drug misuse and diversion in the setting of poor patient credibility and history of drug abuse in the correctional setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/144\">",
"     144",
"    </a>",
"    ]. Patients may have difficulty trusting providers and fear inadequate pain control.",
"   </p>",
"   <p>",
"    Institutional factors, including security protocols and formulation restrictions, often present barriers to adequate pain management for inmates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/144\">",
"     144",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For new entrants into the correctional facility, communication with outside providers who prescribe chronic pain medications to patients in the community is paramount. In addition, follow-up medical visits to assess the adequacy of pain relief with prescribed therapy may be helpful to build trust between provider and patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Hunger strikes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complex practical and ethical concerns complicate the medical management of inmates. A hunger strike, in which a patient who has the capacity to understand the potential medical impact of food refusal and who is not suicidal refuses food for a specific reason, is one example. The medical management of patients on hunger strike should include psychiatric consultation, a medical history and evaluation, assessment of motives for food refusal and the possibility of coercion, and the prisoner's understanding of the risks and benefits of the food refusal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/145\">",
"     145",
"    </a>",
"    ]. The person on hunger strike should finalize an advanced directive, to be followed in the event of their becoming incompetent, to express wishes.",
"   </p>",
"   <p>",
"    Clinician assessment is often initiated after 72 hours of food refusal. Prisoners on hunger strike may accept water, salt, sugar, and vitamin B1. Some may accept liquid nutritional supplements. Refusal of both food and water is unusual, because a rapid death would not allow negotiation to meet demands.",
"   </p>",
"   <p>",
"    Weight loss of approximately 18 percent of initial weight can result in serious medical problems; loss of more than 30 percent is life threatening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/145\">",
"     145",
"    </a>",
"    ]. Force feeding a malnourished individual can result in refeeding syndrome, characterized by electrolyte abnormalities including hypophosphatemia, fluid retention, and hyperglycemia.",
"   </p>",
"   <p>",
"    The World Medical Association Declaration of Malta states that forced feeding is unethical. The 8th Amendment to the Constitution in the United States prohibits cruel and unusual punishment and has been variably interpreted to permit force feeding in certain situations, often involving the court system. Physicians in correctional environments may need to balance divergent ethical principles such as respecting the sanctity of life and respect for individual autonomy. Guidance on such issues has been provided by thoughtful articles in the literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/145-147\">",
"     145-147",
"    </a>",
"    ]. Position statements from the World Medical Association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/148\">",
"     148",
"    </a>",
"    ] and other medical associations are also available to guide physicians. Generally, states have been successful when they have argued that their responsibility to preserve life outweighs the inmates&rsquo; right to starve themselves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     End of life care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The leading causes of death among inmates are heart disease, cancer, chronic liver disease, AIDS, and suicide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/128\">",
"     128",
"    </a>",
"    ]. Challenges in caring for terminally-ill prisoners, compared to the already significant challenge of palliative care in the general population, are heightened by increased health illiteracy, distrust of medical caregivers, and isolation from family in the incarcerated population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/149\">",
"     149",
"    </a>",
"    ]. The system further poses constraints by formulary restrictions; limited access to medicines, and pain medication in particular, other than at fixed scheduled intervals; limited availability of trained hospice workers within the prison system; and issues related to promoting do-not-resuscitate and advanced directives. Participation by prisoners in clinical trials is impeded by laws enacted to protect prisoners from unethical research.",
"   </p>",
"   <p>",
"    Ideally, an interdisciplinary team, involving the patient, family, medical staff, and custody staff, should be involved in developing and implementing a plan for hospice care. Granting compassionate parole at the end of life requires a review process that is often slow; when granted, inmates are frequently in the final days of their life Some have advocated to relax or redefine medical eligibility criteria for compassionate release, since principles of incarceration (retribution, rehabilitation, deterrence, and incapacitation) may no longer be applicable at the end of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/150\">",
"     150",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines have been published with recommendations for palliative care in the prison setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/151,152\">",
"     151,152",
"    </a>",
"    ]. The growing and aging prison population heightens the need for attention and resources dedicated to improving care for the terminally ill and implementing standards of care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     HEALTH RISKS ASSOCIATED WITH RELEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immediate period following release from jail or prison can be a high-risk time for drug users and others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/137,153-157\">",
"     137,153-157",
"    </a>",
"    ]. Multiple studies have looked at the rate of death in the first two weeks following release. These were reviewed in an international meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/156\">",
"     156",
"    </a>",
"    ]. Selected studies include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study in Scotland found a strikingly high risk of death (RR 7.4; 95% CI 3.3-16.3) from drug-related events in the two weeks following release from prison relative to the subsequent two-week periods [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/153\">",
"       153",
"      </a>",
"      ]. The risk of non-drug related death in the two weeks following release was nearly five times the rate expected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/153\">",
"       153",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study from the state of Washington, the adjusted risk of death in the first two weeks following prison release was 12.7 (95% CI 9.2 to 17.4) times that of other state residents and was 3.5 times (95% CI 3.2 to 3.8) that of other state residents over a mean follow-up of 1.9 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/137\">",
"       137",
"      </a>",
"      ]. Drug overdose was the most common cause of death according to data from death certificates, with other deaths attributed to cardiovascular disease, homicide, suicide, cancer, motor vehicle accidents, and liver disease.",
"     </li>",
"     <li>",
"      In a study from New York City, the risk of drug-related death among former jail inmates in the first two weeks following release was eight times the death rate of non-incarcerated individuals adjusted for age, sex, race, and neighborhood. Drug-related death rates were highest in persons who had a history of homelessness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/157\">",
"       157",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Transitions of care and communication between medical providers in and out of correctional facilities, and between different correctional facilities, is critical to ensure that inmates do not have lapses in chronic medications and suffer health risks due to transitions of care at the time of release or transfer to a new facility. A retrospective study of 1750 HIV-infected inmates released from prison in Texas found that only 20 percent had enrolled in an HIV clinic within 30 days of release; those who received enhanced discharge planning were more likely to seek care after release [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/95\">",
"     95",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Initial screening and assessment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Referrals to medical providers in the community should be made for inmates who do not have regular medical care. Dually-based providers in corrections and in community clinics can help address the lack of continuity experienced by many inmates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/158\">",
"     158",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether programs to provide prerelease counseling or transitional support can help curb the risk of death upon release should be determined. Potential homelessness following prison release should be addressed, since homeless shelters are used by 6 to 11 percent of prisoners after release, and homelessness increases risk for medical illness and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/159\">",
"     159",
"    </a>",
"    ]. Appropriate discharge planning for inmates, including referral to community drug rehabilitation programs and housing services, is indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/46/37610/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Healthcare in the correctional system should be available and provided at the same standard as healthcare in the general population. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Screening when individuals enter a correctional facility should include assessment for potential drug and alcohol withdrawal, injuries, conditions that may have an immediate flare or require continuing medication therapy, suicide risk, transmissible diseases, and pregnancy.",
"      <br/>",
"      <br/>",
"      Particular attention should be paid to screening for HIV infection, viral hepatitis, chlamydia, gonorrhea, syphilis, and tuberculosis. These infections are more prevalent among the incarcerated than in the general population, and can be transmitted within correctional facilities if not detected and appropriately treated. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial screening and assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of chronic disease in the inmate population should not be compromised by incarceration. It is important that maintenance medications for underlying conditions be continued without lapse. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Management for specific conditions and populations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Incarceration presents an opportunity for providing preventive care to a population that is often underserved. Cancer is more prevalent among inmates than in the general population. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Cancer'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H30\">",
"       'Healthcare maintenance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The period immediately following release presents a high risk for drug overdose and other fatal events and warrants thoughtful planning. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Health risks associated with release'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/1\">",
"      Roberts TD. Right to treatment for the civilly committed: a new Eighth Amendment basis. Univ Chic Law Rev 1978; 45:731.",
"     </a>",
"    </li>",
"    <li>",
"     Estelle v. Gamble, 429 U.S. 97 (1976)",
"    </li>",
"    <li>",
"     Greifinger, RB. Public Health Behind Bars: From Prisons to Communities, Spring Science + Business Media, New York 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/4\">",
"      Ahalt C, Binswanger IA, Steinman M, et al. Confined to ignorance: the absence of prisoner information from nationally representative health data sets. J Gen Intern Med 2012; 27:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/5\">",
"      Altice FL, Kamarulzaman A, Soriano VV, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010; 376:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/6\">",
"      Bick JA. Infection control in jails and prisons. Clin Infect Dis 2007; 45:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/7\">",
"      Anno BJ. Health care for prisoners. How soon is soon enough? JAMA 1993; 269:633.",
"     </a>",
"    </li>",
"    <li>",
"     Council of State Governments, Trends Alert, Information for State Decision-Makers Corrrections Health Care Costs. Lexington, KY; 2004.",
"    </li>",
"    <li>",
"     www.wbur.org/2011/03/27/prison-health-care.",
"    </li>",
"    <li>",
"     file://www.statesman.com/news/texas-politics/utmb-seeks-changes-to-prison-health-care-plan-1110706.html (Accessed on November 14, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/11\">",
"      Asch SM, Damberg CL, Hiatt L, et al. Selecting performance indicators for prison health care. J Correct Health Care 2011; 17:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/12\">",
"      Stern MF, Greifinger RB, Mellow J. Patient safety: moving the bar in prison health care standards. Am J Public Health 2010; 100:2103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/13\">",
"      Raimer BG, Stobo JD. Health care delivery in the Texas prison system: the role of academic medicine. JAMA 2004; 292:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/14\">",
"      Glaser M, Winchell T, Plant P, et al. Provider satisfaction and patient outcomes associated with a statewide prison telemedicine program in Louisiana. Telemed J E Health 2010; 16:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/15\">",
"      Fisher AA, Hatton DC. A study of women prisoners' use of co-payments for health care: issues of access. Womens Health Issues 2010; 20:185.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Justice. Bureau of Justice Statistics. Number of persons under correctional supervision. file://bjs.ojp.usdoj.gov/content/glance/tables/corr2tab.cfm.",
"    </li>",
"    <li>",
"     Glaze, LE. Correctional Population in the United States, 2010. Bureau of Justice Statistics. Available at: file://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&amp;iid=2237 (Accessed on January 17, 2012).",
"    </li>",
"    <li>",
"     Pew Charitable Trusts. One in 100: Behind Bars in America 2008, The PEW Center on the States, Washington, DC 2008.",
"    </li>",
"    <li>",
"     Sabol WH, West HC, Cooper M. Bureau of Justice Statistics Bulletin: Prisoners in 2008. US Department of Justice, Washington, DC 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/20\">",
"      Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92:1789.",
"     </a>",
"    </li>",
"    <li>",
"     Bureau of Justice Statistics. Criminal Offenders Statistics. U.S. Department of Justice; U.S. Department of Justice, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/22\">",
"      Spaulding AC, Seals RM, Page MJ, et al. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One 2009; 4:e7558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/23\">",
"      Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health 2009; 63:912.",
"     </a>",
"    </li>",
"    <li>",
"     The Health Status of Soon-to-be-Released Inmates, 2002. National Commission on Correctional Health Care.",
"    </li>",
"    <li>",
"     Standards for Health Services in Prisons. National Commission on Correctional Health Care, Chicago, IL 2008.",
"    </li>",
"    <li>",
"     Standards for Health Services in Jails. National Commission on Correctional Health Care, Chicago, IL 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/27\">",
"      Casey C, Vellozzi C, Mootrey GT, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     James DJ. Bureau of Justice Statistics Special Report: Profile of Jail Inmates, 2002. US Department of Justice, Washington, DC 2004.",
"    </li>",
"    <li>",
"     Karberg JC, Mumola CJ. Drug Use and Dependence, State and Federal Prisoners, 2004. Bureau of Justice Statistics. Available at: file://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&amp;iid=778 (Accessed on January 17, 2012).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Illegal drug use. file://www.cdc.gov/nchs/fastats/druguse.htm.",
"    </li>",
"    <li>",
"     Mumola CJ. Substance Abuse and Treatment, State and Federal Prisoner, 1997, Publication no. NCJ 172871. Office of Justice Programs; US Department of Justice, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/32\">",
"      Clarke JG, Stein MD, Hanna L, et al. Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of Incarceration. Subst Abus 2001; 22:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/33\">",
"      Bruce RD, Schleifer RA. Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention. Int J Drug Policy 2008; 19:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/34\">",
"      Sung HE. Prevalence and risk factors of violence-related and accident-related injuries among state prisoners. J Correct Health Care 2010; 16:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/35\">",
"      Baillargeon J, Black SA, Pulvino J, Dunn K. The disease profile of Texas prison inmates. Ann Epidemiol 2000; 10:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/36\">",
"      Boyce SH, Stevenson J, Jamieson IS, Campbell S. Impact of a newly opened prison on an accident and emergency department. Emerg Med J 2003; 20:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/37\">",
"      Bowen RA, Rogers A, Shaw J. Medication management and practices in prison for people with mental health problems: a qualitative study. Int J Ment Health Syst 2009; 3:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/38\">",
"      Kim S, Ting A, Puisis M, et al. Deaths in the Cook County jail: 10-year report, 1995-2004. J Urban Health 2007; 84:70.",
"     </a>",
"    </li>",
"    <li>",
"     Noonan, Margaret. Deaths in Custody Reporting Program: Mortality in Local Jails, 2000-2007. Bureau of Justice Statistics. Available at: file://bjs.ojp.usdoj.gov/content/pub/pdf/mlj07.pdf (Accessed on January 17, 2012).",
"    </li>",
"    <li>",
"     Department of Mental Health. World Health Organization (WHO). Preventing Suicide: A Resource for General Physicians. Available at: file://www.who.int/mental_health/media/en/56.pdf (Accessed on November 14, 2011).",
"    </li>",
"    <li>",
"     Mumola C. Suicide and Homicide in State Prisons and Local Jails. Bureau of Justice Statistics; US Department of Justice, Washington, DC 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/42\">",
"      Shaw J, Baker D, Hunt IM, et al. Suicide by prisoners. National clinical survey. Br J Psychiatry 2004; 184:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/43\">",
"      Preti A, Cascio MT. Prison suicides and self-harming behaviours in Italy, 1990-2002. Med Sci Law 2006; 46:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/44\">",
"      Fruehwald S, Frottier P, Matschnig T, Eher R. The relevance of suicidal behaviour in jail and prison suicides. Eur Psychiatry 2003; 18:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/45\">",
"      Fruehwald S, Matschnig T, Koenig F, et al. Suicide in custody: case-control study. Br J Psychiatry 2004; 185:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/46\">",
"      Kovasznay B, Miraglia R, Beer R, Way B. Reducing suicides in New York State correctional facilities. Psychiatr Q 2004; 75:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/47\">",
"      Daigle MS, Labelle R, C&ocirc;t&eacute; G. Further evidence of the validity of the Suicide Risk Assessment Scale for prisoners. Int J Law Psychiatry 2006; 29:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/48\">",
"      Fickenscher A, Lapidus J, Silk-Walker P, Becker T. Women behind bars: health needs of inmates in a county jail. Public Health Rep 2001; 116:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/49\">",
"      Centers for Disease Control and Prevention (CDC). High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers--Chicago, Birmingham, and San Francisco, 1998. MMWR Morb Mortal Wkly Rep 1999; 48:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/50\">",
"      Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 2004; 81:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/51\">",
"      Sutcliffe S, Newman SB, Hardick A, Gaydos CA. Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates. Sex Transm Dis 2010; 37:585.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. STD Surveillance Slide Show -- STD in Women and Infants Slide Show. National Center for HIV, STD and TB Prevention, Division of Sexually Transmitted Diseases, Atlanta, GA 2001.",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. STD Surveillance 2001 -- Gonorrhea Slide Show. National Center for HIV, STD and TB Prevention, Division of Sexually Transmitted Diseases, Atlanta, GA 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/54\">",
"      Trick WE, Kee R, Murphy-Swallow D, et al. Detection of chlamydial and gonococcal urethral infection during jail intake: development of a screening algorithm. Sex Transm Dis 2006; 33:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/55\">",
"      Baillargeon J, Black SA, Leach CT, et al. The infectious disease profile of Texas prison inmates. Prev Med 2004; 38:607.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. 1999 STD Surveillance -- Syphils Slide Show. National Center for HIV, STD and TB Prevention, Division of Sexually Transmitted Diseases, Atlanta, GA 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/57\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/58\">",
"      Hutton MD, Cauthen GM, Bloch AB. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep 1993; 108:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/59\">",
"      Hanau-Ber&ccedil;ot B, Gr&eacute;my I, Raskine L, et al. A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis 2000; 4:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/60\">",
"      MacNeil JR, Lobato MN, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health 2005; 95:1800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/61\">",
"      Mart&iacute;n S&aacute;nchez V, Alvarez-Guisasola F, Cayl&aacute; JA, Alvarez JL. Predictive factors of Mycobacterium tuberculosis infection and pulmonary tuberculosis in prisoners. Int J Epidemiol 1995; 24:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/62\">",
"      Centers for Disease Control and Prevention (CDC). Tuberculosis prevention in drug-treatment centers and correctional facilities--selected U.S. sites, 1990-1991. MMWR Morb Mortal Wkly Rep 1993; 42:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/63\">",
"      Centers for Disease Control and Prevention (CDC). Drug-susceptible tuberculosis outbreak in a state correctional facility housing HIV-infected inmates--South Carolina, 1999-2000. MMWR Morb Mortal Wkly Rep 2000; 49:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/64\">",
"      Centers for Disease Control and Prevention (CDC). Tuberculosis outbreaks in prison housing units for HIV-infected inmates--California, 1995-1996. MMWR Morb Mortal Wkly Rep 1999; 48:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/65\">",
"      Centers for Disease Control and Prevention (CDC). Probable transmission of multidrug-resistant tuberculosis in a correctional facility--California. MMWR Morb Mortal Wkly Rep 1993; 42:48.",
"     </a>",
"    </li>",
"    <li>",
"     US General Accounting Office. Report to Honorable Eleanor Holmes Norton, Women in Prison. Issues and Challenges Confronting US Correctional Systems. Washington; US General Accounting Office, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/67\">",
"      Centers for Disease Control and Prevention (CDC). Nonfatal, unintentional medication exposures among young children--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/68\">",
"      Centers for Disease Control and Prevention (CDC). HIV screening of male inmates during prison intake medical evaluation--Washington, 2006-2010. MMWR Morb Mortal Wkly Rep 2011; 60:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/69\">",
"      Centers for Disease Control and Prevention (CDC). Routine jail-based HIV testing - Rhode Island, 2000-2007. MMWR Morb Mortal Wkly Rep 2010; 59:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/70\">",
"      Spaulding AC, Arriola KR, Hammett T, et al. Rapid HIV testing in rapidly released detainees: next steps. Sex Transm Dis 2009; 36:S34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/71\">",
"      Beckwith CG, Atunah-Jay S, Cohen J, et al. Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS 2007; 21:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/72\">",
"      Weinbaum C, Lyerla R, Margolis HS, Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/73\">",
"      Spaulding AC, Thomas DL. Screening for HCV infection in jails. JAMA 2012; 307:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/74\">",
"      Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/75\">",
"      Macalino GE, Dhawan D, Rich JD. A missed opportunity: hepatitis C screening of prisoners. Am J Public Health 2005; 95:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/76\">",
"      Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health 2006; 120:33.",
"     </a>",
"    </li>",
"    <li>",
"     National Commission on Correctional Health Care Clinical Guidelines for Correctional Facilities: Asthma Chronic Care. National Commission on Correctional Health Care, Chicago, IL 2003.",
"    </li>",
"    <li>",
"     National Center of Health Statistics. Asthma Prevalence, Health Care Use and Mortality, 2000-2001, Centers of Disease Control and Prevention, Hyattsville, MD 2003.",
"    </li>",
"    <li>",
"     NAEPP Expert Panel Report II: Introduction. Available at: www.nhlbi.nih.gov/guidelines/asthma/index.htm (Accessed on May 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/80\">",
"      Lucas JW, Schiller JS, Benson V. Summary health statistics for U.S. adults: National Health Interview Survey, 2001. Vital Health Stat 10 2004; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/81\">",
"      Petit JM, Guenfoudi MP, Volatier S, et al. Management of diabetes in French prisons: a cross-sectional study. Diabet Med 2001; 18:47.",
"     </a>",
"    </li>",
"    <li>",
"     Federal Bureau of Prisons. Federal Bureau of Prisons Clinical Practice Guidelines for Diabetes September 2002. Federal Bureau of Prisons.",
"    </li>",
"    <li>",
"     National Commission on Correctional Health Care. National Commission on Correctional Health Care Clinical Guidelines for Correctional Facilities: Diabetes Chronic Care, Chicago 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/84\">",
"      Centers for Disease Control and Prevention (CDC). Prevalence of self-reported epilepsy--United States, 1986-1990. MMWR Morb Mortal Wkly Rep 1994; 43:810.",
"     </a>",
"    </li>",
"    <li>",
"     National Commission on Correctional Health Care Clinical Guidelines for Correctional Facilities: Epilepsy Chronic Care, National Commission on Correctional Health Care, Chicago 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/86\">",
"      McClelland GM, Teplin LA, Abram KM, Jacobs N. HIV and AIDS risk behaviors among female jail detainees: implications for public health policy. Am J Public Health 2002; 92:818.",
"     </a>",
"    </li>",
"    <li>",
"     Maruschak LM. HIV in Prisons, 2007-08. Bureau of Justice Statistics. Available at: file://bjs.ojp.usdoj.gov/content/pub/pdf/hivp08.pdf (Accessed on January 17, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/88\">",
"      Krebs CP. Inmate factors associated with HIV transmission in prison. Criminology Public Policy 2006; 5:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/89\">",
"      Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003; 98:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/90\">",
"      Okie S. Sex, drugs, prisons, and HIV. N Engl J Med 2007; 356:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/91\">",
"      Stephenson BL, Wohl DA, Golin CE, et al. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep 2005; 120:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/92\">",
"      Whiteman D, McCall B, Falconer A. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control. J Viral Hepat 1998; 5:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/93\">",
"      Centers for Disease Control and Prevention (CDC). Hepatitis B outbreak in a state correctional facility, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/94\">",
"      Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA 2009; 301:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/95\">",
"      Baillargeon JG, Giordano TP, Harzke AJ, et al. Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep 2010; 125 Suppl 1:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/96\">",
"      Aiello AE, Lowy FD, Wright LN, Larson EL. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis 2006; 6:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/97\">",
"      Ruiz JD, Molitor F, Plagenhoef JA. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS 2002; 16:2236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/98\">",
"      Boutwell AE, Allen SA, Rich JD. Opportunities to address the hepatitis C epidemic in the correctional setting. Clin Infect Dis 2005; 40 Suppl 5:S367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/99\">",
"      Allen SA, Spaulding AC, Osei AM, et al. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med 2003; 138:187.",
"     </a>",
"    </li>",
"    <li>",
"     Maruschak LM. HIV in prisons, 2004. Bureau of Justice Statistics, Washington, DC 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/101\">",
"      Baillargeon J, Kelley MF, Leach CT, et al. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Clin Infect Dis 2004; 38:e92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/102\">",
"      Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/103\">",
"      Tan JA, Joseph TA, Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology 2008; 48:1387.",
"     </a>",
"    </li>",
"    <li>",
"     Federal Bureau of Prisons. BOP Clinical practice guidelines for the management of methicillin-resistant Staphyloccus aureus (MRSA) infections October 2003. Federal Bureau of Prisons.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/105\">",
"      Turabelidze G, Lin M, Wolkoff B, et al. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis 2006; 12:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/106\">",
"      Lowy FD, Aiello AE, Bhat M, et al. Staphylococcus aureus colonization and infection in New York State prisons. J Infect Dis 2007; 196:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/107\">",
"      Main CL, Jayaratne P, Haley A, et al. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol 2005; 16:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/108\">",
"      Wootton SH, Arnold K, Hill HA, et al. Intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus skin infections in a correctional facility in Georgia. Infect Control Hosp Epidemiol 2004; 25:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/109\">",
"      Colsher PL, Wallace RB, Loeffelholz PL, Sales M. Health status of older male prisoners: a comprehensive survey. Am J Public Health 1992; 82:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/110\">",
"      Cropsey K, Eldridge GD, Ladner T. Smoking among female prisoners: an ignored public health epidemic. Addict Behav 2004; 29:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/111\">",
"      Carpenter MJ, Hughes JR, Solomon LJ, Powell TA. Smoking in correctional facilities: a survey of employees. Tob Control 2001; 10:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/112\">",
"      Lincoln T, Chavez RS, Langmore-Avila E. US experience of smoke-free prisons. BMJ 2005; 331:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/113\">",
"      Proescholdbell SK, Foley KL, Johnson J, Malek SH. Indoor air quality in prisons before and after implementation of a smoking ban law. Tob Control 2008; 17:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/114\">",
"      Lincoln T, Tuthill RW, Roberts CA, et al. Resumption of smoking after release from a tobacco-free correctional facility. J Correct Health Care 2009; 15:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/115\">",
"      Richmond RL, Butler T, Belcher JM, et al. Promoting smoking cessation among prisoners: feasibility of a multi-component intervention. Aust N Z J Public Health 2006; 30:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/116\">",
"      Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA 2009; 301:183.",
"     </a>",
"    </li>",
"    <li>",
"     European Monitoring Centre for Drugs and Drug Addiction. Annual report 2003: the state of the drugs problem in the European Union and Norway, Drug users in the criminal justice system: prisoners. Luxembourg Office for Official Publications of the European Communities, Luxembourg, Belgium 2003.",
"    </li>",
"    <li>",
"     Federal Bureau of Prisons. Federal Bureau of Prisons Clinical Practice Guidelines Detoxification of Chemically Dependent Inmates December 2000. Federal Bureau of Prisons.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/119\">",
"      Rich JD, Boutwell AE, Shield DC, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health 2005; 82:411.",
"     </a>",
"    </li>",
"    <li>",
"     Fletcher BW, Chandler RK. Principles of drug abuse treatment for criminal justice populations. NIH publication 06-5316, National Institute of Drug Abuse, Washington, DC 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/121\">",
"      Warren E, Viney R, Shearer J, et al. Value for money in drug treatment: economic evaluation of prison methadone. Drug Alcohol Depend 2006; 84:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/122\">",
"      Dolan KA, Shearer J, MacDonald M, et al. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend 2003; 72:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/123\">",
"      Baillargeon J, Binswanger IA, Penn JV, et al. Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatry 2009; 166:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/124\">",
"      Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees. Implications for public policy. Am Psychol 1991; 46:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/125\">",
"      Jordan BK, Schlenger WE, Fairbank JA, Caddell JM. Prevalence of psychiatric disorders among incarcerated women. II. Convicted felons entering prison. Arch Gen Psychiatry 1996; 53:513.",
"     </a>",
"    </li>",
"    <li>",
"     Mumola CJ. Medical Causes of Death in State Prisons 2001-2004. Bureau of Justice Statistics; Department of Justice, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/127\">",
"      Metzner J, Dvoskin J. An overview of correctional psychiatry. Psychiatr Clin North Am 2006; 29:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/128\">",
"      Stuckman-Johnson C, Struckman-Johnson D. Sexual coercion rates in seven midwestern prison facilities for men. Prison J 2000; 80:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/129\">",
"      Struckman-Johnson C, Struckman-Johnson D. Sexual coercion reported by women in three midwestern prisons. J Sex Res 2002; 39:217.",
"     </a>",
"    </li>",
"    <li>",
"     Bureau of Justics Statistics. Sexual victimzation in state and federal prisons reported by inmates, 2007. file://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&amp;iid=1149.",
"    </li>",
"    <li>",
"     Coolman A, Eisenman D. Sexual Assault: A Critical Health Care Issue. In: Correct Care, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/132\">",
"      Clarke JG, Adashi EY. Perinatal care for incarcerated patients: a 25-year-old woman pregnant in jail. JAMA 2011; 305:923.",
"     </a>",
"    </li>",
"    <li>",
"     www.nchc.org/resources/satements/womenshealth2005.html.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/134\">",
"      Knight M, Plugge E. The outcomes of pregnancy among imprisoned women: a systematic review. BJOG 2005; 112:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/135\">",
"      Clarke JG, Rosengard C, Rose JS, et al. Improving birth control service utilization by offering services prerelease vs postincarceration. Am J Public Health 2006; 96:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/136\">",
"      Mathew P, Elting L, Cooksley C, et al. Cancer in an incarcerated population. Cancer 2005; 104:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/137\">",
"      Binswanger IA, Stern MF, Deyo RA, et al. Release from prison--a high risk of death for former inmates. N Engl J Med 2007; 356:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/138\">",
"      Binswanger IA, White MC, P&eacute;rez-Stable EJ, et al. Cancer screening among jail inmates: frequency, knowledge, and willingness. Am J Public Health 2005; 95:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/139\">",
"      Williams BA, Goodwin JS, Baillargeon J, et al. Addressing the aging crisis in U.S. criminal justice health care. J Am Geriatr Soc 2012; 60:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/140\">",
"      Ginn S. Elderly prisoners. BMJ 2012; 345:e6263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/141\">",
"      Herbert K, Plugge E, Foster C, Doll H. Prevalence of risk factors for non-communicable diseases in prison populations worldwide: a systematic review. Lancet 2012; 379:1975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/142\">",
"      Wang EA, Pletcher M, Lin F, et al. Incarceration, incident hypertension, and access to health care: findings from the coronary artery risk development in young adults (CARDIA) study. Arch Intern Med 2009; 169:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/143\">",
"      Clarke JG, Hebert MR, Rosengard C, et al. Reproductive health care and family planning needs among incarcerated women. Am J Public Health 2006; 96:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/144\">",
"      Lin JT, Mathew P. Cancer pain management in prisons: a survey of primary care practitioners and inmates. J Pain Symptom Manage 2005; 29:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/145\">",
"      Crosby SS, Apovian CM, Grodin MA. Hunger strikes, force-feeding, and physicians' responsibilities. JAMA 2007; 298:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/146\">",
"      Oguz NY, Miles SH. The physician and prison hunger strikes: reflecting on the experience in Turkey. J Med Ethics 2005; 31:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/147\">",
"      Annas GJ. Hunger strikes at Guantanamo--medical ethics and human rights in a \"legal black hole\". N Engl J Med 2006; 355:1377.",
"     </a>",
"    </li>",
"    <li>",
"     The World Medical Association Policy: World Medical Association Declaration on Hunger Strikes. World Medical Association. Pilanesberg, South Africa, 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/149\">",
"      Linder JF, Meyers FJ. Palliative care for prison inmates: \"don't let me die in prison\". JAMA 2007; 298:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/150\">",
"      Williams BA, Sudore RL, Greifinger R, Morrison RS. Balancing punishment and compassion for seriously ill prisoners. Ann Intern Med 2011; 155:122.",
"     </a>",
"    </li>",
"    <li>",
"     National Commission on Correctional Health Care. Standards for Health Services in Prisons. Chicago, 2003.",
"    </li>",
"    <li>",
"     End-of-life care standards of practice for inmates in correctional settings. Innovations in End-of-Life Care. February 2000. Available at: www2.edc.org/lastacts/archives/archivesMay00/standards.asp (Accessed on September 13, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/153\">",
"      Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction 2003; 98:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/154\">",
"      Jones R, Gruer L, Gilchrist G, et al. Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999. Addiction 2002; 97:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/155\">",
"      Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ 1998; 316:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/156\">",
"      Merrall EL, Kariminia A, Binswanger IA, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/157\">",
"      Levinson NA. Psychologic facets of esthetic dental health care: a developmental perspective. J Prosthet Dent 1990; 64:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/158\">",
"      Lincoln T, Kennedy S, Tuthill R, et al. Facilitators and barriers to continuing healthcare after jail: a community-integrated program. J Ambul Care Manage 2006; 29:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/46/37610/abstract/159\">",
"      Williams BA, McGuire J, Lindsay RG, et al. Coming home: health status and homelessness risk of older pre-release prisoners. J Gen Intern Med 2010; 25:1038.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2776 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-4C9EBFD82E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37610=[""].join("\n");
var outline_f36_46_37610=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HEALTH SERVICES IN CORRECTIONAL FACILITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DEMOGRAPHICS (US DATA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INITIAL SCREENING AND ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Drug and alcohol withdrawal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Continuity of care for chronic conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Suicide prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chlamydia, gonorrhea, syphilis, and Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Testing for HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pregnancy testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Hepatitis C",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MANAGEMENT FOR SPECIFIC CONDITIONS AND POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Seizure disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      HIV prevalence, prevention, and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hepatitis A virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Hepatitis B virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Hepatitis C virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Methicillin-resistant Staphylococcus aureus (MRSA)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Tobacco use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Substance abuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Mental illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Sexual violence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1302394819\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12232669\">",
"      Geriatric populations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Healthcare maintenance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SPECIFIC ETHICAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Hunger strikes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      End of life care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      HEALTH RISKS ASSOCIATED WITH RELEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2776\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2776|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/9/1182\" title=\"figure 1\">",
"      Lifetime rate incarceration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2776|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/13/37083\" title=\"table 1\">",
"      Prevalence of disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/59/3004\" title=\"table 2\">",
"      Percent prevalent disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/25/11676\" title=\"table 3\">",
"      NIDA rx drug abusers ciminal justice",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=related_link\">",
"      An overview of asthma management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15607?source=related_link\">",
"      Developmental and behavioral implications for children of incarcerated parents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/31/4602?source=related_link\">",
"      Epidemiology, transmission, and prevention of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/55/15225?source=related_link\">",
"      General principles of insulin therapy in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/18/18728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/46/42728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/18/38186?source=related_link\">",
"      Geriatric health maintenance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/38/1641?source=related_link\">",
"      Hepatitis A virus vaccination and postexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/60/31690?source=related_link\">",
"      Hepatitis B virus vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3897?source=related_link\">",
"      Opioid intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7591?source=related_link\">",
"      Overview of hepatitis A virus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/38/36458?source=related_link\">",
"      Overview of medical care in adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=related_link\">",
"      Overview of preventive medicine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=related_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/51/24378?source=related_link\">",
"      Overview of the management of hepatitis B and case examples",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/39/632?source=related_link\">",
"      Prenatal care for incarcerated women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=related_link\">",
"      Screening for Chlamydia trachomatis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/24/25993?source=related_link\">",
"      Screening for unhealthy use of alcohol and other drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/34/10793?source=related_link\">",
"      Serologic screening for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/12/4298?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/52/29514?source=related_link\">",
"      Treatment of opioid abuse and dependence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_46_37611="Common causes violence";
var content_f36_46_37611=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common and dangerous causes of violent behavior",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Toxicologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol intoxication or withdrawal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stimulant intoxication (eg, methamphetamine, phencyclidine, cocaine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other drugs and drug reactions (eg, anabolic steroid, sedative-hypnotic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Metabolic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Neurologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intracranial lesion (eg, hemorrhage, tumor)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CNS infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seizure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dementia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other medical conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shock",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AIDS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypothermia; Hyperthermia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Psychiatric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Schizophrenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paranoid delusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Personality disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Antisocial behavior",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37611=[""].join("\n");
var outline_f36_46_37611=null;
var title_f36_46_37612="VIT schedules 1";
var content_f36_46_37612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F51030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F51030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Typical conventional dosing schedules for venom immunotherapy: Schedule 1",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Week",
"       </td>",
"       <td class=\"subtitle1\">",
"        Concentration, micrograms/mL",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume, mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monthly",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Injections are generally given weekly. The maintenance dose is achieved in most patients at week 15, after which the interval between injections is extended from weekly to every two weeks, and then to monthly. This schedule is based upon the package insert for Hollister-Stier venom extracts (Spokane, WA).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Reproduced with permission from: Golden DBK. Insect Allergy. In: Middleton's Allergy: Principles &amp; Practice, 7th ed, Adkinson NF Jr, Bochner BS, Busse WW, et al (Eds), Mosby Elsevier, Philadelphia 2009. Illustrations used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37612=[""].join("\n");
var outline_f36_46_37612=null;
var title_f36_46_37613="Wall thickness sudden death HCM";
var content_f36_46_37613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular wall thickness predicts sudden death in HCM",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 429px; height: 300px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 480 patients with a hypertrophic cardiomyopathy (HCM), the incidence of sudden death during a 6.5 year follow-up was directly related to maximal wall thickness. The incidence of sudden death almost doubled for each 5 mm increase in wall thickness.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Spirito, P, Bellone, P, Harris, KM, et al, N Engl J Med 2000; 342:1778.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37613=[""].join("\n");
var outline_f36_46_37613=null;
var title_f36_46_37614="Circadian rhythm in serum cortisol";
var content_f36_46_37614=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F61069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F61069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Circadian rhythm in serum cortisol",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 427px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Circadian rhythm in serum cortisol concentrations in two normal subjects. Blood samples were drawn every 20 to 30 minutes. The shaded areas indicate the hours of the day during which the lights were turned out. To convert serum cortisol values to nmol/L, multiply by 27.6.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Weitzman ED, Fukushima DK, Nogeire C, et al. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects.&nbsp;J Clin Endocrinol Metab. 1971; 33:14.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37614=[""].join("\n");
var outline_f36_46_37614=null;
var title_f36_46_37615="Conjunctival suffusion in Staphylococcal toxic shock syndrome";
var content_f36_46_37615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Conjunctival suffusion in Staphylococcal toxic shock syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Conjunctival suffusion in a patient with staphylococcal toxic shock syndrome (TSS).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles V Sanders. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_46_37615=[""].join("\n");
var outline_f36_46_37615=null;
